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ABSTRACT 
BRANDON DOUGLAS BURCH:  The Use of Reporters to Identify Factors Involved in 3’ 
End Processing of Nonpolyadenylated RNA Polymerase II Transcripts 
(Under the direction of Dr. William F. Marzluff) 
 
 Metazoan replication-dependent histone mRNAs are unique in that, unlike other 
mRNAs in the cell, they are not polyadenylated, ending instead in a conserved 3’ stem loop.  
Because histone pre-mRNAs do not contain introns, they require only a single 
endonucleolytic processing event to form the mature histone mRNA.  The reaction that forms 
the 3’ end of histone mRNAs requires an assembly of several factors, including the stem loop 
binding protein (SLBP) and the U7 snRNP, which contains U7 snRNA, two U7 snRNP-
specific ring proteins, Lsm10 and Lsm11, and, in mammals, ZFP100.  This complex on the 
pre-mRNA recruits a cleavage factor that contains CPSF73, CPSF100, Symplekin, and 
possibly other factors, which cleaves the histone pre-mRNA.  However, the full composition 
of the processing complex remains incompletely defined.  Here I describe the creation and 
use of reporter constructs to identify factors that are required for histone pre-mRNA 3’ end 
formation in Drosophila, as well as other reporters to investigate histone transcription and the 
3’ end formation of another RNA polymerase II transcript, U7 snRNA.  Further, I present the 
results of a reporter-based genome-wide RNAi screen to identify factors required for histone 
pre-mRNA processing.  In this study, we identified 24 proteins that have some role in the 
production of mature histone mRNA, most of which had not been implicated before.  Finally, 
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I describe the characterization of the Drosophila ortholog of FLASH, a newly discovered 
processing factor that binds to Lsm11.  Through biochemical studies, I have defined the 
regions of Lsm11 required to bind FLASH and the regions of FLASH required to bind 
Lsm11.  I have also determined that the binding interaction between dFLASH and dLsm11 is 
not required for recruitment of dFLASH to the histone locus body (HLB).  I have used 
reporters to help characterize the function of dFLASH in Drosophila cultured cells.  These 
studies have demonstrated that removing a portion of the N-terminus of FLASH results in a 
protein that acts as a dominant negative for histone pre-mRNA processing in vivo, 
presumably because it binds Lsm11 but cannot interact with other essential factors for 
processing.   
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CHAPTER I 
INTRODUCTION 
 
Among the most important events occurring within a mitotic cell is duplication of its 
genome in anticipation of cellular division.  This process is strictly governed by a host of 
regulatory mechanisms that ensure not only the fidelity of the DNA sequence but further, that 
the genome is replicated once and only once per cell cycle.  These controls include factors 
and pathways that monitor the timing and level of replication, as well as any introduction of 
damage to the DNA.  If perturbations are detected, these factors allow the cell to mount a 
proper response to repair the damage.  Using these control mechanisms, a normal cell is able 
to proceed efficiently through an entire cell cycle, the culmination of which is its division 
into two identical daughter cells. 
Closely linked to DNA replication is the production of replication-dependent histone 
proteins during S phase of the cell cycle (Robbins and Borun, 1967; Spalding et al., 1966).  
These proteins are required for packaging the newly synthesized DNA into a highly 
condensed form within the nucleus and they play a crucial role in gene expression through 
covalent modifications that culminate in the histone code (Strahl and Allis, 2000).  There are 
five classes of replication-dependent histone proteins, including core histones H2A, H2B, 
H3, and H4 that comprise the histone octamer and histone H1, which acts as a linker protein 
outside the core octamer.  The histone octamer and 146 nt of the newly replicated DNA make 
up the basic unit of chromatin, known as the nucleosome.  Nucleosomes are linked together 
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by another histone protein, histone H1.  At this level of compaction, the chromatin fiber, 
often referred to as “beads on a string,” is approximately 10 nm in diameter.  These fibers 
further condense into higher order chromatin structures, including 30nm fibers and 300nm 
fibers, finally culminating in the most compacted form, the chromosome. 
 
THE ROLE OF HISTONE PROTEINS IN GENE REGULATION 
Protruding from the octamer are the N-terminal tails of the histone proteins, which 
participate not only in facilitating higher order chromatin structures (Peterson and Laniel, 
2004), but also play a key role in gene regulation.  These tails are approximately 20-35 amino 
acids in length, contain a large number of basic amino acids, and are the target of various 
posttranslational modifications that have been collectively dubbed the histone code (Lopez-
Rodas et al., 1993; Tordera et al., 1993; Turner, 1993; Loidl, 1994; Mizzen et al., 1998; 
Strahl and Allis, 2000).  These modifications are crucial for defining regions of active 
chromatin and gene transcription and, conversely, for demarcating heterochromatic regions 
of the genome (Peters et al., 2001; Shiio and Eisenman, 2003).  This complex system of gene 
expression allows for a greater diversity of outcomes and control than would be possible 
from the DNA alone. 
There are several types of posttranslational modifications that have been described for 
histone tails, including acetylation (Allfrey et al., 1964; Grunstein, 1997; Kuo and Allis, 
1998), methylation (Jenuwein and Allis, 2001; Peters et al., 2001), phosphorylation (Roth 
and Allis, 1992; Dou and Gorovsky, 2000; Ren and Gorovsky, 2001; Peterson and Laniel, 
2004), ubiquitination (Robzyk et al., 2000; Henry et al., 2003; Hwang et al., 2003; Wood et 
al., 2003), sumolyation (Shiio and Eisenman, 2003), biotinylation (Stanley et al., 2001; 
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Camporeale et al., 2004), and ADP-ribosylation (Ueda et al., 1975; Burzio et al., 1979; 
Riquelme et al., 1979).  These modifications are not stand-alone signaling marks, however, 
as the same modification can lead to different gene expression outcomes, indicating that this 
code is context-dependent and likely multi-layered.  Indeed, it appears that not only a 
particular modification, but other surrounding modifications on the same molecule and 
within the same nucleosome and the topology of the chromatin in the region are crucial for 
achieving a given readout.  As a result, there has been a suggestion to change the term 
“histone code” into the more inclusive “chromatin code” (Benecke, 2006). 
In addition to posttranslational modification of canonical histone proteins, 
incorporation of variant histone proteins into the chromatin adds yet another level of 
complexity to chromatin structure and gene regulation.  Unlike replication-dependent histone 
proteins, expression of the variant histones is not linked to DNA replication.  Indeed, these 
proteins are constitutively expressed throughout the cell cycle (Wu et al., 1981).  Further, the 
genes that encode the variant histones, unlike replication-dependent histone genes, give rise 
to mRNAs that are polyadenylated, many of which also contain introns (Engel et al., 1982; 
Woudt et al., 1983; Brush et al., 1985).  Because of this, expression of replication-
independent histone genes is not regulated like the replication-dependent histone genes 
(Sittman et al., 1983).  These histone variants participate in a wide array of important 
regulatory mechanisms in the cell, including activation or repression of gene expression, 
response to DNA damage, and formation of chromosomal structures like centromeres. 
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HISTONE EXPRESSION IS LINKED TO THE CELL DIVISION CYCLE AND DNA 
REPLICATION 
The eukaryotic cell division cycle is a highly regulated temporal program that allows 
a cell to replicate its genome and other cellular components and separate these into two new 
daughter cells.  The canonical cell cycle consists of two phases, interphase and mitosis, each 
divided into smaller subphases.  Directly after the cell divides, each new daughter cell enters 
interphase.  This phase consists three subphases, the first of which is a gap phase, termed G1, 
in which the cell assembles all the factors it will require to initiate and sustain genome 
replication.  Next, the cell enters a synthesis (S) phase, which is a time of genome duplication 
and cell growth.  Interphase then concludes with one more gap phase (G2), in which the cell 
prepares to enter mitosis.  Mitosis is itself comprised of several subphases, each 
corresponding to a particular state of genomic separation.  These phases are known as 
prophase (chromosome condensation and nuclear envelope breakdown), metaphase 
(alignment of chromosome along the metaphase plate by spindle fibers radiating from 
duplicated centrosomes, one in each pole of the cell), anaphase (separation of sister 
chromatids and migration toward the spindle poles), and telophase (reformation of the 
nuclear envelope around the segregated chromosomes).  In normally cycling cells, these steps 
are directly followed by cytokinesis, in which the cell divides into two daughter cells, and the 
cell cycle resets to G1. 
Among the most critical and highly regulated steps within the cell replication cycle is 
duplication of the genome during S phase.  It is imperative that the cell accurately and 
efficiently replicate its DNA before entering mitosis; otherwise, catastrophic consequences 
may ensue, including DNA damage, genomic instability, and cell death.  However, accurate 
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replication of the cell’s DNA is not enough; indeed, the cell must replicate its entire 
chromatin, which requires proper coordination of DNA synthesis levels with production of 
canonical histones.  For this reason, there are a number of cellular controls that monitor not 
only proper initiation, fidelity, and termination of DNA replication, but also the state of the 
chromatin environment within the cell. 
The cell prepares for DNA replication during G1 phase with the identification of 
replication origins.  In budding yeast, these origins consist of special sequences, known as 
autonomously replicating sequences (ARS) (Brewer and Fangman, 1987; Huberman et al., 
1988;  Marahrens and Stillman, 1992), that are around 100-200 basepairs long, contain well 
conserved sequence elements, and are spaced approximately every 30 kilobases throughout 
the genome (Bell, 1995).  In higher eukaryotes, the replication origins are poorly defined, and 
the location and identity of the origins appears to be more stochastic, possibly relying more 
on the local chromatin environment than a particular conserved sequence (DePamphilis, 
1993; Bogan et al., 2000; Bell, 2002; Antequera, 2004; Schwob, 2004; Cvetic and Walter, 
2005; MacAlpine and Bell, 2005; Marheineke et al., 2005).  In all eukaryotes, the replication 
origins are bound by the multisubunit origin recognition complex (ORC), which acts as a 
marker of replication origins (Bell and Stillman, 1992; Diffley and Cocker, 1992; 
Romanowski et al., 1996; Rowles et al., 1996; Carpenter et al., 1996; Dutta and Bell, 1997; 
Lee and Bell, 1997).  Once the ORC has identified the origin, Cdc6 (Coleman et al., 1996) 
and Cdt1 (Hofmann and Beach, 1994; Nishitani et al., 2000) are recruited, which in turn are 
responsible for recruiting the Mcm complex, possibly through ATPase-induced 
conformational changes in ORC (Chong et al., 1995; Kubota et al., 1997; Nishitani et al., 
2000).  The MCM complex contains the helicase activity that will unwind the DNA for 
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replication (Koonin, 1993) and its recruitment to the replication origin completes the 
formation of the pre-replicative complex (pre-RC) (Blow and Dutta, 2005). 
Formation of the pre-RC is regulated by several proteins that ensure the proper timing 
of DNA replication during the cell cycle.  One of these, geminin, binds Cdt1 and inhibits its 
ability to associate with ORC (McGarry and Kirschner, 1998; Wohlschlegel et al., 2000).  
During G1, geminin levels are reduced through ubiquitination by the anaphase promoting 
complex (APC) (McGarry and Kirschner, 1998), which targets geminin for degradation (Li 
and Blow, 2004), allowing Cdt1 to bind to ORC.   In addition, other proteins, including 
cyclin dependent kinases, are involved in regulating pre-RC formation and reformation, 
likely through phosphorylation of Cdt1, which targets this protein for ubiquitiation and 
destruction.  This function is especially important during S phase to prevent rereplication of 
DNA sequences. 
Once the pre-RC has been formed and the cell has prepared for entry into S phase, an 
activated cyclinE/Cdk2 complex (Jackson et al., 1995) results in activation of the S phase 
cyclinA/Cdk2 complex, which is partially responsible for activating replication origins 
(Girard et al., 1991).  In addition to cyclinA/Cdk2, activation of another protein kinase, 
Cdc7, through its interaction with Dbf4, is required (Bousset and Diffley, 1998; Donaldson et 
al., 1998).  In this complex, Dbf4 not only stimulates Cdc7 kinase activity, but may also 
target Cdc7 to replication origins, allowing for phosphorylation of Mcm components.  
Importantly, at about the same time as the replication origins are being activated, a critical 
component for histone expression, NPAT, is also activated by cyclin E/Cdk2 
phosphorylation (Ma et al., 2000), linking the processes of DNA replication and histone 
synthesis. 
7 
 
As S phase begins, other proteins localize to the pre-RC, including Mcm10 (Merchant 
et al., 1997; Aves et al. ,1998; Homesley et al., 2000), the Cdc45 complex (Aparicio et al., 
1999), Dbp11/TopBP1 (Kamimura et al., 1998; Kumagai et al., 2006; Pospiech et al., 2010), 
and the GINS complex (Takayama et al., 2003), thus forming the preinitiation complex.  The 
preinitiation complex recruits DNA polymerases, including the primase (DNA pol α), which 
interacts with Cdc45 and Mcm10, pol ε, which is bound by Dpb11, and pol δ (Aparicio et al., 
1999; Walter and Newport, 2000; Ricke and Bielinsky, 2004).  DNA pol α is responsible for 
creating replication primers at the start of replication (Spadari and Weissbach, 1975; 
Conaway and Lehman, 1982), while pol δ (Byrnes et al., 1976) and pol ε (Syväoja et al., 
1990) extend these primers and continue replicating the leading and lagging strands at the 
replication fork. 
Organization of the Histone Genes in Mammals and Flies 
 Along with regulation of DNA synthesis, histone expression is also regulated, with 
much of this regulation taking place at the site of the histone genes.  The general organization 
of histone genes has been conserved in metazoans, with these genes existing in multi-gene 
clusters that make up a histone locus.  Though the clustered nature of the histone genes is 
well conserved, the precise location of these genes and the number of histone genes encoded 
in the genome is not.  In mammals, there are approximately 75 replication-dependent histone 
genes encoded in the genome, existing primarily in two major clusters covering over two 
megabases of DNA (Green et al., 1984; Tripputi et al., 1986).  In contrast, the Drosophila 
genome contains only five replication-dependent histone genes.  These genes are located 
together on chromosome 2 and are arranged in an approximately 5 kb cluster (Fig. 1) that is 
tandemly repeated about100 times (Lifton et al., 1978). 
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The organization of the histone genes into a histone gene cluster likely offers the cell 
the ability to rapidly modulate histone expression levels by targeting a single location in the 
genome, rather than several.  This may be especially important during periods of replication 
stress or DNA damage, when histone levels must be reduced quickly.  One important feature 
of the Drosophila histone gene cluster are cryptic polyadenylation signals within the 
intergenic regions downstream of the normal cleavage site (Fig. 1).  These signals are used if 
normal histone pre-mRNA processing becomes disrupted and probably evolved in response 
to the close proximity of the histone genes to each other as a way to insulate them from 
transcriptional readthrough and prevent the creation of chimeric histone proteins. 
The Histone Locus Body 
During G1 phase, assembly of a subnuclear structure, known as the histone locus 
body (HLB), occurs at the site of the histone genes.  This body has been best described in 
Drosophila (Liu et al., 2006).  There is clearly also an HLB in mammalian cells, although 
this was first described as a Cajal body localized near histone genes (Frey and Matera, 1995).  
A primary component of this structure is the p220NPAT protein, found only at histone genes in 
mammals, which forms discrete foci at the histone locus during mid-G1 phase and around 6 
hours before the onset of S phase in normally cycling mammalian cells (Zhao et al., 2000; 
Ma et al.; 2000; Zheng et al., 2003; Ghule et al., 2008).  Just before the G1/S transition, 
NPAT becomes phosphorylated by cyclin E/Cdk2 and remains phosphorylated into S phase 
(Ma et al., 2000).  In this form, NPAT promotes transcription of histone genes during S 
phase (Ma et al., 2000; Wei and Harper, 2003).  Since NPAT is phosphorylated by the same 
cyclin/Cdk that promotes DNA replication uncovers an important link between histone 
expression and DNA synthesis.  In addition, it provides a key regulatory mechanism within S 
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phase, as inhibition of DNA synthesis results in dephosphorylation of NPAT and its 
subsequent delocalization from the HLB (Su et al., 2004).  As a result, histone expression 
decreases, preventing the accumulation of excess histone proteins under these conditions.  
Similarly, inhibiting histone expression causes a concomitant decrease in DNA replication, 
further suggesting a tight link between these two processes. 
In addition to NPAT, the HLB contains many of the factors that are required for 
transcribing the histone genes and processing the 3’ end of the pre-mRNAs to form mature 
histone mRNAs.  Each of these factors, then, represents a potential target for regulation.  
These include the U7 snRNP and the protein FLASH, identified as a putative transcription 
factor that colocalizes with NPAT in mammalian cells (Barcaroli et al., 2006).  In contrast, 
SLBP, which is required for  the cleavage reaction that leads to the formation of mature 
histone mRNA, is not concentrated in the HLB.  In mammals, SLBP protein is cell cycle 
regulated, with its highest levels of expression occurring from the G1/S phase transition 
through S phase (Whitfield et al., 2000).  At the end of S phase, this protein becomes 
degraded, effectively downregulating histone expression.  In this way, SLBP provides 
another important link between histone expression and the cell cycle. 
 
REGULATION OF REPLICATION-DEPENDENT HISTONE EXPRESSION 
Given the importance of the canonical replication-dependent histone proteins for 
DNA compaction and gene expression, expression of the histone genes is highly regulated 
(Fig. 2).  This regulation ensures proper levels of histone proteins during S phase and 
prevents expression of these proteins outside of S phase.  Aberrant expression of histone 
proteins results in catastrophic consequences for the cell, including chromosome loss in yeast 
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(Meeks-Wagner and Hartwell, 1986), DNA damage in mammals (Ye et al., 2003), and 
developmental arrest in Drosophila (Sullivan et al., 2001).  In support of a tight linkage 
between histone expression and DNA replication, it has been observed that blocking histone 
synthesis inhibits DNA replication (Nelson et al., 2002) and further, that blocking DNA 
replication correspondingly inhibits histone expression (Sittman et al., 1983; Heintz et al., 
1983; Baumbach et al., 1987).  Because of the tight association, several targets for histone 
expression regulation have evolved that help ensure proper coordination of histone 
expression with DNA replication and the cell cycle. 
Histone Gene Transcription 
 Regulation of histone expression occurs largely at the mRNA level, being both 
transcriptional and post-transcriptional.  Overall, an increase in the transcription of histone 
genes accounts for 3.5-fold of a total 35-fold increase in total histone message upon entry 
into S phase in mammals (Harris et al., 1991), making it a highly significant control target 
for histone expression.  Such control likely stems from cell cycle regulation of HLB 
formation and the existence of of histone-specific transcription factors.   Despite these unique 
regulatory properties, transcription of histone genes also shares common factors with 
transcription of non-histone mRNA.  Histone mRNAs are, like other mRNAs in the cell, 
transcribed by DNA-dependent RNA polymerase II.  Further, these messages become 
modified at their 5’ ends by a 7-methyl-guanisine cap that is added cotranscriptionally and is 
required for translation of the message in the cytoplasm.   
As the first step in histone expression (Fig. 3), histone gene transcription presents a 
key target for regulation.  Regulation of histone transcription occurs in a cell cycle-dependent 
manner.  At the G1/S phase transition, NPAT, which localizes to the site of the histone genes, 
11 
 
becomes phosphorylated.  As S phase begins, histone mRNA transcription by DNA-
dependent RNA polymerase II increases (DeLisle et al., 1983; Heintz et al., 1983), likely due 
to the interaction of transcription factors with specific sequence elements within histone gene 
promoters (LaBella et al. 1988; Heintz, 1991) or within the coding region itself (Hurt et al., 
1991; Bowman and Hurt 1995; Eliassen et al., 1998).  A few transcriptional regulators have 
been identified, including factors such as YY1 (Palko et al., 2004) and NPAT (Zhao et al., 
2000), as well as some subtype-specific factors, including the NPAT-interacting proteins 
HiNF-P (Mitra et al., 2003) for histone H4 and OCA-S for histone H2B (Zheng et al., 2003).  
The most recent addition to our understanding of histone transcription is from a study in 
Drosophila revealing the recruitment of POU-domain protein in D. melanogaster 1 (Pdm-1) 
to elements within core histone promoters (Lee et al., 2010).  Together with dmOct-1 
coactivator in S-phase (dmOCA-S), this protein localizes to the HLB only during S phase, 
permitting transcription from the core histone promoters and helping to regulate their S 
phase-specific expression (Lee et al., 2010). 
Central to the regulation of histone expression is the coordination of this process with 
rates of DNA synthesis during S phase.  Indeed, when cultured cells are treated with the 
DNA replication inhibitors hydroxyurea or cytosine arabinonucleoside, histone gene 
transcription is reduced by 80 % (Sittman et al., 1983).  As mentioned above, one of the most 
solid links between histone expression and DNA replication occurs at the level of 
transcription and involves NPAT, a transcriptional regulator of histone transcription in 
mammalian cells that localizes to the HLB from mid-G1 through S phase (Zhao et al., 2000; 
Ma et al., 2000; Zheng et al., 2003, Ghule et al., 2008).  NPAT expression is regulated by the 
E2F transcription factor (Gao et al., 2003), with the highest levels of NPAT mRNA achieved 
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at the G1/S boundary (Gao et al., 2003; Zhao et al., 1998).  NPAT is activated at the end of 
G1 through phosphorylation by the cyclin E-Cdk2 complex (Zhao et al., 1998; Zhao et al., 
2000; Ma et al., 2000), which is itself activated in late G1 and is crucial for S-phase entry 
(Morgan, 1997; Ekholm and Reed, 2000; Roberts and Sherr, 2003).  In addition to linking 
histone transcription to DNA replication under normal conditions, NPAT also does so after 
DNA damage (Su et al., 2004).  Upon exposure of cells to ionizing radiation, DNA 
replication is inhibited and histone mRNA levels are significantly decreased (Su et al., 2004).  
These responses coincide with dephosphorylation of NPAT and its dissociation from the 
histone locus (Su et al., 2004), suggesting coupling through NPAT.  The dephosphorylation 
of NPAT occurs in a p53 and p21CIP1/WAF1-dependent manner and likely results from 
inhibition of cyclin E/Cdk2 upon DNA damage (Su et al., 2004).  Indeed, using chemical 
Cdk2 inhibitors without the presence of DNA damage results in the same loss of NPAT from 
the HLB and downregulation of histone expression (Su et al., 2004). 
Histone pre-mRNA Processing 
 Upon entry into S phase in mammals, there is a net 35-fold increase in histone mRNA 
expression, of which, only 3.5-fold is related to transcription, while the majority, around 10-
fold, occurs at the level of histone pre-mRNA processing (Harris et al., 1991).  There is a 
single processing reaction that involves cleavage of a longer histone transcript, the histone 
pre-mRNA, to form the mature histone mRNA (Birchmeier et al., 1984; Krieg and Melton, 
1984; Fig. 3).  Histone pre-mRNAs do not contain any introns and as such, this single 
endonucleolytic event is all that is required to form the mature histone mRNA (Fig. 4).  The 
cleavage reaction occurs cotranscriptionally (Adamson and Price, 2003) and, while 
reminiscent of the reaction required for processing polyadenylated mRNAs, requires a unique 
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complement of cis sequences and trans factors.  The result is a histone mRNA with a 4-5 nt 
ssRNA overhang that remains nonpolyadenylated.  Following the cleavage reaction, the 3’ 
end of the histone mRNA is further trimmed to a 2-3 nt overhang, most likely by the 3’hExo 
(Dominski et al., 2003a; Yang et al., 2006).  The mature 3’ end of the histone message 
formed by the cleavage reaction is important for downstream events in histone mRNA 
metabolism, including export of the histone mRNA from the nucleus (Eckner et al., 1991; 
Sullivan et al., 2009a) and its subsequent translation (Sun et al., 1992) and degradation 
(Pandey and Marzluff, 1987) in the cytoplasm, as well as coordination of histone mRNA 
levels with DNA synthesis (Levine et al., 1987). 
Histone mRNA Export 
 Once the histone pre-mRNA has been processed, forming the mature histone mRNA, 
it must be exported from the nucleus into the cytoplasm, where it will be translated (Fig. 3).  
Export of histone mRNAs is not well characterized, but certain details are known.  Export is 
a very rapid process (Schochetman and Perry, 1972) that requires the presence of the mature 
histone mRNA 3’ end (Eckner et al., 1991; Sun et al., 1992; Williams et al., 1994) and SLBP 
(Sullivan et al., 2009a).  In addition, other factors, such as the SR proteins 9G8 and SRp20 
may have a role in histone mRNA export, as binding sequences for these proteins have been 
found within the histone ORF and these factors are known to have a role in exporting 
intronless RNAs in both mammalian cells and Xenopus oocytes (Huang and Steitz, 2001).  
These proteins each contain an RNA recognition motif that is adjacent to a positively-
charged, arginine-rich region that facilitates interaction with the export factor Tip-associated 
protein (TAP) (Hargous et al., 2006).  In agreement with this, export of histone mRNA has 
been shown to require the activity of TAP (Erkmann et al., 2005), which functions in export 
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by traversing the nuclear pore complex (NPC) through interactions with NPC proteins 
(Katahira et al., 1999; Bachi et al., 2000). 
Histone mRNA Translation 
 Once the mature histone mRNA has been successfully exported to the cytoplasm, it is 
translated (Fig. 3).  For polyadenylated messages, this process requires the presence of both 
the 5’ cap and the poly(A) tail (Gallie, 1991), which is bound by poly(A) binding protein 
(PABP).  These components participate in the circularization of the mRNA (Wells et al., 
1998), which stabilizes the message and facilitates efficient turnover of terminating 
ribosomes.  Circularization is made possible by interactions between the cap structure and 
eIF4E, which interacts with eIF4G, which itself interacts with the PABP bound to the 
poly(A) tail (Imataka et al., 1998).  Though histone mRNAs are translated via a similar 
mechanism (Cakmakci et al., 2008) and do contain the 5’ cap, they do not have a poly(A) 
tail, ending instead in a stem loop structure that is bound by SLBP.  This means the histone 
3’ end/SLBP complex must interact with some other factor, other than PABP, that allows 
interaction with eIF4G and circularization of the histone mRNA. 
 The mature histone mRNA 3’ end is required for localization of histone mRNA to 
polyribosomes (Sun et al., 1992), where it is associated with SLBP (Whitfield et al., 2004).   
SLBP stimulates translation of histone message both in vitro and in vivo (Sanchez and 
Marzluff, 2002) and is required for binding another translation factor, SLBP-interacting 
protein 1 (SLIP1), which is itself required for efficient translation of histone mRNA 
(Cakmakci et al., 2008).  It is likely that this factor performs the function for histone mRNA 
translation that PABP performs for polyadenylated mRNAs, to bridge the 5’ and 3’ ends of 
the mRNA to facilitate circularization and efficient translation of the message. 
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Histone mRNA Degradation/Stability 
 At the end of S phase or in response to inhibiting DNA replication or the introduction 
of DNA damage, histone mRNA half-life is reduced from 45-60 minutes to around 10 
minutes, and the mRNA is rapidly degraded (Sittman et al., 1983; Fig. 2; Fig. 3).  In a normal 
cell that has reached the end of S phase, this mechanism of degradation prevents aberrant 
expression of histone proteins as the cell enters G2 of the cell cycle.  In a damaged or 
arrested cell, degradation of histone message prevents the toxic accumulation of excess 
histone proteins.  This gives the cell the chance to mount a proper response to the damage 
before allowing DNA replication and histone synthesis to proceed.  A common way to 
induce histone mRNA degradation is to treat cells with a DNA synthesis inhibitor such as 
hydroxyurea or aphidicolin. 
 Histone mRNA is degraded by a mechanism that requires active translation (Graves 
et al., 1987), a correctly spaced stem loop close to the termination codon and the presence of 
SLBP (Kaygun and Marzluff, 2005a).  The nonsense mediated decay (NMD) factor Upf1 is 
also required for histone mRNA degradation and is recruited to the histone mRNA 3’ end by 
SLBP at the end of S phase or when DNA replication has been inhibited (Kaygun and 
Marzluff, 2005b).  Further, both ataxia telangiectasia and Rad3 related (ATR) (Kaygun and 
Marzluff, 2005b) and DNA-activated protein kinase (DNA-PK) (Müller et al., 2007) are 
involved in controlling histone mRNA degradation in response to replication stresss.  It is 
likely that these proteins are required for degradation of histone mRNA under stress 
conditions through a mechanism that involves phosphorylation of Upf1, but not necessarily 
SLBP (Kaygun and Marzluff, 2005b; Müller et al., 2007).  These replication stress response 
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proteins may represent two pathway of histone mRNA degradation control are not 
completely redundant (Müller et al., 2007). 
 Once hyperphosphorylated Upf1 is recruited to the histone mRNA via its interaction 
with SLBP, Upf1 likely mediates recruitment of a terminal uridyl transferase (TUTase) that 
catalyzes the addition of a short poly(U) tail onto the 3’ end of the histone message (Mullen 
and Marzluff, 2008).  Following this, the oligo(U) tail becomes bound by the Lsm1-7 
complex, which recruits the decapping complex, leading to 5’-3’ degradation of the histone 
mRNA.  In addition, it is probable that the exosome is recruited to the degradation complex, 
facilitating 3’-5’ degradation of the histone message.  Once the Lsm1-7 complex has been 
recruited, the histone mRNA is likely degraded by the same mechanism as other mRNAs.  
Indeed, evidence for both mechanisms of decay has been attained for histone mRNAs 
(Mullen and Marzluff, 2008). 
 
FACTORS REQUIRED FOR HISTONE PRE-MRNA PROCESSING 
 The focus of this dissertation primarily lies on the histone pre-mRNA processing 
reaction and identification of the many factors that are required to facilitate cleavage.  When 
I started this project, the two cis elements, the stem loop and histone downstream element 
(HDE) were known and it was known that they bound two factors, SLBP and the U7 snRNP, 
respectively, that are essential for processing (Fig. 5A).  Further, an additional factor, 
ZPF100, which in mammals binds to both SLBP and the U7 snRNP protein, Lsm11, had 
been described.  However, the nuclease was not known at the time.  Since then, our 
understanding of histone pre-mRNA processing and the factors that participate in it has 
grown (Fig. 5B).  Now we know that a core cleavage factor, comprised of CPSF73, 
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CPSF100, Symplekin, and potentially other factors, is recruited to the site of cleavage, 
though the mechanism by which this recruitment occurs is currently unknown.  Another 
protein, FLASH, which makes contacts with the long N-terminus of Lsm11, has also been 
shown to be essential for the cleavage reaction.  In addition, many more factors have been 
implicated for a role in the cleavage reaction and await characterization. 
The Stem Loop and Histone Downstream Element 
 There are two sequence elements within the histone pre-mRNA that are required for 
the processing reaction to occur and which have been conserved in metazoans (Marzluff, 
1992) from sea urchin (Birchmeier et al., 1982; Birchmeier et al., 1983; Birchmeier et al., 
1984) to mammals (Birchmeier et al., 1984; Mowry and Steitz, 1987; Cotten et al., 1988; 
Mowry et al., 1989; Vasserot et al., 1989).  These sequences lie less than 100 nucleotides 
downstream of the stop codon and include a stem loop structure 4-5 nt upstream of the 
cleavage site and a U-rich element 15-20 nt downstream of the stem loop known as the 
histone downstream element (HDE; Fig. 4). 
The stem loop structure is highly conserved both among the various histone mRNAs 
within a single organism and also between metazoans.  This structure consists of a stem that 
is 6 basepairs in length and a 4-nt loop.  The stem loop is cotranscriptionally bound by stem 
loop binding protein (SLBP), also known as hairpin binding protein (HBP).  Together, the 
stem loop and SLBP are required for processing histone pre-mRNA (Dominski et al., 1995; 
Hanson et al., 1996; Wang et al., 1996; Wang et al., 1999; Zanier et al., 2002) and other 
aspects of histone mRNA metabolism including nuclear export (Eckner et al., 1991; Sun et 
al., 1992; Williams et al., 1994; Sullivan et al., 2009a), translation (Sun et al., 1992; Sanchez 
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and Marzluff, 2002, Whitfield et al., 2004,Cakmakci et al., 2008) and degradation (Kaygun 
and Marzluff, 2005a).   
The second critical cis element, the HDE, resides approximately 15-20 nucleotides 
downstream of the stem loop.  The sequence of the HDE is somewhat variable between 
metazoans, and between individual histone genes in the same species, although the core of 
the sequence, containing a region rich in purine residues, is much better conserved 
(Birchmeier et al., 1983; Birnstiel et al., 1985; Mowry and Steitz, 1987; Cotten et al., 1988; 
Mowry et al., 1989).  The role of the HDE in the histone pre-mRNA processing reaction is to 
bind the U7 snRNP particle, which is essential for the cleavage reaction to occur.  This 
interaction occurs through basepairing interactions between the HDE and the 5’ end of the 
U7 snRNA component of the U7 snRNP.  Because of this important interaction, the identity 
of the bases within this HDE, as well as the location of the HDE within the histone pre-
mRNA, are crucial for correct processing to occur.  Indeed, mutation of the sequence 
(Mowry et al., 1989; Vasserot et al., 1989) or moving the sequence downstream of its normal 
location (Georgiev and Birnstiel, 1985; Scharl and Steitz, 1994; Scharl and Steitz, 1996) 
leads to inefficient or abolished cleavage. 
SLBP 
 The histone stem loop structure is bound by the stem loop binding protein (SLBP; 
Fig. 5), which participates in multiple aspects of histone mRNA metabolism, including 
histone pre-mRNA processing, export, translation, and degradation (Fig. 3).  Its role in 
processing is essential in vivo (Pandey et al., 1994; Lanzotti et al., 2002) and is mediated in 
part by its ability to bind the stem loop structure near the 3’ end of the histone pre-mRNA.  
This interaction requires a unique RNA binding domain (RBD) that is approximately 70 
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amino acids in length and is located in the central portion of the protein.  Once bound to the 
stem loop, SLBP interacts indirectly with the U7 snRNP and stabilizes its interaction with the 
histone pre-mRNA substrate, thus facilitating the cleavage reaction (Melin et al., 1992; Streit 
et al., 1993; Spycher et al., 1994; Dominski et al., 1999). 
 Expression of SLBP is tightly linked to the cell cycle in mammals, with levels highest 
from the end of G1 through S phase, then rapidly declining at the end of S phase (Whitfield 
et al., 2000; Fig. 2).  Reduction of SLBP levels at the end of S phase is a result of 
phosphorylation of two threonine residues located at amino acids 60 and 61 (Zheng et al., 
2003; Koseoglu et al., 2008), with phosphorylation of T60 by casein kinase 2 (CK2) and T61 
by cyclinA/Cdk1 (Koseoglu et al., 2008).  Destruction of SLBP at the end of S phase is 
coincident with histone mRNA degradation during this time.  In this way, mammalian SLBP 
represents a key regulatory target that helps coordinate the cell cycle regulation of histone 
expression.  In contrast to the mammalian protein, however, Drosophila SLBP exists 
throughout the cell cycle, at least during development (Lanzotti et al., 2004), suggesting that 
these cells likely utilize an alternative mode of regulating the cell cycle expression of histone 
proteins. 
U7 snRNP 
 The histone downstream element (HDE) acts as a binding site for the U7 snRNP 
complex via basepairing with U7 snRNA (Fig. 5).  The Drosophila U7 snRNA is a 71 nt 
snRNA that contains a trimethylguanosine cap at its 5’ end and, like the spliceosomal snRNA 
genes U1-U5, is transcribed by RNA polymerase II.  In Drosophila, the U7 snRNA gene is 
located within a large intron of the ecdysone-induced protein 63E (Eip63E) gene on 
chromosome 3L (Dominski et al., 2003b).  The mature U7 snRNA contains a 3’ stem loop of 
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30 nt, immediately preceded by an Sm binding region that differs from that of the 
spliceosomal snRNPs, but it very well conserved with the Sm binding sites of U7 snRNAs in 
other organisms.  This unique binding site allows the U7 snRNA to bind 5 canonical Sm 
proteins and two U7 snRNP-specific Sm-like (Lsm) proteins instead of the 7 Sm proteins 
bound by the spliceosomal snRNPs.  This difference is crucial to the ability of the U7 snRNP 
to participate in processing histone pre-mRNAs.  Upstream of the Sm binding site is a string 
of nucleotides that are complementary to the histone downstream element (HDE) within 
histone pre-mRNAs.  The U7 snRNA is able to use this complementarity to bind the HDE 
and participate in the cleavage reaction, for which it is an essential component.  Indeed, null 
mutation of the U7 snRNA gene in Drosophila results in production of only polyadenylated 
histone message (Godfrey et al., 2006). 
Until recently, very little was known about the 3’ end processing reaction that gives 
rise to the mature U7 snRNA.  Despite many of the spliceosomal snRNA processing 
complexes being at least partially characterized, nothing has come to light regarding such a 
complex for processing U7 snRNA.  However, very recent data suggests that U7 snRNA 3’ 
end formation proceeds in a similar manner to other snRNAs, with a multisubunit complex, 
termed Integrator, responsible for a co-transcriptional cleavage reaction resulting in 
formation of the snRNA and releasing the transcript from the template.  In Chapter II, I will 
discuss experiments that were performed using a variety of reporters to address 
characteristics about U7 pre-snRNA processing, including whether or not the processing 
reaction is promoter and/or length-dependent.   
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U7 snRNP COMPONENTS – Lsm10 and Lsm11 
In addition to U7 snRNA, the U7 snRNP is comprised of a heptameric ring of Sm 
proteins (Fig. 5), much like the Sm ring of spliceosomal snRNPs.  In the spliceosomal 
snRNPs, this ring consists of seven conserved Sm proteins known as SmD1, SmD2, SmE, 
SmF, SmG, SmB/B’, and SmD3.  In the U7 snRNP, however, the SmD1 and SmD2 proteins 
are replaced by two Sm-like proteins, Lsm10 and Lsm11, respectively.  Both of these Lsm 
proteins are required for proper processing of histone pre-mRNA, and depletion of one via 
RNAi results in depletion of the other (Wagner et al., 2007), suggesting these proteins exist 
as a stable heterodimer in the cell.  Lsm10, along with SmB and SmD3, binds to a region 
within the histone pre-mRNA that lies between the normal cleavage site and the U7 snRNA 
binding site.  Together, these three proteins likely function as a type of molecular ruler that 
helps the processing machinery determine the proper site for cleavage (Yang et al., 2009a). 
Directly interacting with other members of the cleavage apparatus, Lsm11 is unique 
among known Sm and Sm-like proteins because of its long N-terminus, which is required for 
processing histone pre-mRNAs.  In mammalian cells, the Lsm11 N-terminus interacts with a 
zinc finger protein known as ZFP100 (Fig. 5A), which forms a bridge between the U7 
snRNP and SLBP and acts to stabilize the interaction between these two factors (Dominski et 
al., 2002; Azzouz et al., 2005; Wagner et al., 2006).  To date, no ZFP100 homolog has been 
found outside of mammals, and the sequence within Lsm11 that binds this protein is not well 
conserved.  However, there are many other conserved residues within the N-terminus of 
Lsm11 that may be required for binding other factors.  One such factor, FLASH (Fig. 5B), 
was recently identified as an Lsm11 binding partner and component of the HLB (Yang et al., 
2009b) and is described in Chapter IV. 
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The Cleavage Factor 
 All non-histone mRNAs in the cell become polyadenylated through a process that 
requires recognition of conserved sequence motifs in the pre-mRNA that direct cleavage, 
followed by the subsequent addition of several adenosine residues to the 3’ end of the 
message, to form the mature messenger RNA.  This process of cleavage and polyadenylation 
requires at least 17 proteins and as many as 100 proteins have been identified as possibly 
associated with the complex using a proteomics approach, although the precise function of 
many of these factors remains undefined.  However, a subset of these proteins has been 
described, including the factors that comprise the cleavage and polyadenylation specificity 
factor (CPSF) complex, the cleavage stimulation factor (CstF) complex, and the cleavage 
factor (CF) components (Fig. 6). 
 There are two cis elements within the sequence of mRNAs that are required for 
efficient cleavage and polyadenylation.  These include a polyadenylation signal, AAUAAA, 
which is highly conserved upstream of the cleavage site, and a G/U-rich region downstream.  
These sequences are bound by subunits of the cleavage machinery, with cleavage usually 
occurring 10-30 nt downstream of the polyadenylation signal.  Once the message is cleaved, 
a poly(A) tail is added by poly(A) polymerase (PAP) and the mature mRNA is formed. 
 The CPSF complex is made up of several proteins, including CPSF-160 (CPSF1), 
CPSF-100 (CPSF2), CPSF-73 (CPSF3), CPSF-30 (CPSF4), Symplekin, and Fip1.  The 
CPSF-160 subunit is responsible for binding to the polyadenylation signal (Murthy and 
Manley, 1995), possibly with help from two of the other subunits, CPSF-30 and Fip1 
(Kaufmann et al., 2004).  CPSF-30 also forms important protein-protein interactions within 
the CPSF complex and Fip1 (factor interacting with Pap1) may have a further role in 
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recruitment of PAP to the polyadenylation site.  CPSF-73 and CPSF-100 are both members 
of the metallo-β-lactamase superfamily of hydrolases (Aravind, 1999; Callebaut et al., 2002; 
Dominski, 2007) and comprise the nuclease core of the cleavage complex. These two 
proteins form a heterodimer in the cell, interacting with each other through the non-catalytic 
C-terminus of CPSF-73 (Dominski et al., 2005).   Though both CPSF-73 and CPSF-100 
contain metallo-β-lacatamase domains, only the domain associated with CPSF-73 appears 
able to bind zinc (Mandel et al., 2006), with the CPSF-100 containing mutations in this 
domain that prevent zinc ion binding (Mandel et al., 2006).  This observation has led to the 
common assumption that CPSF-73 is active, while CPSF-100 is not, and the structure of the 
yeast CPSF-100 protein is consistent with this proposal (Mandel et al., 2006).  Indeed, most 
of the important metal binding residues in yeast CPSF-100 are not conserved (Aravind, 
1999).  However, in metazoans, there exist many residues within the metallo-β-lactamase 
domain of CPSF-100 that might be capable of binding metal ions (Kolev et al., 2008).  In 
support of this possibility, recent evidence reveals that mutation within the metallo-β-
lactamase domain of either CPSF-73 or CPSF-100 is capable of reducing processing 
efficiency (Kolev et al., 2008). 
In addition to the contribution of the other CPSF subunits, Symplekin plays a key role 
in processing non-histone pre-mRNAs.  Originally characterized as a component of cellular 
tight junctions (Keon et al., 1996), symplekin likely performs the role of a molecular scaffold 
in the CPSF complex, not only linking the constituent subunits of the CPSF complex, but 
perhaps also joining these to the CstF complex via an interaction with CstF-64 (Takagaki and 
Manley, 2000). 
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 The CstF complex is comprised of three proteins, CstF-50, CstF-64, and CstF-77.  
The primary function of the CstF complex is carried out by the CstF-64 subunit, which is 
responsible for binding the G/U-rich sequence on the mRNA (MacDonald et al., 1994).  This 
subunit also contains binding sites for Symplekin and the CstF-77 subunit (Takagaki and 
Manley, 2000).  CstF-77 acts as a central organizer of the CstF complex, containing binding 
sites for both CstF-64 and CstF-50 (Takagaki and Manley, 2000), and CstF-50 is likely 
involved in mediating other protein-protein interactions within the cleavage complex.  In 
addition, CstF-50 has been found to interact with the BRCA1-associated protein, BARD1, to 
form a complex that represses the cleavage reaction following DNA damage (Kleiman and 
Manley, 2001). 
 Two other proteins, CFI and CFII, are also required for efficient cleavage of non-
histone mRNAs in mammals.  CFI, which is comprised of two subunits (Ruegsegger et al., 
1996; Ruegsegger et al., 1998), binds the mRNA upstream of the polyadenylation signal and 
facilitates CPSF binding (Brown and Gilmartin, 2003; Venkataraman et al., 2005).  The 
function of CFII is less clear and, beyond its requirement for cleavage, very few details have 
emerged (DeVries et al., 2000). 
 Just prior to the genome-wide screen described in Chapter III, two of the CPSF 
subunits, CPSF-73 and Symplekin, were implicated in histone mRNA 3’ end formation 
(Dominski et al., 2005; Kolev and Steitz, 2005).  UV crosslinking experiments in our lab 
utilizing a site-specific phosphothioate residue at the cleavage site resulted in the isolation of 
an 85 kDa protein that could be localized to the site of cleavage (Dominski et al., 2005).  
Subsequently, immunoprecipitation experiments were performed that identified this protein 
as CPSF-73 (Dominski et al., 2005).  Interestingly, the same study found that CPSF-73 can 
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be UV crosslinked to the downstream cleavage product (DCP) of histone pre-mRNA, which 
is cleaved off of the histone pre-mRNA during maturation, suggesting that this protein may 
act as both an endonuclease and an exonuclease (Dominski et al., 2005). 
The other CPSF subunit to be identified as a component of the histone pre-mRNA 
processing machinery prior to the screen was Symplekin.  Early experiments detected the 
presence of a heat labile factor (HLF) that is required for processing histone pre-mRNAs in 
vitro, though the identity of this factor remained unknown (Gick et al., 1987).  This factor 
was later identified through complementation studies as Symplekin (Kolev and Steitz, 2005).  
In these experiments, heat treated nuclear extract which was inactive for histone pre-mRNA 
processing was supplemented with Symplekin, which restored the activity of the extract 
(Kolev and Steitz, 2005).  As is the case with the non-histone cleavage apparatus, it seems 
likely that this protein forms a scaffold that is responsible for organizing other components of 
the histone pre-mRNA processing machinery. 
Following the genome-wide screen, described in Chapter III, a number of factors 
emerged as functional components of the processing machinery.  In addition to identifying 
CPSF73 and Symplekin, two other CPSF subunits, CPSF-100 and Fip1, scored positively 
(Wagner et al., 2007).  While the role of Fip1 in processing is unclear, CPSF-100 has been 
better characterized and, as it does with non-histone pre-mRNAs, likely forms a heterodimer 
with its fellow metallo-β-lactamase domain-containing protein, CPSF-73.  These two 
proteins, along with Symplekin, form a core histone pre-mRNA cleavage complex that is 
essential for processing histone pre-mRNA (Sullivan et al., 2009b).  In support of this, 
chromatin immunoprecipitation experiments reveal that both CPSF-73 and Symplekin 
associate with histone genes cotranscriptionally (Sullivan et al., 2009b).  In addition, RNAi-
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mediated depletion of the other CPSF or CstF factors has no effect on histone pre-mRNA 
processing (Wagner et al., 2007), indicating that not all of the cleavage and polyadenylation 
factors are required for processing histone mRNA.  Further, while RNAi-mediated depletion 
of CPSF-160 or CstF-64 results in decreased levels of Symplekin, it does not affect the 
association of Symplekin with histone genes (Sullivan et al., 2009b).  Together, these results 
argue for the existence of two similar, but distinct cleavage factors that are separately 
responsible for processing either polyadenylated mRNAs or histone mRNAs. 
 
 
DISSERTATION GOALS 
Histone expression is highly regulated and is tightly linked to DNA replication and 
the cell cycle.  Regulation of this expression occurs mainly at the mRNA level, with key 
controls on transcription, 3’end formation/maturation, and message stability.  The primary 
target is 3’ end processing of the histone pre-mRNA, which relies on a unique complement of 
cis elements and trans factors for efficient cleavage.  Among these are the SLBP/stem loop 
complex, the histone downstream element and the U7 snRNP, including ZFP100 in 
mammals, and two components of the cleavage and polyadenylation complex, CPSF73 and 
Symplekin.  As of the start of this dissertation project, this was the extent of our knowledge 
about the composition of the histone pre-mRNA processing complex.  However, despite the 
identification of these key processing factors and other efforts to identify additional 
components of the histone pre-mRNA processing apparatus, the complete characterization of 
this complex machinery and its constituent parts remained unsolved.  This deficiency argued 
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for a novel approach to identify these missing links and led to the creation of a histone pre-
mRNA processing reporter that we used to screen the Drosophila genome. 
In Chapter II, I will describe reporter-based methods for both small-scale and 
genome-wide screening and how they have been used to identify putative 3’ end processing 
factors.  In Chapter III, I will describe a genome-wide screen that we performed using one of 
these reporters and highlight a list of 24 proteins that we identified as being involved in 
processing histone pre-mRNA (Wagner et al., 2007).  In Chapter IV, I will describe another 
factor, FLASH, that escaped validation in the initial screen, but was subsequently picked up 
using a yeast-two-hybrid screen for factors that interact with the N-terminus of Lsm11 (Yang 
et al., 2009).  I will give evidence that supports the role of dFLASH as a histone pre-mRNA 
processing factor and will further characterize its interaction with Lsm11 and the 
implications of this interaction on histone pre-mRNA processing and localization of these 
two proteins to the histone locus body. 
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Figure 1-1. Histone genes are organized into gene clusters that are important for 
modulating histone expression.  Diagram of the Drosophila histone gene cluster, which 
contains all five replication-dependent histone genes arranged in tandem and repeated about 
100 times.  The stemloop and HDE at the end of the histone H3 gene are shown and the 
cleavage site is indicated with an arrow.  Downstream of the region encoding the normal 
mature histone mRNA transcript are cryptic polyadenylation signals that are used if normal 
processing of the histone mRNA is disrupted.  These signals likely evolved as a means to 
prevent transcriptional readthrough. 
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Figure 1-2. Histone mRNA expression is highly regulated and tightly linked to DNA 
replication and the cell cycle.  Diagram of the normal cell cycle-regulated expression of 
mammlian histone mRNA and its response to inhibition of DNA synthesis.  Levels of histone 
mRNA are low during G1, but rapidly increase upon entry into S phase.  This increase 
requires activation of cyclinE/Cdk2 and its phosphorylation of NPAT, which localizes to the 
histone locus body and is required for histone mRNA expression.  At the end of normal S 
phase or in response to inhibition of DNA replication, histone mRNA levels are rapidly 
reduced.  SLBP protein levels are also linked to the cell cycle, increasing rapidly toward the 
end of G1 and decreasing rapidly at the end of S phase in response to the activity of 
cyclinA/Cdk1.  The existence of a checkpoint during G1 that arrests cells with defects in the 
U7 snRNP has been suggested (Wagner and Marzluff, 2007; arrow).  (Figure adapted from 
Marzluff et al., 2009) 
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Figure 1-3. Metabolism of replication-dependent histone mRNAs in mammals.  Histone 
expression begins with the activation of the histone locus through phosphorylation of NPAT 
and subsequent transcription of the histone mRNA.  Histone pre-mRNAs are processed by a 
single endonucleolytic cleavage event requiring an assembly of several processing factors, 
including the stem loop binding protein (SLBP), U7 snRNP, and the cleavage factor complex 
of CPSF73, CPSF100, and Symplekin.  Following cleavage, the mature histone mRNA, still 
bound by SLBP, is exported into the cytoplasm where it is circularized by a complex 
including SLBP, SLBP-interacting protein 1 (SLIP1), and eukaryotic inititation factor 4γ 
(eIF4G) and the histone mRNA is translated.  At the end of S phase, the histone mRNA is 
oligouridylated by a terminal uridylyl transferase (TUTase).  The oligo(U) tail is then bound 
by Lsm1-7, the decapping complex and exosome are recruited, and the histone mRNA is 
degraded.  SLBP is targeted for degradation by cyclinA/Cdk1 phosphorylation.  
Abbreviations:  CPSF = cleavage and polyadenylation specificity factor; DCP = mRNA 
decapping enzyme; HDE = histone downstream element; Lsm = Sm-like protein; NPAT = 
nuclear protein, ataxia-telangiectasia locus; RNA Pol II = DNA-dependent RNA polymease 
II; TUTase = terminal uridylyl transferase; XRN1 = 5’3’ exoribonuclease 1.  (Adapted 
from Marzluff et al., 2009) 
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Figure 1-4. Histone mRNAs have a unique 3’ end.  Histone pre-mRNAs contain two cis 
elements, a stem loop and histone downstream element (HDE) that are bound by essential 
processing factors.  The stem loop is bound by stem loop binding protein (SLBP) and the 
HDE is bound by the U7 snRNP through basepairing interactions with the U7 snRNA.  
Following cleavage, the stem loop remains bound by SLBP and the mature histone mRNA 
remains nonpolyadenylated.  Because histone pre-mRNAs do not contain introns, this single 
cleavage event is all that is required to form the mature histone mRNA. 
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Figure 1-5. The mammalian histone pre-mRNA processing apparatus.  (A)  Model of 
known mammalian histone pre-mRNA processing factors at the beginning of my research (c. 
2004).  Factors that were known at the time include the stem loop binding protein (SLBP), 
U7 snRNA, the U7 snRNP components Lsm10 and Lsm11, and a zinc finger protein 
(ZFP100) that interacts with both SLBP and Lsm11 and forms bridge between these two 
proteins.  (B)  Our current model of the histone pre-mRNA processing machinery, which 
includes cleavage factor components CPSF73, CPSF100, and Symplekin and the pro-
apoptotic factor FLASH, in addition to the factors listed in Panel A.  It is still not known how 
the cleavage factor interacts with the processing complex, but possibly involves an unknown 
factor that links the two.  This unknown factor is depicted in the model as factor “X.” 
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Figure 1-6. The mammlian cleavage and polyadenylation machinery used to process 
polyadenylated mRNAs.  Model of the current understanding of the cleavage and 
polyadenylation machinery.  Included in this model is the role of CPSF160 in binding the 
polyadenylation signal (AAUAAA), the endonucleolytic action of CPSF73 at the cleavage 
site just downstream of a CA dinucleotide, and the recognition of the G/U rich element by 
CstF64.  The complete composition of this complex is unknown.  (Adapted from Mandel et 
al., 2008) 
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CHAPTER II 
DEFINING RNA 3’ END FORMATION USING REPORTERS 
Introduction 
 
 Much success has been achieved over the years identifying and characterizing genes 
and gene products using traditional genetic and biochemical methods.  Among the earliest 
studies were forward genetic screens employing mutagenic agents to introduce single 
changes in the genome of yeast strains and subsequent visual observation of altered 
phenotypes.  By accumulating large numbers of mutants displaying the same or similar 
phenotypes and using the classical genetics tools available to them, researchers were able to 
identify genes that are linked to these phenotypes and often could map out the molecular 
pathways that controlled a given phenotype.  Because of the success of these genetic screens 
and the availability of highly tractable model organisms, such techniques have also seen great 
use in a number of other eukaryotes, including flies and worms. 
 With the advent of the genomic age, large volumes of gene sequence data have 
become available, culminating in complete or nearly complete genome sequences for a wide 
number of organisms.  This information, coupled with an ever expanding molecular toolbox, 
has allowed for novel methods of gene discovery to emerge.  For example, instead of 
randomly mutating an organism and looking for phenotypes to identify candidate genes, as 
per the classical methods of gene discovery, researchers are now able to take a more targeted 
approach using sequence data readily available in online databases to identify candidate 
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genes in silico.  Once genes are identified, the researcher can mutate the genes in the whole 
organism or use methods of gene silencing in cell culture to allow characterization of the 
factor of interest.  A great advantage of this method is that putative homologues of a factor 
can often be identified through sequence similarity searches, and conserved domains can be 
uncovered that may give clues about the function of the factor, which would not have been 
possible before.  However, though this method of highly targeted in silico screening is 
effective, unknown factors of interest may not be readily identifiable through these means.  
Fortunately, other avenues have opened up that allow researchers to use the power of the 
genome to quickly and efficiently identify factors involved in their process of interest. 
One of the most powerful of these methods of gene discovery is the use of RNA 
interference (RNAi) in cultured cells.  On a genome-wide scale, this method allows for the 
development of rapid and convenient reverse genetic screens to identify novel factors 
involved in a pathway of interest (Foley and O’Farrell, 2004; Paddison et al., 2004; 
Armknecht et al., 2005; Silva et al., 2005; Echeverri and Perrimon, 2006; Ramadan et al., 
2007).  Though genome-wide RNAi screens are a relatively new development, much 
progress has been made on this front over the past decade.  In particular, recent years have 
seen the construction of various RNAi libraries that allow high-throughput, cell-based 
screening of the Drosophila genome by means of RNA interference (Foley and O’Farrell, 
2004; Armknecht et al., 2005).  The increased availability of these resources has allowed 
more and more researchers the opportunity to perform genome-wide searches for factors that 
participate in their cellular process of interest.  There are many possible designs for these 
screens, depending upon the information that the researcher wishes to gain, but most utilize a 
visual readout.  These readouts can be as simple as which dsRNA targets result in growth and 
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viability defects (Boutros et al., 2004) or how the cell morphologys (Kiger et al., 2003).  
Other experimental designs may utilize antibody staining to determine factors that are 
required for localization or posttranslational modification of another protein, such as the 
MPM-2 antibody screen introduced in this chapter.   Still others may employ reporter 
constructs to detect factors involved in a specific biochemical process or pathway, such as 
the genome-wide screen for factors involved in the histone pre-mRNA cleavage reaction 
described in Chapter III (Wagner et al., 2007) or the targeted identification of dFLASH as a 
histone pre-mRNA processing factor (Yang et al., 2009), as described in Chapter IV, as a 
result of biochemical experiments. 
 The basis of any screen that utilizes these technologies is the gene-silencing 
mechanisms already in place within the cell and commonly referred to as the RNAi pathway.  
Though RNAi mechanisms exist in most eukaryotes, for molecular biological studies there 
are advantages to choosing one organism over another.  Certainly, the most appropriate 
choice for a system that is directly applicable to problems of human health is a human, or at 
least mammalian, cell line.  However, mammalian cells present challenges that have been 
difficult or expensive to overcome, including the high cost of siRNAs and the limited 
availability of appropriate genome-wide libraries.  The recent arrival of short hairpin RNA 
libraries (Paddison et al., 2004; Silva et al., 2005) has helped alleviate some of these 
challenges, but complete libraries are still difficult to come by and are oftentimes 
prohibitively expensive.   
Another option for RNAi screening is the use of C. elegans genome-wide RNAi 
feeding libraries (Fraser et al., 2000; Kamath and Ahringer, 2003), which consist of 
thousands of T7 RNA polymerase encoding, RNase-deficient bacterial strains containing 
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individual C. elegans ORFs or partial ORFs flanked by T7 promoters.  An advantage of this 
is using bacteria to synthesize dsRNA instead of having to perform in vitro transcription 
reactions for every target.  Because worms eat bacteria, this allows the introduction of 
siRNAs directly into the gut of the worm, where it can be delivered systemically into all the 
cells of the body (Fraser et al., 2000; Kamath and Ahringer, 2003).  Indeed, worms have the 
ability to amplify RNAi signal in a non-cell autonomous fashion that makes this method 
highly effective (Fire et al., 1998). 
However, if a cell-based system is desired, one of the most successful strategies in 
recent years has been the use of genome-wide dsRNA libraries on Drosophila cultured cells.  
There are many advantages to using a Drosophila system for study.  From a biological 
perspective, many genes and molecular pathways found in human cells are very well 
conserved in flies, allowing researchers the ability to advance knowledge of their process of 
interest using a highly tractable and well characterized model system in a way that is highly 
applicable to human biology.  From a technical standpoint, one highly useful property of the 
RNAi pathway in Drosophila is that, unlike mammalian cells which contain an interferon 
response to long dsRNAs that results in global translational inhibition (Williams, 1999), 
Drosophila cells can efficiently process these long dsRNAs into siRNAs that are able to 
downregulate expression of a single target gene (Caplen et al., 2000; Hammond et al., 2000).  
Thus, instead of having to design multiple siRNAs that target independent 21-23 nt regions 
of an mRNA in hopes of identifying one that is sufficiently effective at knocking down the 
message of interest, one is able to select a region within the mRNA of approximately 200-
600 nt in length that will be targeted by a longer dsRNA.  When introduced into the cell, 
these long dsRNAs are processed by Dicer into dozens of siRNAs that target various 
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sequences within the 200-600 nt region, essentially resulting in a library of siRNAs in a 
single cell (Hammond et al., 2000).  These long dsRNAs can be synthesized both 
conveniently and economically in-house using standard in vitro transcription protocols 
followed by annealing of the two strands of RNA together.  A further advantage of using 
Drosophila, and specifically Drosophila cultured cells, is that, unlike mammalian cells, the 
dsRNAs do not have to be transfected into the cells.  Instead, the dsRNAs are simply added 
to the culture medium (Clemens et al., 2000) and the cells take up the dsRNAs by 
endocytosis (Saleh et al., 2006).  In addition, a major benefit of using Drosophila cultured 
cells is that the research can be seamlessly transferred over into an extremely well-
characterized and genetically tractable whole organism for further study.  This allows for 
more in-depth characterization of a factor of interest, including tissue-specific and 
developmental phenotypes, than would be possible in a cell culture system alone. 
For the studies presented in this chapter, a reporter-based method of screening cells 
that have been RNAi-depleted for various factors has been employed.  These reporters allow 
fast and efficient detection of factors of interest for a host of processes, including 
transcription of histone genes and 3’ end processing of both histone pre-mRNAs and U7 pre-
snRNA.  Though the design of each construct is unique to its particular purpose, they all 
share several key features.  First, each relies on a visual readout for detection of 
factors/outcomes of interest.  To this end, an enhanced green fluorescent protein (EGFP) 
open reading frame (ORF) has been included in each of the constructs, allowing signal off 
the reporter to be detected by fluorescence microscopy.  Another aspect of the reporters is 
that they are expressed efficiently in the cell.  Most of the promoters that were used in these 
experiments represent promoters that exist within the Drosophila genome, such as the 
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histone H3 promoter and the Actin 5C promoter.  Each promoter was empirically tested for 
efficacy in Drosophila cultured cells and the ultimate choice of promoter was made based 
upon this information and the dictates of the experimental design.  Finally, each of the 
reporters contains a strong insect polyadenylation signal downstream of the reporter 
sequence, allowing for efficient expression of stable reporter mRNAs. 
 The processes being investigated in these experiments include histone transcription, 
histone pre-mRNA processing, and U7 snRNA 3’ end formation.  That each of these 
seemingly disparate processes can be illuminated using similar methods of inquiry, namely, 
the use of reporters to detect factors that are involved in each of these processes, speaks to 
the power of the reporter method and gives credence to the notion that these types of 
experiments, while not complete in and of themselves, can provide an important stepping 
stone for further study and allow the identification of candidate factors that otherwise may be 
nearly impossible to pinpoint. 
 Through these experiments, I find that the reporters I have used and tested are 
accurate representations of the cellular processes they model and further, that these assays are 
a highly effective method to test for transcription and mRNA processing factors.  These 
assays have allowed me and others to identify several putative histone pre-mRNA processing 
factors (Wagner et al., 2007; Yang et al., 2009; White et al., in preparation), as well as to 
gain new insight into the U7 snRNA processing reaction and the identity of U7 snRNA 
processing factors (Wagner et al., in preparation).  To this end, the experiments contained in 
this chapter are the building blocks of these many lines of research.   
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Materials and Methods 
 
Creation of Reporter Constructs 
 The Hisproc reporter was created by subcloning the histone H3 promoter, partial open 
reading frame, downstream sequence, and an EGFP coding sequence into a promoterless 
pIZ/V5/His vector backbone (Invitrogen).  Briefly, the histone H3 5’UTR and amino acids 1-
67 were amplified by PCR using forward primer 5’ 
GGCCGAATTCCGACAAAAAC CCGAGAGAGTAC 3’ and reverse primer 5’ 
GGCCGGTACCTTAGGCAGCTTG CGGATTAGAAGC 3’ and subcloned into pEGFPN1 
(Clontech, Palo Alto, CA) using EcoRI and KpnI. The 3’ end of the H3 gene starting 
immediately after the stop codon and continuing until 18 nt downstream of the HDE 
was amplified using forward primer 5’ GGCCGGTACCACTTGCAGAT 
AAAGCGCTAGCG 3’ and reverse primer 5’ GGCCGGATCCTTGTTATAAATAG 
TCGGCAACA GAAAATTTTTTCTC 3’ followed by ligation to the 5’ product using KpnI 
and BamHI. The resulting construct contained the H3 promoter, amino acids 1-67 of 
histone H3 ORF, and H3 3’ end containing a portion of the downstream intergenic 
region upstream of an EGFP ORF. Note that the H3 ORF is in frame with GFP and that 
we created a single mutation (U to A) within the HDE in order to disrupt a stop codon 
(red box in Fig. S1). The OpIE2 promoter was removed from pIZ-V5/His (Invitrogen, 
Carlsbad CA) vector by inverse PCR using forward primer 5’ GGCCGCTAGCACAG 
CATCTGTTCGAATTTA 3’ and reverse primer 5’ GGCCGCTAGCAGACAT 
GATAAGATACATTGATGA 3’ followed by digestion with NheI and religation. The 
reporter was then subcloned into the promoterless pIZ/V5/His vector using forward primer 5’ 
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GGCCGAATTCCGACAAAAACCCGAGAGAG TAC 3’ and reverse primer 5’ 
GGCCTCTAGATTACTTGTACAGCTCGTCCAT GCC 3’ followed by digestion with 
EcoRI and XbaI and subsequent ligation to form the pIZ/H3p/H3/GFP construct.  Note that 
the polyA site used by the GFP ORF is the insect OpIE2 polyadenylation sequences 3’ of the 
XbaI site in the pIZ/V5/His vector. 
 To create the Actproc construct, the Drosophila Actin 5C promoter was amplified from 
genomic DNA by PCR using forward primer 5’ 
GGCCAAGCTTTATGTATGTTTTGGCATACAATGAGTAGTTGG 3’ and reverse primer 
5’ CCGGGAATTCGTGTCGGGAGGAGTATCCAC 3’ and subcloned into the 
pIZ/promoterless/H3/GFP plasmid using HindIII and EcoRI.  The resulting Actproc reporter 
gene consisted of the Actin 5C promoter followed by a region encoding the first 67 amino 
acids of histone H3, a portion of the histone H3 3’ UTR that included the SL and HDE, an in-
frame GFP ORF, and a vector-encoded OpIE2 poly(A) signal.   
 The Histrans construct was created by amplifying the histone H3 promoter using 
forward primer 5’ GGCCAAGCTTCGACAAAAACCCGAGAGAGTAC 3’ and reverse 
primer 5’ GGCCACCGGTCTCCGATTTGGGTTTCACTAAAGTTCACGTTC 3’ and 
subcloning this piece into the pIZ/promoterless/H3/GFP plasmid using HindIII and AgeI.  
The resulting Histrans reporter consisted of the Histone H3 promoter followed by an EGFP 
ORF and a vector-encoded OpIE2 poly(A) signal. 
 The Acttrans construct was created by amplifying the Act 5C promoter with forward 
primer 5’ GGCCAAGCTTTATGTATGTTTTGGCATACAATGAGTAGTTGG 3’ and 
reverse primer 5’ CCGGGAATTCGTGTCGGGAGGAGTATCCAC 3’ and the EGFP ORF 
using forward primer 5’ GGCCGAATTCATGGTGAGCAAGGGCGAGGAG 3’ and reverse 
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primer 5’ GGCCTCTAGATTACTTGTACAGCTCGTCCATGCC 3’ and performing a three 
way ligation into the pIZ/promoterless vector using HindIII, EcoRI, and XbaI.  The resulting 
Acttrans reporter consisted of the Actin 5C promoter followed by an EGFP ORF and a vector-
encoded OpIE2 poly(A) signal. 
 The original pIZ/U7p/U7/GFP construct was created by Dr. Eric J. Wagner.  A 
modular version of this reporter allowing simplified promoter and transcript swapping was 
created by amplifying the U7 snRNA promoter using forward primer 5’ 
GGCCAAGCTTGAAACTTACAAGTTAACTTAAAGCC 3’ and reverse primer 5’ 
GGCCGAATTCCTCAACAGAGGCTTGCAGAG 3’, the U7 snRNA transcript + EGFP 
using forward primer 5’ GGCCGAATTCATTGAAAATTTTTATTCTCTTTGAAATTTG 
3’ and reverse primer 5’ GGCCTCTAGATTACTTGTACAGCTCGTCCATGCC 3’, and 
subcloning these into the pIZ/promoterless vector using HindIII, EcoRI, and XbaI.  The 
resulting pIZ/U7p/U7/GFP reporter consisted of the U7 snRNA promoter followed by the U7 
snRNA transcript, including downstream sequences, and and EGFP ORF, all followed by a 
vector-encoded OpIE2 poly(A) signal.  To create the pIZ/Act5C/U7/GFP construct, the U7 
snRNA transcript + EGFP was amplified off of the pIZ/U7p/U7/GFP reporter using forward 
primer 5’ GGCCGAATTCATTGAAAATTTTTATTCTCTTTGAAATTTG 3’ and reverse 
primer 5’ GGCCTCTAGATTACTTGTACAGCTCGTCCATGCC 3’ and subcloning this 
fragment into the pIZ/Act5Cp/H3/GFP vector using EcoRI and XbaI.  The resulting 
pIZ/Act5Cp/U7/GFP reporter consisted of an Actin 5C promoter followed by the U7 snRNA 
transcript, including downstream sequences, and and EGFP ORF, all followed by a vector-
encoded OpIE2 poly(A) signal.  To create the pIZ/U7p/U7-H3insert/EGFP reporter, an XhoI 
restriction site was introduced into the U7 snRNA transcript by amplifying the the U7 
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promoter and 5’ portion of the U7 snRNA transcript off of the pIZ/U7p/U7/GFP reporter 
using forward primer 5’ GGCCAAGCTTGAAACTTACAAGTTAACTTAAAGCC  3’ and 
reverse primer 5’ GGCCCTCGAGAAAGAGAATAAAAATTTTCAATCTCAACAG 3’ and 
by amplifying the 3’ portion of the U7 snRNA transcript + EGFP off the pIZ/U7p/U7/GFP 
reporter using forward primer 5’ CCGGCTCGAGGAAATTTGTCTTGGTGGGAC 3’ and 
reverse primer 5’ GGCCTCTAGATTACTTGTACAGCTCGTCCATGCC 3’ and subcloning 
these pieces into the pIZ/promoterless vector using HindIII, XhoI, and XbaI, resulting in the 
pIZ/U7p/U7+XhoI/GFP construct.  A portion of the histone H3 open reading frame was 
amplified using forward primer 5’ CGCGCTCGAGGCAAATCGACTGGTGGAAAG 3’ 
and reverse primer 5’ CCGGCTCGAGGCACACAAGTTGGTATCTTCGA 3’ and 
subcloned in the reverse orientation into the the pIZ/U7p/U7+XhoI/GFP construct using 
XhoI.  Subcloning in the reverse orientation is essential to eliminate a cryptic start codon 
within the H3 insert sequence in the forward orientation that puts the ATG of the EGFP ORF 
out of frame.  The resulting pIZ/U7p/U7-H3insert/EGFP reporter consisted of a U7 snRNA 
promoter, followed by a U7 snRNA transcript with an inserted histone H3 sequence, 
followed by downstream U7 snRNA sequence, an EGFP ORF, and a vector-encoded OpIE2 
poly(A) signal. 
 
Generation of dsRNAs and RNA interference 
 DNA templates for double stranded RNAs (dsRNAs) were generated by PCR using 
Drosophila Gene Collection library clones (Open Biosystems) or genomic DNA, if 
appropriate, and primers containing a T7 promoter (Table 2-1).  Transcription was carried 
out in a total volume of 100 µl using T7 RNA polymerase and RiboMAX kit (Promega), as 
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recommended by the manufacturer.  Following transcription, the RNA was treated with 5 
units of RNase-free DNase Q (Promega), purified on G-50 micro columns (GE Healthcare), 
boiled for 5 minutes and cooled to room temperature to form dsRNA.   
 To induce RNAi-mediated knockdown of a factor of interest, dsRNAs targeting the 
factor were introduced into Drosophila D.Mel-2 cultured cells by adding the dsRNAs 
directly to the growth medium.  For 384-well experiments, 5 ul diluted dsRNA containing 
250 ng dsRNA in water was added to 10 µl SF-900II SFM (Gibco) containing 8x103 cells in 
a black-walled, clear bottom tissue culture plate (Corning) in a final volume of 15 µl.  For 
96-well plates, 8x104 cells were plated in 40 µl SF-900II SFM and supplemented with 800 ng 
dsRNA.  For 24-well plates, 5x105 cells were plated in 250 µl SF-900II SFM to which 5 µg 
dsRNA was added.  For 6-well plate experiments, 3x106 cells were plated in 1 ml SF-900II 
SFM and 30 µg dsRNA was added.  For all experiments, the cells were allowed to 
knockdown at 27 °C in a humidified growth chamber for 3-6 days, depending upon the 
experiment and dsRNA target.  If RNAi was to proceed longer than 3 days, an amount of 
dsRNA equal to the original application was added every 2 days to ensure continuous 
knockdown for all plating formats except 384-well format, for which dsRNA was added only 
on Day 0. 
 
Cell Transfections and Reporter Assays 
 For the initial optimization experiments using the Hisproc construct, cells were treated 
dsRNA and allowed to knock down for 3 days, followed by transfection of the reporter 
construct into the cells using Effectene reagent (Qiagen) on Day 3 and viewing of the cells by 
fluorescence microscopy on Day 5.  For 384-well experiments, 20 µl fresh SF-900II SFM 
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was added on Day 3 to bring the total volume to approximately 35 µl.  A master mix was 
created for all wells to be transfected such that each well contained the following:  50 ng of 
reporter plasmid was diluted into 8.75 µl Buffer EC per well.  To this mixture, 0.2 µl of 
enhancer reagent was added, followed by incubation at room temperature for 5 min.  Next, 
0.3 µl of Effectene transfection reagent was added and the mixture incubated at room 
temperature for 10 min., after which, 10 µl was dispensed into each well.  The cells were 
allowed to grow at 27 °C for 2 days, after which the cells were viewed with an inverted 
fluorescence light microscope using 100X magnification.  For 6-well transfections, the same 
protocol was used, with the following volumes and amounts (per well): 400 ng plasmid DNA 
was combined with 3.2 µl enhancer in a total of 100 µl Buffer EC, followed by 
supplementation with 10 µl Effectene.  The entire volume was then added to the cells, which 
were allowed to grow as above until viewing. 
 For later experiments involving the Actproc, Acttrans, Hisproc, Histrans and snRNA 
reporters, RNAi-depleted cells were transfected using the Amaxa Nucleofector 
electroporation system (Lonza) and the Nucleofector V kit (Lonza) according to the 
manufacturer’s protocol for the Drosophila S2 cell line.  Briefly, 5x106 RNAi-depleted 
D.Mel-2 cells were isolated by centrifugation at 1000xg for 3 min., followed by aspiration of 
the media from the cell pellet and addition of 100 µl room-temperature supplemented 
Nucleofector solution.  To this was added 2 µg reporter plasmid DNA and the cells were 
resuspended gently and transferred to a Nucleofector electrporation cuvette.  The cuvette was 
capped and placed inside the Nucleofector device and the cells were subjected to 
electroporation using the G-030 Nucleofector program.  After electroporation, 500 µl of 
room temperature growth medium (SF-900II Serum Free Medium supplemented with 
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antibiotic/antimycotic solution) was added to the cuvette and the cells were transferred with a 
plastic pipette into 6-well tissue culture plates containing 400 µl room temperature growth 
medium.  The cells were then allowed to grow at 27 °C in a humidified growth chamber until 
viewing. 
 The Actproc construct was ultimately integrated stably into Drosophila D.Mel-2 cells 
using the Amaxa transfection protocol above and selection of the cells from Day 3 through 
Day 10 with 500 µg/ml Zeocin selection reagent (Invitrogen).  Note that most of the 
experiments using this reporter utilized the reporter stable line instead of the transiently 
transfected reporter.  RNAi experiments were performed in this cell line the same way as was 
done for experiments in which the reporter was transiently transfected. 
 
RT-PCR Analysis 
 Relative reporter and endogenous mRNA levels were measured using reverse 
transcriptase PCR (RT-PCR).  D.Mel-2 cells were harvested after treatment with dsRNAs 
and total RNA was isolated using TRIzol reagent (Invitrogen).  An aliquot of the isolated 
RNA (2 µg) was incubated with RNase-free DNase Q (Promega) followed by reverse 
transcription using MMLV-RT (Invitrogen) and random hexamers, as suggested by the 
manufacturer.  PCR amplification was carried out with 0.5 µl of cDNA using the following 
forward (F) and reverse (R) primers written in the 5’-3’ orientation: Misprocessed reporter (F 
within H3 ORF-GAGCACCGAGCTTCTAATCC, R within GFP ORF-
GGCGGACTTGAAGAAGTCGTGC); Histone H2A misprocessed (F-
GTGACAACAAGAAGACTAGAATTATTC, R-CTAATTACAACAAATTGCCAAGC); 
α1-Tubulin 84B (F-GCCCTACAACTCCATCCTGA, R-
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GGTCACCAGAGGGAAGTGAA).  PCR products were run on a 2 % agarose gel and 
detected by ethidium bromide staining. 
 
S1 Nuclease Protection Assay 
 To create the probe construct for the assay, Drosophila histone H2A sequence was 
cloned into a TA vector.  From a standard plasmid preparation (Qiagen), aproximately 3 µg 
of the plasmid was combined with 2 µl 10X bovine serum albumin (NEB), 2 µl 10X 
NEBuffer 3 (NEB), qs to 18 µl with dH2O, and 2 µl BspE I restriction enzyme (NEB), for a 
total reaction volume of 20 µl.  The digest was then incubated at 37 °C for 2 h.  Next, the 
reaction was purified using a PCR purification kit (Qiagen) and eluted the digested DNA in 
Buffer EB (Qiagen) for a final volume of 28 µl.  The result of the initial digest was a 
linearized construct with a 5'-CCGG-3' overhang at the 5' end of the histone H2A sequence. 
 To label the DNA, the purified digest was combined with 4 µl 10X dG,A,T 
deoxynucleotide mix, 4.5 µl 10X NEBuffer 2 (NEB), 4 µl α-P32 dCTP (MP Biomedicals), 
and 3 µl large fragment of DNA polI (Klenow) enzyme (NEB), for a total reaction volume of 
43.5 µl.  The reaction was incubated at 25 °C for 20 min.  This reaction results in the filling-
in of the recessed 3’ end and 3’-end labeling of the histone H2A sequence with α-P32 dCTP. 
 After the labeling reaction, the reaction was spun through a ProbeQuant G-50 Micro 
Column (Amersham) to remove unincorporated deoxynucleotides.  Next, to the cleaned-up, 
labeled construct 5 µl 10X BSA (NEB), 1 µl 10X NEBuffer2 (NEB), and 4 µl HindIII 
restriction enzyme (NEB) was added for a total reaction volume of 60 µl.  The reaction was 
then incubated at 37 °C for 2 h.  After incubation, the reaction was run on a 2 % agarose gel 
and the labeled fragment was purified using a gel extraction kit (Qiagen).  These steps result 
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in a 650 nt, labeled histone H2A probe that is ready to be used in the S1 nuclease protection 
assay. 
 For the S1 nuclease protection assay, 5 µg total RNA from Dmel-2 cells was 
combined with 1 µl of the labeled histone H2A probe and the solution was dried using a 
Speedvac SC100 (Savant).  The dried RNA-probe pellet was resuspended in 10 µl 1X 
hybridization buffer (40 mM Pipes, pH 6.4, 500 mM NaCl, 1 mM EDTA, 80 % deionized 
formamide) and boiled for 5 minutes.  After boiling, the samples were incubated at 52 °C 
overnight to allow hybridization of the probe to its target RNA sequence. 
 After hybridization, 80 µl dH2O, 9 µl 10X S1 buffer (Promega), and 0.6 µl S1 enzyme 
(Promega) was added to the samples followed by incubation at 25 °C for 1.5 h.  After 
incubation, the DNA/RNA hybrids were precipitated by adding 300 µl 100 % ethanol and 1 
µl GlycoBlue (Ambion) to each sample and placing the samples at – 80 °C for 30 minutes.  
After precipitation, the samples were centrifuged at 16000xg in an Eppendorf 5415C 
microcentrifuge for 30 minutes at 4 °C.  After removing the supernatant, the pellet was 
washed with 80 % ethanol and spun the samples again at 16000xg for 10 min. at 4 °C.  The 
ethanol was then removed and the samples were allowed to air dry.  After the pellets had 
dried, they were resuspended in 40 µl formamide loading dye (>99 % formamide with 
bromophenol blue and xylene cyanole), boiled for 5 min. and loaded onto a 6 % Sequagel 
Sequencing System acrylamide gel (National Diagnostics) in 1X TBE (Tris-borate-EDTA) 
buffer. 
 After running the gel, the gel was dried on a SGD200 Slab Gel Drier (Savant) for 1.5 
hours at 80 °C.  After drying, the gel was placed either on a storage phosphor screen 
(Molecular Dynamics) or onto blue autoradiography film (Denville Scientific) for detection.  
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Phosphor screens were developed on a Storm Scanner (Amersham), and film was developed 
using a SRX-101A film developer (Konica). 
 
Western Blot Analysis 
D.Mel-2 cells were lysed in a buffer containing 50mM Tris-HCl (pH 8.3), 0.1% NP-
40, and 50mM NaCl for 30 min. on ice.  Lysates were separated with SDS-PAGE using 
standard techniques and were then transferred to immobilon-PVDF membrane (Biorad) and 
probed with either a 1:1000 dilution of an α-GFP JL8 monoclonal antibody (Clontech), a 
1:1000 dilution of α-dSLBP antibody (10), a 1:1000 dilution of α-Lsm11 antibody, or a 
1:1000 dilution of α-Lsm10 antibody (24).  Blots were then probed using a secondary HRP-
conjugated antibody and developed using chemiluminescence.  Sufficient material could be 
obtained for Western blotting using cells from 6 wells of a 384 well plate. 
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Results 
 
Creation, Validation, and Optimization of Histone mRNA Reporters 
A reporter to detect misprocessing of histone pre-mRNA.  To facilitate the identification 
of histone pre-mRNA processing factors, a novel screening reporter was created consisting of 
a histone H3 promoter driving expression of a partial histone open reading frame (ORF), 
without its stop codon, along with downstream sequence that includes the stem loop, normal 
cleavage site, and histone downstream element (HDE), all followed by an enhanced green 
fluorescent protein (EGFP) ORF and a strong, vector-encoded polyadenylation signal 
(Hisproc) (Fig. 2-1A).  The GFP was placed in frame with the histone ORF and a stop codon 
present in the intergenic region was mutated.  Under normal conditions (Fig.2-1A, top), the 
reporter message is cleaved at its 3’ end like a normal histone mRNA, and this cleavage is 
efficient based on the fact that the cells do not fluoresce.  Because the transcript does not 
contain the EGFP coding region, the cells exhibit no fluorescence.  However, if the normal 
cleavage reaction is perturbed (Fig. 2-1A, bottom) by depleting an essential processing 
factor, the reporter transcript is not processed normally, resulting in a reporter transcript that 
includes the EGFP coding region.  When these transcripts are translated, histone H3-EGFP 
fusion protein is created, which is readily visualized under a fluorescence microscope. 
To test the ability of the Hisproc reporter to assess processing defects, dsRNAs 
targeting LacZ and pyrimidine tract binding protein (dPTB), as negative controls, and 
dLsm10, dLsm11, and dSLBP, as positive controls, were synthesized and added to 
Drosophila D.Mel-2 cultured cells.  Additionally, a 2’-OCH3 oligonucleotide antisense to the 
5’ end of U7 snRNA, which prevents the binding interaction between the U7 snRNP and the 
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HDE, was used as a positive control.  After incubating the cells with their respective 
dsRNA/modified oligonucleotide for three days, the reporter construct was transfected into 
the cells and the cells were viewed 48 hours later.  RNAi against the negative control targets 
resulted in only background levels of fluorescence, while RNAi targeting each of the positive 
controls or introduction of the U7 2’-OCH3 oligonucleotide elicited much higher levels of 
fluorescence (Fig. 2-1B).  Western blot analysis of these cells using an α-GFP antibody 
confirms this result (Fig. 2-1C), and allows one to quantify the amount of GFP produced.  
Further, western blotting reveals a marked decrease in the protein level of each of the 
processing factors that were targeted for knock down by their respective dsRNAs (Fig. 2-
1C).  Note that RNAi-mediated depletion of dLsm10 or dLsm11 results in depletion not only 
of the target, but also of the other Lsm protein (Fig.2-1C, lanes 3 and 4).  This is likely 
attributable to the existence of these proteins together as a dimer in the cell and suggests that 
the stability of one protein relies on its binding with the other.  Addition of the dsRNA 
against SLBP was quite effective at reducing SLBP levels in the cell, but had no effect on 
Lsm10 or Lsm11 levels (Fig. 2-1C, lane 5).  Further, addition of the 2’-OMe oligonucleotide 
against the U7 snRNA did not affect levels of any of the other factors (Fig. 2-1C, lane 6), 
consistent with its function in disrupting the activity of the U7 snRNA by preventing its 
binding to the HDE rather than affecting its protein partner levels.  Thus there is not a general 
co-regulation of multiple factors for histone pre-mRNA processing. 
To determine whether the Hisproc reporter was accurately reporting misprocessing of 
the endogenous histone message, the S1 nuclease protection assay was used.  These assays 
reveal misprocessed histone mRNA species as bands that migrate more slowly on a gel than 
those corresponding to properly cleaved histone mRNA (Lanzotti et al., 2002; Godfrey et al., 
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2006).   For this assay, total RNA was isolated from mock-treated cells and polyadenylated 
mRNA was isolated from cells RNAi-depleted of dLsm11.  The results of the S1 nuclease 
protection assay reveal that, in the absence of RNAi, only a single band appears on the gel 
(Fig. 2-1D, lane 2), corresponding to the correctly processed histone mRNA species.  
However, treating cells with a dsRNA that targets a processing factor, such as Lsm11, results 
in the appearance of multiple bands on the gel (Fig. 2-1D, lane 3), indicating that the histone 
pre-mRNA is not correctly processed under these circumstances. 
In order to use the reporter for carrying out a genome-wide screen, optimization of 
the assay conditions was required, including the number of cells to plate, the amount of 
dsRNA to add, the amount of reporter DNA to be transfected, the timing of the transfections, 
and the appropriate amounts of transfection reagents to use.  To this end, these conditions 
were systematically tested using the 384-well plating scheme shown in Fig. 2-2A.  In this 
experiment, either 1 or 4 µl of dsRNA were added to each well, corresponding to 50 and 200 
ng dsRNA, respectively.  DNA concentration was assayed at 25, 50, 100, 150, and 200 ng 
per well.  Effectene transfection reagent (Qiagen) was used to introduce the reporter DNA 
into the cells after the cells were grown in the presence of dsRNAs for 3 days.  Using this 
system, the quantity of two reagents, an enhancer solution and Effectene, must be 
coordinated together for optimal results.  For these experiments, enhancer amounts of 0.1, 
0.3, 0.5, 0.8, and 1 µl per well and Effectene amounts of 0.3, 0.4, and 0.5 µl were used.  On 
Day 5, these cells were imaged by fluorescence microscopy.  The individual well images 
were combined into a 384-image collage, representative of the 384 wells of the assay plate, 
and the images were put through an algorithm using the Metamorph program (MDS 
Analytical Technologies Inc.) that calculated fluorescence intensity within each well.  The 
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output of this algorithm is the same 384-well collage, but with each fluorescence dot 
converted into a vertical bar, with the height of the bar scaled to the intensity of the dot (Fig. 
2-2B).  As expected, the negative control dsRNA, targeting dPTB, gave no appreciable 
fluorescence under any condition assayed, while the positive control dsRNA, targeting 
dLsm11, and the U7 2’-Ome oligonucleotide gave higher levels of fluorescence for all 
treatments (Fig. 2-2B).  Note, however, that the fluorescence signal elicited from the positive 
control cells varies widely and that maximal fluorescence output, still with very low noise, is 
achieved for only a subset of the tested conditions.  In this case, the best signal was obtained 
for cells supplemented with a higher amount of dsRNA (200 ng), a lower amount of DNA 
(25-50 ng), lower volume of enhancer (0.1-0.3 µl), and 0.3 µl Effectene reagent (Fig. 2-2B). 
A reporter that only targets histone pre-mRNA processing.  Though the Hisproc reporter is 
highly effective, it is likely that any factors that are required for both histone gene 
transcription and pre-mRNA processing will be missed as a result of the presence of the 
histone promoter driving the reporter construct.  To alleviate this, I created another histone 
pre-mRNA processing reporter that utilizes a constitutively expressed Actin 5C promoter 
driving transcription of the reporter message (Actproc) (Fig. 2-3A, top).  RNAi experiments to 
test the effectiveness of this reporter reveal high levels of fluorescence when obligate 
processing factors are depleted and very little background under mock treatment (Fig. 2-3A, 
bottom).  As is the case for the Hisproc reporter, misprocessing of endogenous histone mRNA 
is accurately reflected by the Actproc reporter.  RT-PCR assays performed using cDNA 
created from cells depleted of SLBP reveal misprocessed reporter message that coincides 
with misprocessing histone H1, H2A, and H2B message (Fig. 2-3B).  In contrast, when PTB 
is knocked down, there is only background misprocessing of the endogenous histone 
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message, which is mimicked by the reporter message (Fig. 2-3B).  This reporter was 
ultimately used to create a stable cell line, eliminating variables introduced by having to 
transfect the reporter during the experimental timecourse.  This stable reporter cell line works 
very well, although a stable cell line using the reporter driven by the histone promoter did not 
give sufficient fluorescence to be useful. 
A reporter that targets histone transcription.  In order to assay the effect of RNAi-
mediated depletion of factors of interest on transcription from the histone promoter, a third 
reporter construct was made (Histrans).  This reporter consists of a histone promoter driving an 
EGFP ORF (Fig. 2-3C, top) followed by a polyadenylation signal, allowing a direct visual 
readout of histone gene transcription.  Importantly, this reporter is expressed efficiently in the 
cell (Fig. 2-3C bottom).  Using this reporter, factors that reduce histone gene transcription 
will result in a reduction of the GFP signal, although this loss of fluorescence readout is 
much less sensitive than the gain of fluorescence of the processing reporters.  
 
Use of Reporters to Help Characterize Other Aspects of Histone mRNA Metabolism 
A genome-wide screen for factors that affect the presence in the HLB of a cell cycle 
regulated, MPM-2 antibody reactive phosphoepitope was performed by Anne White in Dr. 
Bob Duronio’s lab here at UNC.  Initial positive hits from this screen revealed a number of 
factors of interest that localize to the HLB, including multi-sex combs (Mxc), CG34415, 
FLASH and Spt6.  These factors were tested in a secondary assay using the three reporters: 
Hisproc, Actproc, and Htrans to determine in which steps in histone mRNA metabolism they 
were involved.  As negative controls I used (PTB) or the Cajal body-specific factor coilin and 
SLBP was used as a positive control for processing.   
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Figs. 2-4A-C show the results of testing the 3 reporters with the four genes from the 
screen and the controls.  When cells were RNAi-depleted of CG34415 or Spt6, only 
background fluorescence from the Hisproc reporter was observed, similar to the result of 
knocking down the negative controls.  However, when Mxc was depleted, there was 
increased fluorescence, albeit considerably less than that observed for cells depleted of SLBP 
(Fig. 2-4A). 
Using the Actproc reporter to assay the same factors as in Fig. 2-4A, a similar result 
was obtained.  Again, RNAi depletion of CG34415 or Spt6 gave only background levels of 
fluorescence, similar to coilin depletion, but Mxc now gave considerably higher levels of 
fluorescence relative to SLBP (Fig. 2-4B).  Of note, the relative level of fluorescence off this 
reporter when Mxc is depleted compared to that arising in control cells is somewhat higher 
than the relative levels observed for the Hisproc reporter, consistent with a possible role in 
transcription of the histone genes.  The results for CG34415 and Spt6 in these experiments 
suggest these factors are not involved in processing histone mRNA, although they do not rule 
out their possible involvement in histone gene transcription. 
To determine whether these factors are required for histone gene transcription, a 
reporter containing the histone promoter driving expression of an EGFP ORF was used.  
When this reporter is transiently transfected into cells depleted of Mxc or Spt6, fluorescence   
lower than that observed for control-treated cells is observed (Fig. Fig 2-4C), suggesting that 
they might be involved in histone transcription.  In cells depleted of CG34415 a more 
significant reduction in fluorescence is observed (Fig. 2-4C) indicating that this factor is 
likely important for normal levels of histone transcription.  As expected, RNAi depletion of 
PTB, SLBP, and coilin had no effect on transcription of the reporter (Fig. 2-4C). 
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These results were representative of only a few of the earliest factors identified in the 
MPM-2 genome-wide screen.  Clearly this approach allows the rapid initial classification of 
the unknown factors for potential roles in histone mRNA metabolism.  After the screen was 
completed, nearly 100 of the top hits were rescreened, in duplicate, using the Actin 5C 
promoter-driven histone pre-mRNA processing reporter stable line, to assess whether any of 
these genes might also be involved in histone pre-mRNA processing.  While most of the 
targets scored negatively for involvement in histone pre-mRNA processing, FLASH scored 
very strongly and several other factors, including MCRS1, MBD-R2, Mxc, Dgt1, DMAP1, 
and a few unnamed proteins, including CG8142, CG9772, and CG31111, scored as weakly 
to moderately positive (Fig. 2-4D).  Besides FLASH, whose involvement in histone pre-
mRNA processing has been validated and partially characterized, the precise role, if any, of 
these factors in histone mRNA 3’ end formation remains to be determined. 
 
Use of Reporters to Define the Relationship between Histone mRNA Metabolism and 
DNA Replication 
Since histone mRNA levels are tightly coupled with DNA replication, I tested 
whether knocking down factors required for DNA replication resulted in inhibition of histone 
pre-mRNA processing.  To determine whether depletion of the origin recognition complex 
(ORC) subunits results in reduced transcription from the histone promoter, I transfected cells 
treated with dsRNAs targeting Orc1 and Orc3 with the Histrans reporter.  In parallel, I also 
used a transcription reporter containing the Actin 5C promoter (Acttrans) in order to control 
against global effects on transcription.  Depletion of these DNA replication factors has no 
effect on transcription from the constitutive promoter (Fig. 2-5A).  However, there is an 
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effect on histone transcription, as reduced fluorescence is detected from the histone promoter 
when these factors are targeted by RNAi (Fig. 2-5B). 
To discover whether ORC subunit depletion affects histone pre-mRNA 3’ end 
formation, I used the Actproc reporter.  When the reporter is transfected into cells RNAi-
depleted of Orc1 or Orc3, low level fluorescence is detected off the reporter (Fig. 2-5B).  
This experiment was repeated in the processing reporter stable line, this time using dsRNAs 
targeting three ORC subunits, Orc1, Orc2, and Orc5.  Again, RNAi against the DNA 
replication factors resulted in low level fluorescence that is above background, but which is 
well below levels exhibited by the positive control cells (Fig. 2-5C). 
Finally, dsRNAs targeting several other DNA replication factors, including several 
Mcm subunits and Doubleparked (DUP, dCdt1), gave rise to only background levels of 
fluorescence (Fig 2-5D and 2-5E).  Of note, among the DNA replication factors tested, only 
RNAi-mediated depletion of DUP gave any appreciable effect on cell morphology and 
survival, giving rise to small cells (Fig. 2-5E, bottom) and lethality by day 2-3 of the 
experiment.  RNAi-mediated depletion of geminin, an inhibitor of Cdt1 function, resulted in 
cells that became very large (Fig. F2-5E, bottom) and, like the other RNAi targets, did not 
result in any significant increase in fluorescence off the reporter (Fig. 2-5E, top).  I conclude 
that there is a very small, if any, effect on histone pre-mRNA processing when DNA 
synthesis is blocked, but that there is likely a reduction in the rate of histone gene 
transcription. 
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Pre-snRNA Processing Reporters 
 The other class of RNA polymerase II transcripts that are not polyadenylated are the 
small nuclear RNAs.  These are also generated by endonucleolytic cleavage of the nascent 
transcript.  In order to investigate the cleavage reaction responsible for creating the mature 
U7 snRNA 3’ end, a reporter was created by Dr. Eric J. Wagner that includes the entire U7 
genomic sequence, from the U7 promoter through the end of the intron in which the U7 gene 
resides, fused at the 3’ end to an EGFP ORF and all followed by the strong, vector-encoded 
polyadenylation signal (Fig. 2-6A).  Much like the histone pre-mRNA processing reporters, 
failure to use the normal cleavage site of the U7 snRNA results in translation of a protein 
containing the EGFP ORF, causing the cells to fluoresce green.  However, unlike the histone 
reporters, the only start codon occurs at the ATG of EGFP, essentially making the U7 
transcript a 5’ UTR.  This reporter was initially used together with RNAi of specific factors 
to demonstrate that members of the integrator complex were required for snRNA processing 
in Drosophila and then was subsequently used by Dr. Wagner to perform a genome-wide 
screen for factors involved in processing U7 snRNA (Wagner et al., in preparation). 
 When the U7 snRNA processing reporter is transfected into cells depleted of dPTB or 
dCPSF30, both negative control factors, there is only background fluorescence detectable 
from the reporter (Fig. 2-6B).  However, when an essential processing factor, such as Int9, is 
depleted, robust GFP signal is observed (Fig. 2-6B).  Western blot analysis using an α-GFP 
antibody confirms this (Fig. 2-6B, right panel). 
A rotation student whom I mentored, Kirston Barton, and I used this reporter to probe 
some of the requirements for production of snRNAs.  In particular, in mammalian cells 
formation of the 3’ end of snRNAs requires that transcription initiate from an snRNA 
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reporter.  To test whether this is the case in Drosophila, I created reporters with alternative 
promoters, including the Actin 5C and histone H3 promoters (Fig. 2-6C).  I also created a 
reporter that contained an insertion of histone H3 sequence within the region coding the U7 
snRNA transcript in order to test for any transcript length dependence of the processing 
reaction (Fig. 2-6C).  Each of these requirements of snRNA processing has precedents from 
other mammalian snRNAs, but none have been defined for U7 snRNA in any species or for 
any Drosophila snRNAs. 
 Substitution of the Actin 5C promoter in place of the natural U7 snRNA promoter 
results in substantial misprocessing of the U7 snRNA processing reporter as evidenced by 
robust fluorescence arising in these cells in the absence of any other treatment (Fig. 2-6D, 
top).  Addition of Int9 dsRNA to these cells to knock down this essential processing factor 
does not give increased fluorescence (Fig. 2-6D, bottom), indicating that the presence of the 
strong constitutive promoter results in nearly complete failure to process the snRNA.  This 
contrasts markedly with the original U7 snRNA processing reporter containing the U7 
snRNA promoter, which shows almost no fluorescence when treated with mock dsRNA, but 
presents robust fluorescence when dsRNA targeting Int9 is added (Fig. 2-6B and E).  Thus 
processing of the U7 snRNA does not occur when transcription is initiated from the 
Drosophila actin promoter. 
 In order to test whether the promoter requirement is absolute, a construct was made 
with the Drosophila histone H3 promoter in place of the normal U7 promoter.  When treated 
with mock dsRNA, these cells displayed fluorescence that was greater than that of cells 
transfected with the U7 promoter-driven reporter (Fig. 2-6E).  However, unlike the reporter 
containing the Actin 5C promoter, addition of Int9 dsRNA resulted in a dramatic increase in 
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fluorescence (Fig. 2-6E).  This suggests that the histone promoter allows some processing of 
the U7 snRNA, although processing is inefficient.  Whether this is because the histone 
promoter normally transcribes a non-polyadenylated mRNA is not known.  In mammalian 
cells and frog oocytes, snRNAs transcribed from histone promoters are not processed.  In sea 
urchins the snRNA transcripts transcribed from the histone promoter can be inefficiently 
processed, although other promoters were not tested.    
 Another property that was tested was whether the length of the U7 snRNA transcript 
affects processing efficiency.  Experiments with mammalian U1 snRNA suggested that 
processing of longer transcripts ending in snRNA 3’ ends was less efficient.  To test this, 
reporters were created in which pieces of the histone H3 gene of varying length were inserted 
in the middle of the U7 snRNA transcript.  Note that these constructs were made such that 
they contained no cryptic start codons to ensure that the EGFP ORF remained translatable in 
frame.  Introduction of an insert of 310 nt into the middle of the U7 transcript resulted in 
fluorescence off the reporter under mock RNAi conditions at levels similar to that of the 
histone H3 promoter-driven U7 snRNA reporter (Fig. 2-6E).  Also like the histone H3 
promoter-driven reporter, addition of Int9 to the reporter containing the extended U7 region 
elicited a robust fluorescence (Fig. 2-6E).  Thus this 380 nt transcript (containing the U7 
snRNA plus the histone fragment) was not processed efficiently, suggesting that there is a 
length dependence for maximally efficient processing of U7 snRNAs, and that longer 
transcripts were not processed efficiently.  Insertion of smaller fragments of the histone gene 
did not result in inefficient processing, consistent with the fact that these transcripts were of 
the size range (< 250nts) of normal snRNAs.  
67 
 
 
Discussion 
 
 The use of RNA interference coupled with visual reporter-based screening strategies 
has been a great addition to our molecular toolbox (Wagner et al., 2004; Levinson et al., 
2006) for studying transcription and alternative splicing.  In this chapter, I report the creation 
and implementation of a number of novel reporters that have been quite effective in 
broadening our understanding of 3’ end formation of RNA polymerase II transcripts, histone 
mRNAs and snRNAs.  These reporters can be designed to identify cis elements involved in 
different steps of metabolism of an RNA.  They can also help determine at what step a 
factors participates in metabolism of an RNA.  Finally, they also can be used to identify 
novel factors involved in metabolism of the RNA in vivo, for example by using these 
reporters in genome-wide screens utilizing RNAi.  Eric Wagner and I carried out a genome-
wide RNAi screen using the histone processing reporter (described in Chapter III) and Eric 
has subsequently carried out a successful genome-wide RNAi screen with the snRNA 
reporter.   
The histone promoter-driven histone pre-mRNA processing reporter allowed us to 
identify putative histone pre-mRNA processing factors on a genome-wide scale (Wagner et 
al., 2007).  However, this reporter would not detect any factors that are required for both 
transcription and processing.  The creation of the constitutive Actin 5C promoter-driven 
histone pre-mRNA processing reporter allows the detection of any factors involved in 
processing whether or not they are involved in other steps in histone mRNA biosynthesis.  
An unexpected advantage of this reporter is that it is active enough to be used when 
integrated into the genome.  The histone H3 promoter used in the Hisproc reporter was not 
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active enough to use after integration into a chromosome.  Thus the assay has evolved into a 
more sensitive and reproducible method that allows experimental time to be cut in half, since 
there is no transfection of the reporter.  This reporter was very useful in assessing the 
functional role of dFLASH in histone pre-mRNA processing (Yang et al., 2009), and is very 
easy to use to assay large numbers of factors, as it has in the secondary screening strategy for 
factors identified in the MPM-2 screen (White et al., in preparation).  Finally the histone 
promoter-driven EGFP construct allowed me to assess effects of factors on histone gene 
transcription.  Together these three reporters allow me to distinguish in which of the multiple 
steps in histone mRNA metabolism a factor participates. 
 
Design and Optimization of Histone mRNA Reporters 
 At the beginning of this work, several factors were known to be involved in histone 
pre-mRNA processing.  These factors include the stem loop binding protein (SLBP), the U7 
snRNP components Lsm10, Lsm11, and in mammals, ZFP100 and at least two proteins also 
involved in processing polyadenylated mRNAs, CPSF73 and Symplekin.  However, it 
seemed likely that there were other factors, potentially many more, which remained to be 
identified. 
In order to help in the identification of additional processing factors, a novel 
screening reporter was created.  The design of this reporter relied on a property of 
Drosophila histone genes noted previously, that downstream of the normal cleavage site of 
each of the histone genes there exist cryptic polyadenylation sites that are used when normal 
cleavage is inhibited (Lanzotti et al., 2002).  The initial design concept for the reporter 
included the histone ORF and downstream sequence containing the stem loop and histone 
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downstream element followed by an in-frame fluorescent protein ORF.  The idea behind this 
was to create an assay in which, under normal cellular conditions, the reporter will be 
transcribed and the 3’ processing elements will be bound by their respective processing 
factors, resulting in cleavage of the reporter mRNA in a way that mimics a normal histone 
mRNA.  In this case, the final reporter transcript will not contain the fluorescent protein 
coding region.  Thus, when the reporter message is translated, there will be no fluorescent 
protein made and the cells will exhibit no fluorescence.  However, if the histone pre-mRNA 
cleavage reaction is perturbed by depleting an essential processing factor, the reporter 
transcript will not be processed normally either.  Instead, the mature reporter mRNA will 
include the fluorescent protein coding region and this misprocessed message will become 
polyadenylated through use of a vector-encoded polyadenylation signal.  When these reporter 
messages are translated, a histone H3-fluorescent protein fusion will be created, which will 
cause the cells to appear green under a fluorescence microscope. 
Once the initial reporter design was decided upon, much work remained to be done.  
Included in this were experiments to choose a promoter to drive expression of the reporter, 
modification of downstream sequences, and a determination of which fluorescent protein to 
include downstream.  In the end, these experiments led to the creation of a construct that 
consisted of a histone H3 promoter driving a partial histone H3 ORF, without the stop codon, 
and downstream sequences modified to eliminate a cryptic stop codon in the HDE, followed 
by an enhanced green fluorescent protein (EGFP) coding region.   
When this construct was tested using RNAi-mediated depletion of known processing 
factors, cells produced robust green fluorescence.  Just as importantly, when factors unrelated 
to the histone pre-mRNA cleavage reaction were knocked down, very little signal was 
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observed.  These observations suggested that this reporter could be an effective tool for 
discovering proteins required for processing histone message. 
Though this reporter has been used with great success, most notably in the genome-
wide screen presented in Chapter III, one  concern about its design was whether the presence 
of the histone promoter driving its expression was essential.  There is evidence that, at least 
for some non-histone messages, the maturation of their mRNA 3’ ends is in some way 
coupled to transcription (Mifflin and Kellems, 1991; Cramer et al., 2001; Bentley, 2002; 
Proudfoot et al., 2002).  If this is the case with histone messages, then it seems likely that a 
factor that is required for both transcription and processing of the histone message would not 
score positively using the histone promoter-driven reporter because this promoter would be 
silenced.  To address this possibility, I designed several reporter constructs that incorporated 
a constitutive promoter in place of the histone promoter.  Three different promoters were 
tested, including Drosophila Actin 5C and α-tubulin at 48B promoters and the lepidopteron 
OpIE2 promoter.  In the end, the Actin 5C promoter was chosen, as it gave the best signal to 
noise ratio overall, although none of these reporters resulted in GFP synthesis in normal S2 
cells.  In an effort to make these reporter experiments as reproducible as possible, this 
construct was ultimately transfected into Drosophila D.Mel-2 cells, which were selected to 
create a stable cell line containing the reporter construct integrated into its genome.  The final 
result was a reporter that is not sensitive to depletion of histone-specific transcription factors, 
gives more robust fluorescence signal than the original reporter, and allows for more 
reproducible results in nearly half the time since the transfection step has been eliminated.  
The latter is a key advantage for screening factors that are possible processing factors but that 
71 
 
may also result in lethality before Day 5, which was the standard experimental length for the 
histone-promoter-driven reporter. 
Since its creation, the constitutive histone pre-mRNA reporter has been used to test a 
number of factors in targeted screens to determine whether they are required for processing 
histone pre-mRNA.  One highly successful use of this reporter is the initial characterization 
of dFLASH as a histone pre-mRNA processing factor (Yang et al., 2009), which is described 
in Chapter IV.  Another example includes the use of this reporter in a secondary screen of 
positive hits from a genome-wide screen for factors required for the existence of a specific 
cell cycle regulated phosphoepitope at the HLB (White et al., in preparation), as described in 
this chapter.  In each of these cases, novel factors were identified as putative processing 
factors that were not revealed during the genome-wide screen. 
In addition to detecting misprocessed histone message, I desired the ability to test 
factors for a role in transcription off the histone promoter.  To this end, an additional 
reporter, with the histone H3 promoter driving expression of GFP, was created that can be 
used to measure downregulation of histone transcription upon depletion of a factor of 
interest.  This reporter, while effectively expressed in the cell, does not offer as simple a 
readout as the processing reporters.  The reason for this is that, unlike the processing 
reporters, which rely on a gain-in-fluorescence phenotype that is easy to detect over 
background, this reporter utilizes a loss-of-fluorescence readout that can be difficult to detect 
by eye.  Though not employed in the experiments presented here, the use of quantification 
software or Western blotting for to quantify GFP levels should be a great help in this regard. 
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Application of the reporters: characterization of factors in the MPM-2 Screen 
The constitutive histone pre-mRNA processing reporter was has been employed 
extensively since it was created in an effort to identify putative processing factors that were 
missed in the original genome-wide screen.  In this role, it was used as part of a secondary 
screen of proteins identified as positive hits in a genome-wide antibody-based screen for 
factors that affect the existence of an MPM-2 reactive epitope at the HLB in Drosophila 
cultured cells (White et al., in preparation).  The MPM-2 antibody binds to a poorly defined 
phosphoepitope that in fly cells is cell cycle regulated and concentrates at the histone locus 
body.  The purpose of the screen was to identify the protein containing this MPM-2 reactive 
epitope, and further, to identify other gene products that affect its appearance at the HLB.  
Once the initial screen was complete, around 100 of the top hits were chosen for secondary 
screening.  Included in these secondary screens were additional antibody-based experiments 
to determine whether localization of other HLB factors is affected by depletion of the same 
proteins that cause the loss of the MPM-2 reactive epitope from the HLB. 
Initial hits from this screen, including Mxc, CG34415, and FLASH, as well as Spt6, 
which was identified by mass spectrometry of proteins co-immunoprecipitated with the 
MPM-2 antibody, were tested for any role in histone pre-mRNA processing and histone 
transcription.  Using the three reporters, I was able to determine that each of these factors 
likely participates in different ways in histone mRNA metabolism:  FLASH only affected 
processing, Mxc affected processing and transcription, and CG34415 and Spt6 only affected 
transcription.  Both Mxc and Spt6 partially reduced transcription, but CG34415 was essential 
for histone gene transcription. 
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At the conclusion of the MPM-2 antibody primary screen, the top 95 out of 140 hits 
were tested.  Interestingly, three factors that have been independently implicated in histone 
pre-mRNA processing were identified in the primary screen.  These factors were MBD-R2 
and MCRS1, which were positive hits in the original histone pre-mRNA processing screen 
(Wagner et al., 2007; Chapter III of this dissertation), and FLASH (Yang et al., 2009; 
Chapter IV of this dissertation).  Not surprisingly, these factors again scored positively in the 
secondary histone pre-mRNA processing screen.  Though FLASH was the only strong hit of 
the group, MBD-R2, MCRS1, and Mxc qualify as moderate hits, making them interesting 
targets for further study.  Though implicated as factors of interest, very little is currently 
known about any of the factors identified in this secondary screen beyond dFLASH (Yang et 
al., 2009; Chapter IV of this dissertation). 
Among the moderate hits from the secondary screen, MBD-R2, also known as 
TAM3, is represented by two protein species, one of 1169 amino acids and the other of 1081 
amino acids.  The sequences of these proteins are identical, with the exception of a THAP 
domain, which is a putative DNA binding domain, at the very N-terminus of the long form 
that is not found in the shorter protein.  Both protein species contain a methyl-CpG binding 
domain (MBD), for which the protein is named, that may function as a DNA binding motif.  
In addition, the protein contains putative PHD-finger and Tudor domains, which represent 
protein interaction domains.  Beyond the identification of these domains, very little is known 
about this protein in flies. 
Drosophila MCRS1, alternatively known as Reduction in Cnn dots 5 (Rcd5), is 578 
amino acids long and is the homolog to human microspherule protein 1 (MCRS1; also known 
as, MCRS2, p78, MSP58).  In both species, this protein contains a forkhead-associated 
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(FHA) domain, which binds phosphopeptides.  In humans, this protein is represented by 
several isoforms.  At least one of these localizes, at least in part, to the nucleolus, where it 
participates in upregulating transcription of ribosomal genes (Shimono et al., 2005).  Many 
other roles have been suggested for the isoforms of this protein, including enhancement of 
transcriptional repression (Du et al., 2006), participation in cell cycle regulation (Song et al., 
2004; Zhang et al., 2007), translational regulation (Davidovic et al., 2006), centrosome 
activity (Hirohashi et al., 2006), and telomere maintenance (Song et al., 2004).  It remains to 
be seen exactly how this protein may function in histone mRNA expression, but it is clear 
that depletion of this factor results in direct effects on the HLB and the processes that occur 
there. 
Mxc (multi sex combs) was identified as a moderate hit in my reporter assays.  This 
protein is 1837 amino acids long and contains a LisH domain in its N-terminus.  This domain 
is responsible for mediating protein-protein interactions, including dimerization and 
tetramerization.  Importantly, this protein localizes to the HLB and, based upon the reporter 
experiments in this chapter, appears to have a role in both histone gene transcription and 
histone mRNA 3’ end formation.  Because the amount of readthrough of the histone pre-
mRNA processing reporter is only moderate, it may be that this factor is more indirectly 
involved in the processing reaction, perhaps through some structural role at the HLB.  
Indeed, it has been observed that depletion of this protein in fly cells results in delocalization 
of other HLB-localizing factors, including dFLASH (White et al., in preparation), which is 
reminiscent of the result of knocking down NPAT in human cells.  Based upon this and other 
collected evidence, as well as the presence of a LisH domain that is 51 % identical between 
the two proteins, it almost certain that this protein is the Drosophila NPAT homolog. 
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Are DNA Replication and Histone mRNA Biosynthesis coupled? 
Depletion of DNA replication factors in Drosophila cultured cells reduces 
transcription of histone mRNA, as assayed by the histone promoter-driven transcriptional 
reporter.  This agrees with results from mammalian cells that show a 3-4 fold reduction in the 
rate of histone gene transcription, as well as rapid degradation of histone mRNA when DNA 
replication is inhibited.  Combined with destabilization of histone message, as has been 
observed in mammals, transcriptional silencing is an effective strategy to prevent the toxic 
accumulation of free histone proteins under these conditions.  The results of experiments 
using the constitutive 3’ end processing reporter suggest that, while there is some amount of 
misprocessed histone message under conditions of DNA replication factor depletion, there is 
not nearly the effect as one would see for RNAi versus a dedicated processing factor.  This 
seems to rule out the possibility of perturbations in DNA replication directly targeting a 
histone pre-mRNA processing factor.  Instead, it seems to point to a scenario in which any 
effect on histone pre-mRNA processing is secondary and likely arises as a consequence of a 
more global response to DNA replication inhibition. 
Of note from these experiments, treating cells with dsRNAs targeting the ORC 
subunits did not result in any appreciable effect on cell growth or viability, not matter which 
subunit was targeted.  Indeed, use of dsRNAs targeting two independent regions within each 
of the ORC subunits resulted in nothing more aberrant than a slight slowing of cell 
proliferation, if any defect was observed at all.  This may suggest insufficient knockdown of 
the ORC subunits or redundant functions within the cell.  The result of knocking down Dup 
is more in line with what one might expect; that is, the cells show a distinct morphological 
phenotype, in this case very small cells, and then die within a few days.  As might be 
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expected, depletion of geminin, which actively inhibits the action of Dup during the cell 
cycle to prevent rereplication, results in cells that are very large, presumably due to their 
existence in a perpetually active S phase during which the cell continues to grow and the 
genome is replicated again and again. 
 
Using Reporters to Help Characterize U7 snRNA 3’ End Formation 
The snRNA reporters described in this chapter have been a great help to our 
understanding of the U7 snRNA processing reaction.  The original screening reporter was 
used by Dr. Eric Wagner for his genome-wide screen for U7 snRNA processing factors 
(Wagner et al., in preparation), and subsequent reporters made by me have given us greater 
insight into how the structure of the U7 snRNA gene affects the processing reaction.  
Together, all of these reporters have contributed to a more complete understanding of critical 
mechanisms within the cell. 
 In addition to their usefulness in detecting misprocessing of histone mRNA 3’ ends, 
reporters can be used to identify factors involved in the 3’ end processing reactions of other 
RNAs, including small nuclear RNAs (snRNAs).  Such an approach to gene discovery again 
utilizes the basic elements of the original screening reporter, that is, a promoter to drive the 
reporter transcript and a way to detect readthrough of the normal cut site, such as inclusion of 
a fluorescent protein ORF downstream.  In addition to identifying factors involved in 
processing these RNAs, other aspects of their metabolism can be tested using similar reporter 
strategies.  For example the cis elements required for snRNA 3’ end formation have not been 
thoroughly described in Drosophila, and introducing mutations into the reporter allows 
detection of sequences required for snRNA 3’ end formation.  In this way, properties such as 
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promoter, sequence element, and transcript length requirements can be identified and 
characterized in a way that may not be as easily detectable by other means. 
 There have been many studies that have addressed the link between transcription and 
3’ end formation and some of these point to the promoter as a crucial determinant of 
processing efficiency.  It is known in vertebrates that recognition of an essential processing 
element at the 3’ end of the snRNA transcript, known as the 3’ box, only occurs when the 
snRNA is transcribed off of an snRNA promoter (Neuman de Vegvar et al., 1986; Hernandez 
and Weiner, 1986).  Indeed, use of a histone promoter to drive an snRNA transcript results in 
transcriptional readthrough and failure to form mature snRNAs (Pilch and Marzluff, 1991; 
Ramamurthy et al., 1996).  Only recently was the mechanism of 3’ end formation of snRNAs 
elucidated with the discovery of the Integrator complex, a multi-subunit complex containing 
homologues of CPSF73 and CPSF100, that likely cleaves the pre-snRNA cotranscriptionally.  
While there is a conserved downstream element in snRNA genes, an AU rich 3’ box, there is 
not a conserved upstream element and what sequences are required for snRNA 3’ end 
formation are not known.  Indeed substitution of a histone stem loop (or mutant stem loop 
with the stem reversed), allows efficient 3’ end formation (Ramamurthy et al., 1996).   
In addition, phosphorylation of the CTD of RNA polymerase II on Ser7, and possibly 
Ser2, has been implicated in efficient snRNA 3’ end formation (Medlin et al., 2003; Medlin 
et al., 2005; Jacobs et al., 2004; Egloff et al., 2007).  This requirement suggests that the 
Integrator complex, which contains the snRNA cleavage factor (Baillat et al., 2005), is 
recruited to the RNA pol II CTD only when the Ser7 residue is phosphorylated (Egloff et al., 
2007).  It has been postulated that this interaction may involve the concerted action of an 
snRNA promoter-specific protein, proximal sequence element-binding transcription factor 
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(PTF), and the CTD of pol II to actively recruit processing factors, including the Integrator 
complex, to the snRNA 3’ end (Egloff et al., 2008). 
 Despite early work that determined promoter and sequence elements required for 
correct processing of spliceosomal snRNAs (Hernandez and Weiner, 1986; Neuman de 
Vegvar et al., 1986; Ach and Weiner, 1987; Wendelburg and Marzluff, 1992a,b) and the 
identification of the Integrator complex as a mediator of snRNA 3’ end formation for the 
RNA polymerase II-transcribed spliceosomal snRNAs U1 and U2 (Baillat et al., 2005), very 
little is known about U7 snRNA 3’ end formation.  Since U7 snRNA is transcribed by RNA 
pol II and the Integrator complex directly interacts with the RNA pol II large subunit 
carboxy-terminal domain (CTD), one may reason that this complex is also required for 
processing U7 snRNA.  However, experimental evidence that this is indeed the case is just 
now coming to light with the results of a very recent genome-wide RNAi screen carried out 
by Dr. Eric Wagner (Wagner et al., in preparation).  From this work, it has been determined 
that only a subset of the Integrator subunits are functionally required for U7 snRNA 
processing, which is reminiscent of the findings from the histone pre-mRNA processing 
screen in which only select cleavage and polyadenylation factors are required for processing 
histone mRNA.  Interestingly, two of the Integrator factors are homologs of two of the core 
CPSF factors, with Int11 and Int9 sharing homology with CPSF73 and CPSF100, 
respectively (Dominski et al., 2005).  In addition to these key results, further work from this 
study has gone on to elucidate processing signals within the region downstream of the cut 
site that are required for proper processing of U7 snRNA.  In collaboration, I devised a 
number of reporter constructs to help determine any promoter and length requirements for 
U7 snRNA processing. 
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 By creating reporters in which the U7 promoter was substituted with other promoters 
of varying strengths and characteristics, I hoped to gain better insight into any promoter 
dependence of the U7 snRNA processing reaction.  These experiments revealed that 
inclusion of the Actin 5C promoter, which is strong and constitutively active, resulted in very 
high levels of reporter readthrough.  Indeed, even RNAi-mediated depletion of the Int9 
subunit of the Integrator complex, which results in high levels of misprocessing, did not 
enhance the fluorescence signal from the reporter suggesting that there was essentially no 
snRNA 3’ end formation when the actin promoter was used.  However, when the histone H3 
promoter was substituted, there was detectable fluorescence, but it was not nearly the amount 
that was seen for the actin promoter, and knockdown of int9 resulted in a large increase of 
fluorescence, consistent with the interpretation that the histone promoter could direct snRNA 
3’ end formation, although not efficiently.  Interestingly, this is similar to results obtained for 
the U1 snRNA in sea urchin.  In these experiments, Wendleburg and Marzluff found that, in 
contrast to vertebrate snRNAs, 3’ end formation of the sea urchin U1 snRNA does not 
require the snRNA promoter and further, that substitution of a histone promoter still results 
in correct processing of U1 snRNA with about 50% efficiency (Wendelburg and Marzluff, 
1992b).  Together with my results from fly cells, this supports the idea that snRNA 
processing requirements vary between vertebrates and invertebrates, and that invertebrate 
histone promoters are compatible with snRNA 3’ end formation at a reduced efficiency 
compared to snRNA promoters. 
 A dependence of vertebrate snRNA 3’ end formation on the length of the transcript 
was previously reported (Ramamurthy et al., 1996).  In addition to testing the promoter 
requirement of U7 snRNA 3’ end formation, I also tested whether there is a transcript length 
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requirement in Drosophila.  To do this, I used a construct much like the original U7 snRNA 
screening reporter, but with a portion of the histone H3 gene inserted into the middle of the 
region encoding the U7 transcript.  These constructs were designed such that no cryptic start 
codons were included in the insert sequence.  When an insert of 310 nt was included in the 
U7 transcript, making the transcript length about 370 nts, misprocessing of the reporter was 
evident to a level similar to that of the histone promoter-driven construct, with the level of 
fluorescence well below that arising when Int9 is depleted from the cells. 
These results illustrate that maximal U7 snRNA processing efficiency is dependent 
upon a U7 snRNA transcript that this sufficiently short, which agrees with data from a study 
of U1 snRNAs in which the efficiency of processing was dependent upon the length of the 
insert (Ramamurthy et al., 1996).  In this study, the researchers found that transcripts less 
than 350 nts resulted in processing efficiency above 90 %, while efficiency dropped to 50-70 
% for transcripts of 450 nt and to 10-20 % when the insert length was extended above 650 nt 
(Ramamurthy et al., 1996).  The reason behind this may lie in the observation that the 
transcriptional machinery can pause or terminate with relative ease earlier in transcription, 
but sometime during elongation this attribute changes, making the polymerase resistant to 
termination (Kephart et al., 1992; Marshall and Price, 1992).  In this way, a sufficiently close 
3’ box may permit the transcriptional machinery to pause or terminate, allowing the 
processing factors associated with the polymerase to cleave the pre-snRNA.  However, if the 
distance between the promoter and the 3’ box is sufficiently large, the polymerase may enter 
a more pause-resistant state, reducing the amount of time the processing machinery has to 
cleave the snRNA and effectively decreasing processing efficiency. 
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The Possible Use of Reporters to Detect Inhibitory Factors 
 The use of reporters to detect factors that are required for a cellular function, such as 
histone pre-mRNA processing, is a highly effective method of gene discovery.  However, 
determining the identity of these factors may only tell half the story.  The mechanisms that 
occur within the cell are very complex and often changing, being both upregulated and 
downregulated at a given moment depending upon the needs of the cell and the dictates of 
the cell’s internal and external environments.  Therefore, just as important as those factors 
that allow a process to go forward are those factors that actively work to inhibit it.  
Expression of a factor that inhibits pre-mRNA or snRNA processing will also result in 
synthesis of GFP.   
 As shown in Chapter IV of this dissertation, introduction of a recombinant FLASH 
protein missing part of its N-terminus into a stable cell line containing a GFP-based, 
constitutively expressed histone pre-mRNA processing reporter results in misprocessing of 
the reporter and green fluorescence.  In this case, this protein functions as a dominant 
negative, actively inhibiting processing of histone pre-mRNA 3’ ends.  A natural inhibitor of 
histone pre-mRNA processing would act in much the same way.  Introduction of this protein 
in sufficient quantities into a cell harboring the reporter should prevent proper cleavage of the 
reporter message, and presumably the endogenous histone message, resulting in detectable 
green fluorescence.  Thus, a candidate factor can be overexpressed in the reporter cell line 
and assessed for inhibitory activity based upon this readout.  This should not be too difficult 
on a very small scale with a limited number of putative inhibitory factors to test.  However, if 
one wishes to screen the genome for these factors, the task becomes a bit more daunting.  
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The challenge, then, is to find a way to individually overexpress every protein in the cell in a 
way that is conducive to high throughput screening. 
 One way to address this is to develop an overexpression screening library, which 
contains all of the protein-encoding sequences in the genome subcloned into an expression 
vector and driven by a strong promoter.  These clones could be arrayed into plates, together 
with a transfection reagent, and cells added to initiate the transfection, in much the same was 
as dsRNA is added to the wells prior to performing an RNAi-based screen.  Cells stably 
expressing the GFP-based reporter construct can then be plated into these wells and allowed 
to take in the DNA.  After an appropriate incubation period, the cells can be viewed using 
fluorescence microscopy to determine any increase in GFP fluorescence over the negative 
control.  The result of these experiments would be a list of possible factors that act as 
inhibitors of RNA 3’ end formation.  Once these factors have been identified, it may be 
possible, depending upon your system, to validate the hits biochemically.  In the case of 
histone pre-mRNA processing, this would include in vitro processing assays.  Further 
experiments, including crosslinking and immunoprecipitation assays, among others, may 
help define the mechanism of inhibition. 
 Though the reporters presented in this chapter have been very useful coupled with 
RNA interference to deplete factors of interest, this is not the limit of their applicability.  
These reporters can also be used to screen chemical compounds to find pharmaceutical 
inhibitors of transcription or RNA 3’ end formation.  The availability of small molecule 
libraries is increasing, examples of which exist locally at UNC Chapel Hill and the 
Biomanufacturing Research Institute and Technology Enterprise (BRITE) program at North 
Carolina Central University.  These libraries allow high throughput screening of thousands of 
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chemical compounds, making it possible to discover compounds that one day might find 
therapeutic use in human health and/or provide valuable reagents that can be used by 
researchers to more effectively study key processes in the cell. 
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Table 2-1.  Oligonucleotides used to create DNA template for transcription of dsRNAs.  
Shown is a list of oligonucleotides that were used to prime amplification of DNA to make 
template for transcription.  The final amplicon contained T7 promoter sequences on each 
end, allowing for transcription off of both strands.  “Target” indicates the gene being 
amplified, “Annotation ID” is the CG number for that gene, “Forward” and “Reverse” 
indicate primers that prime in these orientations with respect to the gene being amplified.  
Note that the T7 promoter sequence is abbreviated as “T7” for brevity.  The T7 promoter 
sequence is GGTAATACGACTCACTATAGGG. 
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Target Annotation ID Forward Reverse 
PTB CG31000 T7-GCCCATAGCGACTACAGC T7-TGGAATGAATTGTTCTTTGTGAA 
LSM10 CG12938 T7-ATGCAGCAGTTTAGTGCG T7-TTAGGTTTCCTTATTCTT 
LSM11 CG12924 T7-ATGGAATCGAGGGACCGGAAAAC T7-CAACAGTTCACCCTCGACACTGCC 
SLBP CG11886 T7-TCCAGTTCCTTGAATAGCAG T7-AGTCCGCTCGTCCTTTG 
FLASH CG4616 T7-CGAAAGTAAGCGTCCGAAAG T7-ATTCCTGTGATGATCTCGCC 
MXC CG12124 T7-CCCATGAATCTGGCAAAGAA T7-AACTGGGGCGTATCCATAAT 
MUTE CG34415 T7-TTCCCCTCAAGTCGACAAAC T7-TTCCGATCTATCTTCGGTGG 
SPT6 CG12225 T7-TGAAAATGAACGGGATGTCA T7-GCGTGTATGGCGTATTGATG 
COILIN CG8710 T7-ATGTTCCGCGCATATTTCA T7-AACATCCTTCGAATCAACGT 
ORC1 CG10667 T7-GCCCAGGCGCAGTATTC T7-CCAGTGCCCGGAACTCC 
ORC2 CG3041 T7-AGCGATGCTGGCAACTC T7-TATCCAGCATATCCTTGATGG 
ORC3 CG4088 T7-AAAGAGGTAGTGCAGCAGCC T7-AAAACCAATGTCTCAACGGC 
ORC5 CG7833 T7-GAACAGTTCGCCCAGGATAA T7-GCATAGTAGGGCAGCTCCAG 
MCM3 CG4206 T7-AGCAAGGAGAGCAATTTGGA T7-GGTCTCCTGATCCGTGGTAA 
MCM5 CG4082 T7-TATCGCTGTCGACGTTCAAG T7-TGAGTGTTTCCTGGTCCTCC 
DUP CG8171 T7-ATGTCGCCGCGTCACA T7-GGATTCATGGACGTCGACT 
GEMININ CG3183 T7-ATCACGGCAGAGGATCTCAC T7-TTAGACCAGCCGTTGTGTTG 
INT9 CG5222 T7-GGTCTTTTGTGGCCATCCTA T7-TAAATTCGATCCAGCTTCCG 
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Figure 2-1.  Creation and validation of a histone pre-mRNA processing reporter.  (A) 
Diagram of the design and action of the Hisproc reporter under normal conditions (top) and 
when an essential processing factor has been depleted (bottom).  (B) Drosophila D.Mel-2 
cells were treated with dsRNAs targeting the indicated factors for 3 days before transfecting 
with the Hisproc reporter.  Two days later, cells were viewed under a fluorescence microscope 
to detect GFP signal.  dsRNAs targeting LacZ and dPTB are used as negative controls, 
dsRNAs targeting dLsm10, dLsm11, and dSLBP are used as positive controls.  A 2’-OCH3 
oligonucleotide targeting the U7 snRNA was also used as a positive control.  (C) Western 
blot analysis of the cells from Panel B.  Antibodies targeting dLsm11, dLsm10, and dSLBP 
were used to indicate knockdown of these factors. An antibody to GFP was used to detect 
translated misprocessed reporter.  (D) S1 nuclease protection assay probing histone H2A and 
using total RNA from Drosophila S2 cells and oligo(dT)-selected poly(A) mRNA from S2 
cells treated with dsRNA to dLsm11.  A diagram of the S1 nuclease assay is shown below 
the figure.  Abbreviations:  Hisproc = histone H3 promoter-driven histone pre-mRNA 
processing reporter; RNAPII = DNA dependent RNA polymerase II; H3 ORF = histone H3 
open reading frame; SLBP = stem loop binding protein; HDE = histone downstream element; 
EGFP = green fluorescent protein; pA = polyadenylation signal; LacZ = β-galactosidase; 
dPTB = pyrimidine tract binding protein; dLsm = Sm-like protein; dU7 2’-OCH3, U7, and α-
U72’Ome = 2’-O-methyl oligonucleotide; α-dLsm11, α-dLsm10, α-SLBP, and α-GFP = 
antibodies targeting these factors. 
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Figure 2-2.  Optimization of the histone pre-mRNA processing reporter for use in high-
throughput experiments.  (A) Plating strategy for optimization of the conditions for 
screening for histone pre-mRNA processing factors in 384-well format.  Cells were treated 
with varying amounts of reporter DNA, dsRNAs targeting dPTB (negative control) or 
dLsm11 (positive control), and Effectene reagents (enhancer and Effectene).  Cells were 
treated with dsRNAs or 2’-OCH3 oligonucleotide for 3 days before transfection of the Hisproc 
reporter with Effectene reagent.  Cells were then incubated for 2 additional days before 
viewing on a fluorescence microscope.  (B). Final image of the 384-well plate after running a 
Metamorph algorithm to convert the GFP signal into vertical bars with height corresponding 
to the intensity of the signal (top).  Zoomed images of three matched wells from the 
experiment that were subjected to the same transfection conditions, but different dsRNAs.  
Abbreviations:  Hisproc = histone H3 promoter-driven histone pre-mRNA processing reporter; 
GFP = green fluorescent protein. 
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Figure 2-3.  Creation and validation of a constitutively expressed histone pre-mRNA 
processing reporter and a histone transcription reporter.  (A) Diagram showing the 
features of the Actproc reporter (top).  Drosophila D.Mel-2 cells stably expressing the Actproc 
reporter were treated with dsRNAs targeting dPTB (negative control) or dSLBP (positive 
control) and incubated for 3 days before viewing on a fluorescence microscope to detect GFP 
signal (bottom).  (B) Total RNA taken from the cells in Panel A were used as template for 
PCR either with (+) or without (-) prior reverse transcription to detect read-though histone 
mRNA transcripts.  A diagram of the histone-specific primer targets is shown below.  (C) 
Drosophila D.Mel-2 cells stably expressing the Histrans reporter were treated with dsRNAs 
targeting dPTB and dSLBP for 3 days and viewed using a fluorescence microscope to detect 
GFP.  Abbreviations:  Actproc = actin 5C promoter-driven histone pre-mRNA processing 
reporter; Histrans = histone H3 promoter-driven transcription reporter; prm = promoter; ORF = 
open reading frame; EGFP = enhanced green fluorescent protein; pA = polyadenylation 
signal; PTB = pyrimidine tract binding protein; SLBP = stem loop binding protein. 
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Figure 2-4.  Using reporters to determine steps in histone mRNA metabolism in which 
specific proteins function.  (A) Drosophila D.Mel-2 cells were treated with dsRNAs 
targeting the indicated factors and after 3 days, were transfected with the Hisproc reporter.  
Two days later, the cells were viewed using a fluorescence microscope to detect GFP signal.  
(B) Drosophila D.Mel-2 cells containing the Actproc reporter were treated with dsRNAs 
targeting the indicated factors and after 5 days, were viewed using a fluorescence microscope 
to detect GFP signal.  (C) Drosophila D.Mel-2 cells were treated with dsRNAs targeting the 
indicated factors and after 3 days, were transfected with the Histrans reporter.  Two days later, 
the cells were viewed using a fluorescence microscope to detect GFP signal.  (D) Drosophila 
D.Mel-2 cells containing the Actproc reporter were treated with dsRNAs targeting nearly 100 
factors from the genome-wide MPM-2 antibody screen (Anne White).  Shown is a 
representation of some of these factors.  Note that Mute was negative, FLASH scored very 
strongly positive, and the remainder scored weakly (above background) to moderately 
positive.  Abbreviations:  Hisproc = histone H3 promoter-driven histone pre-mRNA 
processing reporter; Actproc = actin 5C promoter-driven histone pre-mRNA processing 
reporter; Histrans = histone H3 promoter-driven histone transcription reporter; GFP = green 
fluorescent protein. 
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Figure 2-5.  Effect of depletion of DNA replication factors on histone mRNA 
metabolism.   (A) Drosophila D.Mel-2 cells were depleted of dPTB, dSLBP, dORC1, or 
dORC3, incubated 3 days and transfected with the Histrans reporter.  As a control, a second 
reporter, containing an Actin 5C promoter driving GFP, was used.  Cells were viewed after 5 
days using a fluorescence microscope to detect GFP.  (B) Drosophila D.Mel-2 cells were 
depleted of dPTB, dSLBP, dORC1, or dORC3, incubated 3 days and transfected with the 
Actproc reporter.  Cells were viewed 2 days later using a fluorescence microscope to detect 
GFP.  (C) Drosophila D.Mel-2 cells stably expressing the Actproc reporter were depleted of 
dPTB, dSLBP, dORC1, or dORC3.  Cells were viewed after 5 days using a fluorescence 
microscope to detect GFP.  (D) Drosophila D.Mel-2 cells stably expressing the Actproc 
reporter were treated with dsRNAs targeting dPTB, dLsm11,dMcm3, or dMcm5 and viewed 
after 5 days using a fluorescence microscope to detect GFP.  (E) Drosophila D.Mel-2 cells 
stably expressing the Actproc reporter were treated with dsRNAs targeting dPTB,dSLBP, 
Dup, or dGem and viewed after 3 days using a fluorescence microscope to detect GFP signal 
(top).  A zoomed image of cells treated with dsRNA targeting Dup or Gem is shown in 
comparison to mock treated cells (bottom).  Note the small size of cells depleted of Dup and 
the large size of cells depleted of Gem relative to the control.  All images are shown at 100X 
magnification.  Abbreviations:  Histrans = histone H3 promoter-driven histone transcription 
reporter; Acttrans = actin 5C promoter-driven transcription reporter; Actproc = actin 5C 
promoter-driven histone pre-mRNA processing reporter; GFP = green fluorescent protein; 
dPTB = pyrimidine tract binding protein; SLBP = stem loop binding protein; ORC = origin 
recognition complex subunit; dLsm11 = Sm-like protein 11; Mcm = minichromosome 
maintenance protein subunit; Dup = doubleparked (Drosophila Cdt1); dGem = geminin. 
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Figure 2-6.  The use of novel reporters to characterize U7 pre-snRNA processing.  (A)  
Diagram of the U7 pre-snRNA processing screening reporter.  (B)  Drosophila D.Mel-2 cells 
were treated with dsRNAs to PTB (negative control), CPSF30 (negative control), and Int9, 
incubated 3 days, transfected with the U7 pre-snRNA processing reporter and viewed using a 
fluorescence miscrosope to detect GFP 2 days later (left).  Western blot analysis of protein 
lysates from these cells using antibodies targeting Symplekin (loading control) and GFP (to 
aid in quantification of fluorescence) (right).  (C)  Diagram of U7 snRNA processing 
reporters containing either a U7 promoter or Actin 5C promoter (top).  Drosophila D.Mel-2 
cells were transfected with the indicated reporter and viewed after 3 days using a 
fluorescence microscope to detect GFP (bottom).  RNAi was not used.  (D)  Diagram of U7 
snRNA processing reporters containing either a U7 snRNA or histone H3 promoter driving a 
wild type U7 transcript sequence or a U7 snRNA promoter driving a U7 snRNA sequence 
containing an insertion from the histone H3 gene (top).  Drosophila D.Mel-2 cells were 
transfected with the indicated reporter and treated with mock dsRNA or dsRNA targeting 
Int9 after 3 days, then viewed on a fluorescence microscope to detect GFP after 2 more days 
(bottom).  Abbreviations:  U7 = U7 snRNA transcript; GFP = green fluorescent protein; Int9 
= integrator subunit 9; Eip63 = ecdysone-induced protein 63; αHDE = U7 snRNA sequence 
complementary to the histone downstream element in histone mRNA; Sm = Sm binding 
region; AUG = start codon; EGFP = enhanced green fluorescent protein; UGA = stop codon; 
PTB = pyrimidine tract binding protein; CPSF30 = cleavage and polyadenylation specificity 
factor subunit 30; Int9 = integrator subunit 9; α-Sym = antibody targeting Symplekin; α-GFP 
= antibody targeting GFP.  These experiments were carried out with rotation student, Kirston 
Barton.  (Panels A, B courtesy of Eric Wagner) 
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CHAPTER III 
A GENOME-WIDE RNA INTERFERENCE SCREEN FOR HISTONE PRE-MRNA 
PROCESSING FACTORS 
Introduction 
 
 Metazoan histone pre-mRNAs lack introns and require only a single 3’ end 
processing event to form mature mRNA, which terminates in an evolutionarily conserved 
stem loop (SL) rather than a polyA tail.  Processing occurs by endonucleolytic cleavage 
downstream of the SL and 5’ of a purine-rich sequence, the histone downstream element 
(HDE) (Fig. 1A).  Cleavage requires a protein that binds the SL (the Stem Loop Binding 
Protein or SLBP) (Wang et al., 1996), and U7 snRNP, which interacts with the HDE via 
base-pairing with U7 snRNA (Mowry and Steitz, 1987).  The 3’ SL remains bound by SLBP 
and is necessary for the export, translation, and eventual decay of histone mRNA.  Thus, 
accurate pre-mRNA processing is essential for the expression of histones during S phase. 
 A number of histone pre-mRNA processing factors have been identified from 
mammals, Drosophila, and Xenopus, including SLBP, U7 snRNA, and U7 snRNP-specific 
components Lsm11, Lsm10, and ZFP100 (Dominski et al., 2002; Pillai et al., 2001; Pillai et 
al., 2003).  Recent in vitro experiments have unexpectedly found that factors involved in the 
canonical cleavage/polyadenylation reaction, such as CPSF73 and Symplekin, also 
participate in histone pre-mRNA processing (Dominski et al., 2005; Kolev and Steitz, 2005).  
However, it is unclear whether all or only a subset of the cleavage/polyadenylation factors 
are necessary for processing histone pre-mRNAs.  To address this and to identify additional 
factors necessary for histone pre-mRNA processing in intact cells, we carried out a genome 
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wide RNA interference screen in cultured Drosophila cells to identify proteins necessary for 
production of mature histone mRNA.    
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Materials and Methods 
 
Cloning of GFP reporter 
The histone pre-mRNA processing reporter was created by subcloning the histone H3 
promoter, partial open reading frame, downstream sequence, and an EGFP coding sequence 
into a promoterless pIZ/V5/His vector backbone (Invitrogen).  Briefly, the histone H3 5’UTR 
and amino acids 1-67 were amplified by PCR using forward primer 5’ 
GGCCGAATTCCGACAAAAAC CCGAGAGAGTAC 3’ and reverse primer 5’ 
GGCCGGTACCTTAGGCAGCTTG CGGATTAGAAGC 3’ and subcloned into pEGFPN1 
(Clontech, Palo Alto CA) using EcoRI and KpnI. The 3’ end of the H3 gene starting 
immediately after the stop codon and continuing until 18 nt downstream of the HDE 
was amplified using forward primer 5’ GGCCGGTACCACTTGCAGAT 
AAAGCGCTAGCG 3’ and reverse primer 5’ GGCCGGATCCTTGTTATAAATAG 
TCGGCAACA GAAAATTTTTTCTC 3’ followed by ligation to the 5’ product using KpnI 
and BamHI. The resulting construct contained the H3 promoter, amino acids 1-67 of 
histone H3 ORF, and H3 3’ end containing a portion of the downstream intergenic 
region upstream of an EGFP ORF. Note that the H3 ORF is in frame with GFP and that 
we created a single mutation (U to A) within the HDE in order to disrupt a stop codon 
(red box in Fig. S1). The OpIE2 promoter was removed from pIZ-V5/His (Invitrogen, 
Carlsbad CA) vector by inverse PCR using forward primer 5’ GGCCGCTAGCACAG 
CATCTGTTCGAATTTA 3’ and reverse primer 5’ GGCCGCTAGCAGACAT 
GATAAGATACATTGATGA 3’ followed by digestion with NheI and religation. The 
reporter was then subcloned into the promoterless pIZ/V5/His vector using forward primer 5’ 
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GGCCGAATTCCGACAAAAACCCGAGAGAG TAC 3’ and reverse primer 5’ 
GGCCTCTAGATTACTTGTACAGCTCGTCCAT GCC 3’ followed by digestion with 
EcoRI and XbaI and subsequent ligation to form the pIZ/H3p/H3/GFP construct.  Note that 
the polyA site used by the GFP ORF is the insect OpIE2 polyadenylation sequences 3’ of the 
XbaI site in the pIZ/V5/His vector. 
 
Construction of transgenic Drosophila expressing the histone/GFP reporter 
The GFP reporter was subcloned into pCaSpeR-4 to generate transgenic Drosophila.  
Brains dissected from wandering third instar larvae of the genotype w1118; P [GFP reporter]/P 
[GFP reporter]; U7EY11305/ U7EY11305 or w1118; P [GFP reporter]/P [GFP reporter]; Slbp15 / 
Slbp15 were fixed for 20 minutes in 4% formaldehyde/PBS, incubated with 1o antibodies 
rabbit α-GFP (1:1000; Upstate) and mouse α -phosphotyrosine (1:500; Abcam) followed by 
2o antibodies goat α -rabbit-Cy2 (1:500; Abcam) and goat α-mouse-Cy3 (1:500; Abcam), 
mounted in fluoromount-G (Southern Biotech), and analyzed with a Zeiss 510 Laser 
scanning confocal microscope.     
 
Immunofluorescence of Polytene Nuclei and Brains 
Salivary glands from early wandering 3rd instar larvae were dissected into 1X PBS 
containing 0.1% Triton-X-100. Glands were fixed for 2 minutes in 3.7% 
paraformaldehyde in 1X PBS-Triton X-100, and then for 2 minutes in 3.7% 
paraformaldehyde/50% acetic acid. Glands were immediately squashed and gently 
tapped under a coverslip onto a polylysine Q coated slide. Slides were washed 3X in 
PBS containing 0.1% Tween 20. Slides were incubated in the following primary 
112 
 
antibodies diluted in PBS-Tween 20 overnight at 37 degrees: HP1 (mouse C1A9 1:100 
from Developmental Studies Hybridoma Bank, rabbit Lsm11 1:200 generously provided 
by Dr. Joe Gall (Carnegie Institute)). Slides were washed 3X in PBS-Tween 20, and 
incubated at room temperature for 1 hour with mouse α-Cy3 (1:500) or rabbit α-Cy5 (1:500) 
(Jackson Immunolabs). Slides were washed 1X in PBS-Tween 20 and stained with DAPI 
(1mg/ml) 1:1000 for 1 minute. Slides were washed in the dark 3X in PBS-Tween 20 and 
mounted in Fluoromount medium. Brains from wandering 3rd instar larvae were dissected 
into 0.1% Triton X-100 in PBS. They were then fixed in 4.5% formaldehyde in 0.1% Triton 
X-100 in PBS for 22 minutes. Brains were washed 3X in 0.1% Triton X-100 in PBS and 
subsequently treated for 1 hour in 1% Triton X-100 in PBS. Samples were blocked for 1 hour 
at RT in 5% Normal Goat Serum in 0.1% Triton X-100 in PBS. After blocking, samples were 
washed 3X in 0.1% Triton X-100 in PBS. Samples were incubated with primary antibodies 
overnight at 37 °C (rabbit α-Lsm11 (1:1000), mouse α-MPM-2 (1:1000) (Upstate)). Slides 
were washed 3X in 0.1% Triton X-100 in PBS, and incubated at room temperature for 1 hour 
with mouse α-Cy3 (1:500) or rabbit α-Cy5 (1:500). Slides were washed three times in 0.1% 
Triton X-100 in PBS and mounted with Fluoromount media. 
 
Cell culture and transfection 
D.Mel-2 cells (Invitrogen) were grown in serum free conditions in SF900II-SFM 
media (Invitrogen).  For RNA interference in 384-well plates, 8000 cells were plated in each 
well in 10 µl of serum free media and incubated with 250ng of dsRNA resuspended in 5 µl of 
water.  Cells were allowed to grow unperturbed for 72 hours.  On the third day, 20 µls of 
serum free media was added to each well. Transfections were performed using Effectene 
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reagent (Qiagen) with a master mix using the following conditions per well:  50 ng of GFP 
reporter was incubated in 8.75 µl of EC reagent at RT for 5 minutes.  0.2 µl of Enhancer 
reagent was added to the DNA and incubated at RT for 5 minutes.  0.3 µl of Effectene 
reagent was added to the mixture and incubated for 10 minutes at RT.  10 µl of the mixture 
was pipetted into each well containing cells growing in 35 µl of serum free media.  For hit 
validation, the RNA interference was done identically with the exception that cells were 
supplemented with an additional 500ng of dsRNA 12 hours post transfection and hence 
received two doses of dsRNA. For 6 well transfections, 2 X106 cells were plated in 2 mls of 
serum free media, followed by addition of 10µg of dsRNA.  Each of the following 2 days an 
additional 10µg of dsRNA was added.  The next day cells were transfected with 400ng of 
reporter using the manufacturer’s protocols. 
 
Genome-wide RNA interference 
The screen was performed at the Drosophila RNAi Screening Center (DRSC) at 
Harvard University.  250ng of each dsRNA included in the library are pre-aliquotted into 
384-well, black-walled, clear-bottom plates at a concentration of 50ng/ul.  The library of 
22,000 dsRNAs was distributed into a total of 63 384-well plates and each plate had an 
empty well in grid position B1 in which the 2’-OCH3 oligonucleotide to Drosophila U7 
snRNA was added as a positive control.  In grid position B2 of each plate there is a dsRNA 
against thread which kills the Dml-2 cells to control for the effectiveness of the RNAi. 
 The screen was performed as follows: On Day 0, 8000 D.Mel-2 cells in a total of 10 
µl of Drosophila SFM-II media (Gibco) plus antibiotic/antimycotic solution (1X) were plated 
into each well using a Wellmate microplate dispenser (Matrix Technologies).  After plating, 
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the cells were incubated in a 24oC humidified incubator (Percival).  On Day 3, 20 µl of SFM-
II media were added to the cells, followed by transfection of the reporter construct into the 
cells according to the transfection protocol outline above using the microplate dispenser.  
Following transfection, the cells were incubated at 24 ºC for two more days.  They were 
imaged using the Discovery-1 high content screen system (Molecular Devices) equipped 
with a CataLyst Express (Thermo Scientific) robotic arm.  Each plate was imaged using a 4x 
objective lens using a FITC filter set (ex. 470 nm).  Using the Metamorph software suite 
(Molecular Devices) included with the imaging system, the images from each plate were 
combined into a 384-image collage and converted into fluorescence intensity plots using the 
software within the Metamorph program. 
 We compared the fluorescence signal in each well visually to that of surrounding 
wells and to the well containing the U7 2’-OCH3 oligonucleotide.  Positive hits were 
independently scored by two people (BDB and EJW).  Our compiled lists were combined 
and each hit subsequently scored on a scale from 1-3, with “1” being a weak hit, “2” a 
moderate hit, and “3” a strong hit.  To validate the hits, we synthesized templates and 
dsRNAs to 90 hits and used these dsRNAs in repeated RNA interference/reporter 
transfection experiments (N>6).  dsRNAs reproducibly resulting in increased fluorescence 
were included in the final list. 
 
S1 Nuclease Protection Assay 
 To create the probe construct for the assay, Drosophila histone H2A sequence was 
cloned into a TA vector.  From a standard plasmid preparation (Qiagen), aproximately 3 µg 
of the plasmid was combined with 2 µl 10X bovine serum albumin (NEB), 2 µl 10X 
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NEBuffer 3 (NEB), qs to 18 µl with dH2O, and 2 µl BspE I restriction enzyme (NEB), for a 
total reaction volume of 20 µl.  The digest was then incubated at 37 °C for 2 h.  Next, the 
reaction was purified using a PCR purification kit (Qiagen) and eluted the digested DNA in 
Buffer EB (Qiagen) for a final volume of 28 µl.  The result of the initial digest was a 
linearized construct with a 5'-CCGG-3' overhang at the 5' end of the histone H2A sequence. 
 To label the DNA, the purified digest was combined with 4 µl 10X dG,A,T 
deoxynucleotide mix, 4.5 µl 10X NEBuffer 2 (NEB), 4 µl α-P32 dCTP (MP Biomedicals), 
and 3 µl large fragment of DNA polI (Klenow) enzyme (NEB), for a total reaction volume of 
43.5 µl.  The reaction was incubated at 25 °C for 20 min.  This reaction results in the filling-
in of the recessed 3’ end and 3’-end labeling of the histone H2A sequence with α-P32 dCTP. 
 After the labeling reaction, the reaction was spun through a ProbeQuant G-50 Micro 
Column (Amersham) to remove unincorporated deoxynucleotides.  Next, to the cleaned-up, 
labeled construct 5 µl 10X BSA (NEB), 1 µl 10X NEBuffer2 (NEB), and 4 µl HindIII 
restriction enzyme (NEB) was added for a total reaction volume of 60 µl.  The reaction was 
then incubated at 37 °C for 2 h.  After incubation, the reaction was run on a 2 % agarose gel 
and the labeled fragment was purified using a gel extraction kit (Qiagen).  These steps result 
in a 650 nt, labeled histone H2A probe that is ready to be used in the S1 nuclease protection 
assay. 
 For the S1 nuclease protection assay, 5 µg total RNA from D.Mel-2 cells was 
combined with 1 µl of the labeled histone H2A probe and the solution was dried using a 
Speedvac SC100 (Savant).  The dried RNA-probe pellet was resuspended in 10 µl 1X 
hybridization buffer (40 mM Pipes, pH 6.4, 500 mM NaCl, 1 mM EDTA, 80 % deionized 
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formamide) and boiled for 5 minutes.  After boiling, the samples were incubated at 52 °C 
overnight to allow hybridization of the probe to its target RNA sequence. 
 After hybridization, 80 µl dH2O, 9 µl 10X S1 buffer (Promega), and 0.6 µl S1 enzyme 
(Promega) was added to the samples followed by incubation at 25 °C for 1.5 h.  After 
incubation, the DNA/RNA hybrids were precipitated by adding 300 µl 100 % ethanol and 1 
µl GlycoBlue (Ambion) to each sample and placing the samples at – 80 °C for 30 minutes.  
After precipitation, the samples were centrifuged at 16000xg in an Eppendorf 5415C 
microcentrifuge for 30 minutes at 4 °C.  After removing the supernatant, the pellet was 
washed with 80 % ethanol and spun the samples again at 16000xg for 10 min. at 4 °C.  The 
ethanol was then removed and the samples were allowed to air dry.  After the pellets had 
dried, they were resuspended in 40 µl formamide loading dye (>99 % formamide with 
bromophenol blue and xylene cyanole), boiled for 5 min. and loaded onto a 6 % Sequagel 
Sequencing System acrylamide gel (National Diagnostics) in 1X TBE (Tris-borate-EDTA) 
buffer. 
 After running the gel, the gel was dried on a SGD200 Slab Gel Drier (Savant) for 1.5 
hours at 80 °C.  After drying, the gel was placed either on a storage phosphor screen 
(Molecular Dynamics) or onto blue autoradiography film (Denville Scientific) for detection.  
Phosphor screens were developed on a Storm Scanner (Amersham), and film was developed 
using a SRX-101A film developer (Konica). 
 
RT-PCR Analysis 
D.Mel-2 cells were treated with dsRNA for three consecutive days and then allowed 
to grow for two more days. The cells were then harvested and total RNA was isolated 
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using Trizol reagent (Invitrogen). 4 µg of RNA was used for a reverse transcription 
reaction using random hexamers as primers according to manufacturer’s protocols 
(MMLV, Invitrogen). Drosophila PTB was amplified using standard PCR techniques 
using primers F 5’GTTTCTTTAAAGTGGGTAGCGACC 3’ and R 
5’TGGTGGCCAGGTCCTGATTGTC 3’ at 35 cycles (55 °C annealing temp) and 
resolved on a 3% agarose gel using ethidium staining to visualize PCR products. 
Analysis of the CPSFs and CstFs were done using the following primer sets and cycling 
conditions: CPSF30 primers F 5’GCATCCGCACTTCGAGCTGCCC 3’ and R 5’ 
TTGACGAAGCCGGGACCATGC 3’ using 63°C as an annealing temp. and 32 cycles. 
CPSF73 primers F 5’GTATGATGCAGTCGGGATTGTCGC 3’ and R 5’ 
TGCTCGCCGTGGACGAGCACGAC 3’ using 63°C as an annealing temp and 28 
cycles. CPSF100 primers F 5’ AGAGAGCAGTTCCGAGTCCGAGG 3’ and R 5’ 
AACTCATAGCCTGTCGCATCCGC 3’ at an annealing temp or 60°C and 28 cycles. 
CPSF160 primers F 5’TGTCGGTAATCTCGGACAGCAGC 3’ and R 5’ 
CCTTTCACTGTGAATAGTCCTG 3’ using 49°C as an annealing temp. and 40 cycles. 
CstF50 primers F 5’ CCCGGAACCACATTCCTACGAAACC 3’ and R 5’ 
TCGCGCGAGGCGGAGGCCAGGA 3’ using 55°C as an annealing temp and 37 cycles. 
CstF 64 primers F 5’ GGCCAATGTCCATCCGAACGATATCG 3’ and R 5’ 
TGCTGAGGACCAGGTCCTGCCC3’ using 61°C as an annealing temp and 36 cycles. 
CstF77 primers F 5’ ACGAGTCGCTAGTTAATGTGTTTCC 3’ and R 5’ 
CTGAACGAGTGTAGATCCATGCCG 3’ using 55°C as an annealing temp and 36 
cycles. Symplekin primers F 5’ CCTTCAGTCGAGAGCCGCCAATGC 3’ and R 5’ 
AGTTGCGTGGCAGAGGCTTGGTG 3’ using 63°C as an annealing temp and 36 
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cycles. Fip1 primers F 5’ GAGGAACCCTTCTTCCACGAGCC 3’ and R 5’ 
GTTGGGTGGCATAATGCCGCGCAA 3’ using 55°C as an annealing temp and 36 
cycles. 
To the analyze the expression of the domino gene, 2µg of total RNA from D.Mel-2 
cells was incubated with 200ng of random hexamer primers (GE Healthcare Bio- 
Sciences AB) at 95°C for 1 minute and cooled to room temperature. Reverse 
transcription reactions were done in a total of volume of 20 µl according to 
manufacturer’s protocols (Invitrogen). 2 µl of each RT reaction was used as template 
for a PCR reaction using the cycling conditions: 95ºC/30sec, 57.5ºC/30sec, and 
72ºC/40sec for a total of 32 cycles. The domino B isoform was amplified using the 
primer set: F 5’ GCCAAAGC TGCCGAAGAAAGAAG 3’ and R 5’ CACCACTGACTGC 
TGCTGATGAG ‘3. The domino A isoform was amplified using the primer set: F 
5‘ATCAGCTCAAGCCCT GGCTGCGG 3’, and R 5’ CCAGCGGTTG 
GACCCGCAATACTT 3’. All RT-PCR products were sequenced to confirm identity and 
in all cases there were no products in the absence of RT. 
Western Blot Analysis 
D.Mel-2 cells were lysed in a buffer containing 50mM Tris-HCl (pH 8.3), 0.1% NP-
40, and 50mM NaCl for 30’ on ice. Lysates were separated with SDS-PAGE using 
standard techniques and were then transferred to immobilon-PVDF membrane (Biorad, 
Hercules CA) and probed with either a 1:1000 dilution of an α-GFP JL8 monoclonal 
antibody (Clontech), a 1:1000 dilution of α-dSLBP antibody (10), a 1:1000 dilution of α- 
Lsm11 antibody, or a 1:1000 dilution of α-Lsm10 antibody (24). Blots were then probed 
using a secondary HRP-conjugated antibody and developed using chemiluminescence. 
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Sufficient material could be obtained for Western blotting using cells from 6 wells of a 
384 well plate. 
Northern Blot 
RNA was isolated from wandering third instar H2Av mutant larvae of the genotype 
w1118; +/+; H2Av810/H2Av810 (identified using a TM6B balancer) using TRIzol Reagent 
(Gibco/Invitrogen). 2 µg of total RNA from each sample was resolved by formaldehyde 
agarose gel electrophoresis, and probed with probes to either the histone H3 or histone 
H2a coding regions. 
 
Nuclear extracts from RNAi treated cells 
107 D.Mel-2 cells were plated in 10 mls of SFII-900M media and incubated with 
100µg of dsRNA.  The same amount of dsRNA was added to the culture each day for 2 more 
days.  The cells were allowed to grow for 2 more days and then were harvested.  Nuclear 
extracts were prepared as described previously (Dominski et al., 2002) with the exception 
that the cells were lysed in Buffer A using 40 strokes through a 27.5 gauge needle.  Lysates 
were dialyzed overnight in Buffer D using a slide-a-lyzer cassette (Pierce).  Processing 
reactions were done using 12.5µl of nuclear extract and in conditions described previously 
(Dominski et al., 2002). 
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Results 
 
Creation and validation of the histone pre-mRNA processing reporter 
To facilitate screening, we developed a visual reporter assay for histone pre-mRNA 
processing.  The mini-gene reporter contains a GFP ORF and polyadenylation signal 
downstream of the SL and HDE of the histone H3 gene (Fig. 1B).  Normal histone pre-
mRNA processing results in mRNA lacking the GFP ORF, while misprocessing leads to 
read-through transcription and production of mRNA encoding GFP.  Transgenic flies 
containing the reporter display robust GFP expression in U7 snRNA or Slbp null mutant 
brains compared to wild type controls (Fig. 3-1C).  Thus, the reporter accurately reflects the 
requirements for endogenous histone mRNA biosynthesis. 
Transfection of the reporter into D.Mel-2 cells depleted of SLBP using dsRNA, or 
with U7 snRNA inhibited using a 2’OCH3 oligonucleotide complementary to the 5’ end of 
U7 snRNA (αU7), resulted in GFP expression (Fig. 3-1D). Little GFP signal was seen in 
cells treated with control dsRNA or a 2’OCH3 oligonucleotide complementary to human U7 
snRNA (Fig. 3-1E).  GFP expression occurred after SLBP depletion despite only a low 
amount of transcriptional readthrough of the endogenous histone genes (Fig. 3-1F, lane 3 and 
5; Fig. S2) and a modest (10-20%) readthrough of the reporter gene (Fig. 3-1F, lane 7), 
underscoring the sensitivity of the reporter to small amounts of misprocessing.  
  
Genome-wide RNAi screen for factors that participate in histone pre-mRNA processing 
 Using this reporter we performed a genome-wide RNAi screen at the Drosophila 
RNAi Screening Center (www.flyrnai.org) (Boutros et al., 2004).  D.Mel-2 cells were 
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incubated with dsRNA for 3 days, transfected with the reporter, and analyzed by 
fluorescence microscopy 48 hours later. About 22,000 dsRNAs were tested in duplicate, 
resulting in 63 collages of 384-well plates.  Plate 18 is shown as an example (Fig.2- 2A).  
The two positive wells (Fig. 3-2A, inset) contained dsRNA targeting the Drosophila 
orthologs of the human Lsm10 and Lsm11 proteins, specific components of the U7snRNP 
(Azzouz and Schumperli, 2003).  We synthesized these dsRNAs and found they knocked 
down endogenous Lsm10 and Lsm11 proteins (Fig 3-2B). 
By visual inspection, we initially scored 354 genes as potentially positive (Appendix 
A).  We synthesized dsRNA targeting each of the top 90 genes and assayed them under 
identical conditions.  Of these, 24 were found to score repeatedly above background (Fig. 3-
3A).  We designed dsRNAs targeting two independent regions of these factors (Fig. 3-3B).  
Each of the identified factors scored positively using the first set of dsRNAs (Fig. 3-3C) and 
were confirmed with dsRNA targeting a second site of the mRNA (Fig. 3-3D).  Western blot 
analysis of protein taken from RNAi-treated cells transfected with the reporter verifies 
enhanced expression of GFP when these factors are depleted (Fig. 3-3E).   
 
Only four of the polyadenylation factors are required for histone pre-mRNA processing 
in vivo. 
 While it has been suggested that many of the proteins involved in cleavage and 
polyadenylation might have some role in histone pre-mRNA processing (Kolev and Steitz, 
2005), only four of these 9 factors (CPSF73, CPSF100, Symplekin, and Fip1) scored in our 
screen.  We depleted each of the 9 known factors involved in cleavage/polyadenylation and 
only the same four factors activated the reporter (Fig. 3-4A, B).  All of the dsRNA-treated 
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cells grew at near normal rates, suggesting that polyadenylation factors are present in excess 
in D.Mel-2 cells.  Indeed, the reporter requires polyadenylation to score positively.  To 
determine whether the dsRNA treatment for each of the polyadenylation factors caused a 
functional reduction in polyadenylation, we tested the usage of polyadenylation sites in 
domino mRNA, which has short and long isoforms resulting from utilization of two different 
polyadenylation sites within distinct 3’ terminal exons (Ruhf et al., 2001).  Depletion of 7 of 
the 9 polyadenylation factors we tested resulted in increased usage of the distal domino 
polyadenylation site (Fig. 3-4C).  Depletion of CPSF30, CstF64, or CstF50 resulted in the 
greatest usage of the distal polyadenylation site, although there was no effect on histone pre-
mRNA processing.  In contrast, knockdown of Symplekin scored strongly for histone pre-
mRNA processing but did not affect polyadenylation of domino mRNA.  We conclude that 
only a subset of cleavage/polyadenylation factors is necessary for histone pre-mRNA 
processing in Drosophila cultured cells.   
 
Symplekin is concentrated in the histone locus body. 
 A nuclear structure termed the histone locus body (HLB) is associated with the 
Drosophila histone gene cluster (Liu et al., 2006).  The HLB is distinct from the Drosophila 
Cajal body, which contains SMN and the U85 snRNA (Liu et al., 2006).  U7 snRNP is 
enriched in the HLB and is visualized with antibodies against Lsm11 (Fig. 3-4D).  Other 
components of the HLB are likely involved in histone mRNA biosynthesis.  We transiently 
or stably expressed Myc-tagged versions of the proteins identified in the screen and analyzed 
their localization with anti-Myc antibodies.  Most of these proteins localized to the nucleus 
but did not concentrate in subnuclear foci.  An exception was Myc-tagged Symplekin, which 
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concentrated in the HLB (Fig. 3-4D).  Myc-MCRS1 was detected in several nuclear foci, one 
of which often overlapped with the HLB (Fig. 3-4D).  In HeLa cells, the MCRS1 orthologue 
localizes to several discrete nuclear foci (Davidovic et al., 2006), some of which are 
coincident with Cajal bodies (EJW, WFM unpublished).  Myc-tagged CPSF100 and CPSF73 
did not specifically concentrate in the HLB.  All known mammalian U7 snRNP proteins 
(Lsm10, Lsm11 and ZFP100) localize to Cajal bodies.  The failure to find additional proteins 
in the HLB other than Symplekin, Lsm10, and Lsm11, suggests that we did not identify any 
U7 snRNP-specific proteins.   
 
Depletion of the histone variant H2Av prevents localization of U7 snRNP to the HLB 
and histone pre-mRNA processing 
 Our screen unexpectedly identified the variant histone proteins H3.3 and H2Av, 
which are expressed from polyadenylated mRNAs whose synthesis is not replication-
coupled.  The role of H2Av in histone pre-mRNA processing was confirmed in vivo by 
transgenic reporter gene expression in H2Av null mutant larvae (Fig. 3-5A).  Northern blot 
analysis demonstrated read-through of both endogenous histone H3 and H2A mRNA (Fig. 
5B).  Loss of H2Av expression might cause misprocessing of histone pre-mRNAs because of 
increased histone gene transcription, which itself might reduce processing efficiency.  This is 
unlikely as the RNAi-mediated depletion of H2Av also results in misprocessing of a strong 
actin promoter-driven reporter construct (Fig. 3-5C).  
 To determine how H2Av contributes to histone pre-mRNA processing, we assessed 
the localization and activity of processing factors in H2Av-depleted cells.  In wild type 
salivary gland nuclei, Lsm11 antibodies detect the HLB as a prominent focus adjacent to the 
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chromocenter, visualized by HP1 staining (Fig. 3-5D).  In contrast, there was no detectable 
Lsm11 focus in H2Av mutant salivary gland nuclei (Fig. 3-5D).  To determine whether the 
HLB had assembled, Mpm-2 monoclonal antibodies, which stain a phosphoprotein present in 
the HLB during S-phase (White et al., 2007), were used to analyze both brains from H2Av 
mutant larvae (Fig. 3-5E) and cultured cells with H2Av knocked down (Fig. 3-4D).  All cells 
in the wild-type larval brain contained an HLB stained by Lsm11, which co-localized with 
Mpm-2 staining in cells positive for Mpm-2.  In contrast, many cells in H2Av mutant larval 
brains contained foci stained by Mpm-2 and lacked foci stained by Lsm11 (Fig. 3-5E, 
bottom).  Similarly, numerous H2Av-depeleted D.Mel-2 cells contained Mpm-2 foci but not 
Lsm11 foci (Fig. 3-5F).  Thus, H2Av depletion results in a loss of Lsm11 from the HLB. 
Western blot analysis of lysates from H2Av dsRNA treated cells demonstrated that, 
in addition to a reduction in H2Av protein levels, there was also a slight decrease in the level 
of Lsm11 protein (Fig. 3-5G, top three panels). There is a similar reduction in the level of 
U7snRNA (Fig. 3-5G bottom panel).  The Lsm11 mRNA levels were unchanged in H2Av 
depleted cells relative to a control mRNA (Fig. 3-5G lower panels).  Therefore, the 
misprocessing seen in H2AV null flies could result from either mislocalization of the 
processing machinery or a consequence of reduced levels of U7 snRNP.  To address this 
question, we prepared nuclear extracts from control cells (PTB dsRNA), and cells treated 
with H2Av, Lsm11, or SLBP dsRNA and asked if they were competent to process a synthetic 
histone pre-mRNA substrate.  We analyzed processing after a 1hr incubation of a labeled 
histone pre-mRNA substrate in equal amounts of the various nuclear extracts (Fig. 3-5H).  
Depleting Lsm11 or SLBP greatly reduced processing (Fig. 3-5H).  Mixing the extracts from 
Lsm11 and SLBP depleted cells restored activity (Fig. 3-5H, lane 5), indicating that the 
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knockdown removed only the expected component required for processing.  Strikingly, 
extracts from cells with H2Av knocked down had the same activity as control extracts (Fig. 
3-5H, lanes 1 vs. 3), and could rescue processing when mixed 1:1 with either SLBP- or 
Lsm11-depleted extracts (lanes 6 and 7).  The failure to accumulate U7 snRNP at the HLB 
resulted in a slight decrease in the overall level of U7snRNP that was not sufficient to reduce 
the processing activity in H2Av-depleted cells. More importantly, these data suggest- that the 
defect in processing in H2Av mutants in vivo is a result of a failure to localize U7 snRNP to 
the HLB, and not a defect in any processing factor.  
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Discussion 
 
 Here we report the use of a novel reporter assay to identify factors that participate in 
histone pre-mRNA processing.  The assay was based on our observation that mutation of 
either the Slbp or U7 snRNA genes in Drosophila results in expression of incorrectly 
processed histone mRNAs (Godfrey et al., 2006; Sullivan et al., 2001).  These misprocessed 
mRNAs are polyadenylated due to transcriptional read-through and subsequent usage of 
canonical polyadenylation signals downstream of the HDE.  We postulated that read-through 
to a downstream polyadenylation site would be a general phenotype associated with reduced 
expression of any factor required for histone pre-mRNA processing, and designed a mini-
gene capable of reporting histone pre-mRNA misprocessing. 
Using the histone pre-mRNA processing reporter to screen a genome-wide 
Drosophila RNAi library, we discovered 24 factors that play some role in histone pre-mRNA 
processing.  We identified 5 previously known components of the histone pre-mRNA 
processing machinery (SLBP, Lsm11, Lsm10, Symplekin, and CPSF73).  Among the other 
19 genes are 2 cleavage/polyadenylation factors (CPSF100, Fip1), 4 proteins involved in 
chromatin structure and assembly (H2a.V, H3.3A, H3.3B, Asf1), 4 zinc finger proteins 
(MBD-R2, CG17361, Lola, CG9684), and 4 known/putative signaling molecules (RACK1, 
CG8866, CKIIα-iI, Cdk2).  Many of these proteins (all of which have potential mammalian 
orthologues) are largely unstudied, except for the mammalian SR protein 9G8, implicated in 
alternative splicing (Cramer et al., 2001) and histone mRNA nuclear export (Huang et al., 
2003);  the cyclin-dependent kinase Cdk2, essential for progression through S-phase 
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(Knoblich et al., 1994), and NELF-E, a component of the negative transcription elongation 
factor (Wu et al., 2005).  We did not identify proteins required for U7 snRNP biosynthesis, 
such as SMN, snRNA transcription factors, or Integrator factors required for snRNA 3’ end 
formation (Baillat et al., 2005), suggesting that the screen detected factors directly involved 
in histone pre-mRNA processing.  None of these dsRNAs had a large effect on cell growth.  
In contrast, dsRNAs against spliceosomal Sm proteins, some of which are also components 
of U7 snRNP, all caused cell death, accounting for our failure to identify these proteins in the 
screen. 
 
Polyadenylation factors and histone pre-mRNA processing 
Biochemical fractionation of histone pre-mRNA processing factors from human cells 
suggested many of the proteins involved in cleavage and polyadenylation might be involved 
in histone pre-mRNA processing (Kolev and Steitz, 2005).  However, only four of these, 
CPSF73, CPSF100, Symplekin, and Fip1, were identified in our genome-wide screen.  
CPSF73 (Dominski et al., 2005) and Symplekin (Kolev and Steitz, 2005) were previously 
identified as histone pre-mRNA processing factors, and CPSF100 interacts with CPSF73.  
CPSF73 and CPSF100 each contain a nucleolytic β-lactamase domain, although this domain 
may be inactive in CPSF100 (Mandel et al., 2006).  Based upon crosslinking experiments, it 
appears likely that CPSF73 is the nuclease responsible for cleaving the histone pre-mRNA to 
form mature histone mRNA (Dominski et al., 2005).  Symplekin, first identified as a 
component of tight junctions (Keon et al., 1996), likely acts as a scaffold for assembly of 
other processing factors, while the role of Fip1 in processing is less clear. 
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The role of histone variants in histone pre-mRNA processing 
From the screen, we identified three variant histone proteins, H2Av, H3.3A, and 
H3.3B, suggesting that these proteins have a role in processing replication-dependent histone 
pre-mRNAs.  H3.3 is assembled into chromatin preferentially at active genes, and can be 
incorporated in the absence of DNA replication (Ahmad and Henikoff, 2002).  Drosophila 
H2Av is a functional orthologue of both human H2A.X and H2A.Z and plays an important 
role in defining the boundary between euchromatin and heterochromatin and in the DNA 
damage response (Swaminathan et al., 2005).  H2Av is present throughout the genome, 
including at the histone locus (Swaminathan et al., 2005; HRS and RJB, unpublished).  We 
find that depletion of H2Av in flies results in a failure to accumulate Lsm11 at the HLB, but 
that nuclear extract from cells RNAi depleted of H2Av exhibit no decrease in processing 
efficiency relative to that of control extract.  Further, mixing H2Av extract with extract from 
SLBP or Lsm11-depleted extract, which are inactive for processing, restored processing 
activity.  Together these data suggest that H2Av has some role in recruitment of U7 snRNP 
to the site of processing rather than a direct effect on levels of essential processing factors. 
 
Conclusions 
 Here we present in vivo evidence that a subset of proteins involved in mRNA 
polyadenylation are also involved in the production of histone mRNAs, which are not 
polyadenylated, thus demonstrating a remarkable conservation in the machinery needed to 
generate different mRNA 3’ ends in animal cells.  We postulate that the histone pre-mRNA 
cleavage factor contains CPSF73/CPSF100, Symplekin and Fip1 and other polypeptides that 
may be among the uncharacterized proteins identified in the screen.  Of these, only 
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Symplekin may concentrate in the HLB, consistent with its proposed role in organizing the 
active cleavage factor (Kolev and Steitz, 2005).    
 Since we did not identify known factors in snRNA or snRNP biosynthesis, many of 
the proteins identified in our screen are likely directly involved in histone pre-mRNA 
processing.  In addition, we identified factors that may regulate histone pre-mRNA 
processing, such as Cdk2, or serve to couple transcription and processing in vivo, such as 
NELF-E, recently shown to be required for efficient histone pre-mRNA processing in 
mammalian cells (Narita et al., 2007), and H2Av, necessary for concentration of the U7 
snRNP in the HLB.    
 This latter result suggests that cells balance assembly of variant and canonical 
histones by regulating pre-mRNA processing of the canonical histones.  Cells deficient in 
H2Av do not assemble the HLB properly, and the U7 snRNP particle is not concentrated in 
the HLB, although it is active.  The failure to properly localize the U7 snRNP to the HLB 
results in inefficient processing of the histone mRNA in vivo.  Future experiments will help 
determine whether the failure to localize U7 snRNP is due to a specific defect in the amount 
of H2Av at the histone locus, or to a general H2Av deficiency.   
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Figure 3-1.  A reporter for Drosophila histone pre-mRNA processing.  (A) Schematic of 
Drosophila histone pre-mRNA processing machinery.  (B) Diagram of Drosophila histone 
gene cluster showing the H3-H1 intergenic region containing the cryptic cleavage and 
polyadenylation sites (gray boxes) (Lanzotti et al., 2002), and a schematic of the reporter.  
(C) Confocal images of third instar larval brains containing the transgenic reporter and 
stained with anti-GFP (green), anti-phosphotyrosine (for cell cortex labeling; red) and DAPI 
(blue). Scale bar = 50 µm.  (D)  Left:  Brightfield (left) and fluorescence images (right) of 
D.Mel-2 cells treated with dsRNA to PTB (control) or SLBP or with the αU7 
oligonucleotide.  Right:  Corresponding Western blot analysis.  (E) Bright field and 
fluorescence images and corresponding western blot analysis of cells treated with PTB 
dsRNA or a 2’O-CH3 oligonucleotide targeting Drosophila or human U7 snRNA.  (F) S1 
nuclease protection assay (schematic at bottom) of endogenous H2A mRNA (lanes 2-5) or 
the reporter mRNA (lanes 6,7) isolated from D.Mel-2 cells treated with PTB dsRNA (lanes 
2, 4, 6) or a dsRNA that activated read through (lanes 3,5,7). Note that lanes 4 and 5 are a 
darker exposure of lanes 2 and 3.  Lane 1 contains input probe. Abbreviations:  GFP = green 
fluorescent protein; PTB = pyrimidine tract binding protein; SLBP = stem loop binding 
protein.  (panel C courtesy of Ashley Godfrey) 
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Figure 3-2.  Example plate from the screen.  (A) Fluorescence images of D.Mel-2 cells 
grown on plate 18 of dsRNA library and transfected with reporter. Cells in column 1, row 2 
were treated with αU7 oligonucleotide.  The inset is a higher magnification view of 16 wells, 
two of which contain dsRNA for Lsm10 or Lsm11, from replicate experiments.  (B) Western 
blot analysis of lysates from D.Mel-2 cells treated with dsRNA targeting PTB (control), 
Lsm10, or Lsm11.  Abbreviations:  PTB = pyrimidine tract binding protein; Lsm = Sm-like. 
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Figure 3-3.  Results of the screen.  (A) Table of hits from the genome-wide screen 
categorized numerically by qualitative strength of reporter signal and by color for relevant 
domains or putative/known functions.  (B) Schematic of nucleotide positions of all first and 
second site targeting with dsRNA.  The first targeting sites (labeled 1) were chosen by the 
DRSC and we designed the second sites not to overlap with the first, with the exception of 
CG17361 (due to its small size).  (C) Fluorescence microscopy of first site targeting relative 
to negative control dsRNA (PTB) and positive control dsRNA (CPSF73).  The lower panels 
are brightfield images.  (D) Fluorescence microscopy of second site targeting relative to 
negative control dsRNA (PTB) and positive control dsRNA (CPSF73).  Note that second site 
targeting was performed in serum-dependent S2 cells, and that the amount of fluorescence in 
the CPSF73 control (with site 1 oligonucleotide) was lower than in panel C.  (E) Lysates 
from D.Mel-2 cells treated with dsRNA targeting genes identified in the screen were 
analyzed by Western Blot.  Lysates were probed with α-GFP antibodies to detect the amount 
of readthrough from the reporter.  The asterisk indicates a background band that served as a 
loading control.  Abbreviations:  DRSC = Drosophila RNAi Screening Center; dsRNA = 
double stranded ribonucleic acid; CPSF = cleavage and polyadenylation specificity factor; S2 
= Schneider 2; GFP = green fluorescent protein. 
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Figure 3-4.  A subset of cleavage and polyadenylation factors is required for histone 
pre-mRNA processing. (A)  Fluorescence images of D.Mel-2 cells treated with dsRNA 
targeting the indicated genes and then transfected with reporter. (B)  Western blot analysis of 
lysates from cells in panel A.  (C) Top: Schematic of the 3’ end of the Drosophila domino 
gene containing two alternative polyadenylation sites. Bottom: RT-PCR analysis of domino 
mRNA after treatment of D.Mel-2 cells with the indicated dsRNAs.  Band A corresponds to 
use of the distal polyA site and band B to the proximal polyA site.  PCR products were 
cloned to confirm identity and in all cases there were no products in the absence of RT.  (D)  
Confocal images of D.Mel-2 cells transiently transfected with genes expressing the indicated 
myc-tagged proteins and stained with anti-Lsm11 (green) and anti-myc (red) antibodies.  In 
merged images, yellow arrows indicate colocalization of a myc-tagged protein with Lsm11 
and green arrows indicate HLB with Lsm11 only.  Note that all cells contained HLB, not all 
of which could be visualized in the particular focal plane shown. Abbreviations:  RT-PCR = 
reverse transcriptase polymerase chain reaction; HLB = histone locus body.  (panels C and D 
courtesy of Eric Wagner) 
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Figure 3-5.  Knockdown of histone variants affect canonical histone pre-mRNA 
processing. (A) Confocal microscopy images of third instar larval brains from H2Av null 
mutant flies containing the reporter and stained with anti-GFP (green), anti-phosphotyrosine 
(for cell cortex labeling; red) and DAPI (blue).  Scale bar = 50 µm.  (B) Top:  Western blot 
of H2Av from wild type and H2Av mutant 3rd instar larvae.  Bottom:  Northern blot of 
endogenous H2A mRNA (upper) and H3 mRNA (lower) from wild-type, H2Av null, and U7 
snRNA null mutant whole third instar larvae.  (C) D.Mel-2 cells were treated with either PTB 
dsRNA (negative control), Lsm11 dsRNA (positive control), or with dsRNA targeting H2Av.  
Cells were transfected with a GFP-based processing reporter driven by either the Actin 5C 
promoter or the histone H3 promoter and visualized for GFP expression and by brightfield.  
(D) Confocal images of salivary gland nuclei isolated from either wild type or H2Av null 
third instar larvae stained for DNA (DAPI, blue), Lsm11 (green), and HP1 (pink).  Scale bar 
= 20 µm.  (E,F) Confocal images of a region of a third instar larval brain from wild type or 
H2Av mutant (E) and D.Mel-2 cells treated with control dsRNA (PTB) or with H2Av dsRNA 
(F) stained for Lsm11 (green) and Mpm2 (red).  In the merged field, green arrows indicate 
HLB positive for Lsm11 and negative for Mpm-2 (cells not in S phase), yellow arrows 
indicate HLB containing both Lsm11 and Mpm-2 (cells in S phase), pink arrows indicate 
HLB with Mpm-2 and reduced levels of Lsm11, and red arrows indicate HLB in H2Av-
depleted cells that only contain Mpm-2.  Scale bar in panel E = 5 µm. Bottom panels in F are 
a higher magnification view of a different H2Av field.  (G) D.Mel-2 cells treated with PTB 
dsRNA or H2Av dsRNA were analyzed by Western blot for H2Av and Lsm11 protein (top 3 
panels). RNA prepared from the same cells served as a template for RT-PCR analysis for the 
indicated endogenous mRNAs (next 4 panels).  Note that the CstF77 RT-PCR serves as the 
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loading control for all of the RT-PCRs shown.  The bottom panel is a Northern blot analysis 
of U7 snRNA in the same RNAs used in the RTPCR analysis.  (H) In vitro processing of a 
labeled histone pre-mRNA incubated in nuclear extracts isolated from D.Mel-2 cells treated 
with the indicated dsRNA.  S/L, H/S, and H/L indicate processing reactions in a 1:1 mixture 
of nuclear extract from SLBP-, Lsm11-, or H2Av-depleted cells (S, L, H, respectively). 
Abbreviations:  H2Av = histone H2A variant; PTB = pyrimidine tract binding protein; Lsm = 
Sm-like; DAPI = 4’,6-diamidino-2-phenylindole; HP1 = heterochromatin protein 1; MPM-2 
= mitotic protein monoclonal #2; HLB = histone locus body.  (panels A, D, and E courtesy of 
Harmoney Salzler, panels B, F, and H courtesy of Eric Wagner, panel G done in 
collaboration with Eric Wagner) 
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CHAPTER IV 
CHARACTERIZATION OF THE INTERACTION BETWEEN FLASH AND LSM11 
IN DROSOPHILA 
Introduction 
 
 FLASH is a large (~2000 amino acid) protein originally identified as a protein 
involved in apoptosis, and later as a protein present in the mammalian histone locus bodies, 
where it was postulated to play a role in transcription of histone genes.  Zbig Dominski 
recently identified FLASH as a histone pre-mRNA processing factor, and in this chapter I 
show that the critical biochemical function of a putative Drosophila FLASH orthologue is in 
histone pre-mRNA processing.  
Fas-associated death domain-like IL-1-converting enzyme (FLICE) associated huge 
protein (FLASH), also known as caspase 8-associated protein 2 (CASP8AP2), is a multi-
functional protein with roles in apoptosis, cell cycle regulation, transcription, and histone 
expression.  This protein was first identified in a yeast-two-hybrid screen of a mouse T-cell 
cDNA library using two tandem-repeat death-effector domains (DED) of procaspase-8 as 
bait (Imai et al., 1999).  Further characterization revealed a DED-recruiting domain (DRD) at 
its C terminus between amino acids 1684-1785 that interacts with the DED domains of both 
caspase-8 (FLICE/MACH/Mch5) and FADD/MORT1, both involved in CD95/Fas-mediated 
apoptosis.  Previous studies showed that caspase-8, FADD, and activated CD95 form a pro-
apoptotic complex known as the death-inducing signaling complex (DISC).  Based upon this 
work and the observation that FLASH only associates with CD95 when CD95 is in its 
activated form, FLASH was classified as a new component of DISC (Imai et al., 1999).  In 
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agreement with a cytoplasmic role for FLASH, a putative nuclear exclusion signal (NES) 
was documented in the mouse protein between amino acids 1124-1133 (Imai et al., 1999).  
Interestingly, however, at least two putative nuclear localization signals (NLS), one from 
amino acids 1152-1169 and the other from 1813-1830, were also found, suggesting a more 
complex localization and functional profile for this protein (Imai et al., 1999). 
Although the early observations about FLASH all supported a primary role as a pro-
apoptotic protein, this notion began to change rapidly as additional functions of FLASH 
began to emerge that pointed to roles distinct from its participation in promoting apoptosis.  
One of the first of these diverse roles to be described was participation by FLASH in the 
NFκB pathway though its interaction with TRAF2.  This interaction, involving the region 
between amino acids 856-1191 in the human protein, is required for TNFα-induced NFκB 
activation (Choi et al., 2001).  Ultimately, this interaction results in the degradation of IκB, 
an inhibitor of NFκB, and accumulation of NFκB in the nucleus, which in turn allows 
transcription of NFκB responsive genes.  NFκB activation is part of a protective pathway that 
leads to cell proliferation and survival, thereby offering an interesting counterpoint to the role 
of FLASH in pro-apoptotic pathways and adding further complexity to our understanding of 
this protein. 
Despite these studies suggesting a purely cytoplasmic localization of FLASH, 
researchers began to describe functions of the protein that required nuclear localization.  One 
of these involves translocation of FLASH into the nucleus and its participation in the 
regulation of glucocorticoid target genes through a suppressive effect on members of the 
p160 family of steroid hormone receptor coactivators (Kino et al., 2003; Kino et al., 2004; 
Obradovic et al., 2004).  Specifically, FLASH is able to interact with glucocorticoid 
153 
 
receptor-interacting protein 1 (GRIP1), and thyroid hormone receptor activator molecule 1 
(TRAM1) through the nuclear-receptor binding domains of these proteins, thereby inhibiting 
the interaction between these proteins and the glucocorticoid receptor (GR) and preventing 
GR transcriptional activity (Kino et al., 2004).  This suppressive interaction involves the 
region of FLASH between amino acids 1709-1982, just downstream of the DRD (Kino et al., 
2004).   
Shortly after the initial glucocorticoid receptor studies, other researchers discovered a 
link between FLASH and histone gene expression.  In these studies, FLASH was shown to 
localize to Cajal bodies (Barcaroli et al., 2006a,b; Kiriyama et al., 2009; Yang et al., 2009) 
and, even more specifically, in the same bodies in which the histone transcriptional regulator 
p220NPAT (nuclease protein, ataxia-telangiectasia locus) is found.  Its localization to the 
histone locus was further indicated by chromatin immunoprecipitation experiments in which 
FLASH coprecipitated with histone gene chromatin (Barcaroli et al., 2006a).  Significantly, 
both the N-terminus and C-terminus of human FLASH are required for the formation of 
NPAT foci in the nucleus, suggesting that FLASH plays a critical role in organizing the HLB 
(Kiriyama et al., 2009).  These experiments demonstrated that FLASH is present on histone 
genes, leading Barcaroli and colleagues to postulate a role for FLASH in histone gene 
transcription (Barcaroli et al., 2006b).  The role of FLASH in histone gene transcription was 
further inferred from the observation that overexpression of FLASH results in increased 
transcription of a luciferase reporter construct driven by a histone H4 promoter (Barcaroli et 
al., 2006b).  In addition, FLASH was shown to be required, not only for NPAT body 
integrity, but for the integrity of the Cajal body, with loss of FLASH resulting in Cajal body 
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fragmentation, delocalization of NPAT from the histone locus, reduced levels of histone 
mRNA and protein, and arrest of cells in S-phase (Barcaroli et al., 2006a,b). 
Together, these studies point to a diversity of functions for FLASH and the 
importance of this protein’s participation in several critical pathways in the cell.  In addition 
to the functions described previously, FLASH has an additional role in RNA metabolism.  
Here, I discuss the newly-discovered role of the Drosophila orthologue of FLASH in histone 
pre-mRNA processing and describe characterization of key regions within the N-terminus of 
this protein that are required for its activity and localization to the Drosophila histone locus 
body. 
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Materials and Methods 
 
Creation of Reporter Constructs 
 The Hisproc reporter was created by subcloning the histone H3 promoter, partial open 
reading frame, downstream sequence, and an EGFP coding sequence into a promoterless 
pIZ/V5/His vector backbone (Invitrogen).  Briefly, the histone H3 5’UTR and amino acids 1-
67 were amplified by PCR using forward primer 5’ 
GGCCGAATTCCGACAAAAAC CCGAGAGAGTAC 3’ and reverse primer 5’ 
GGCCGGTACCTTAGGCAGCTTG CGGATTAGAAGC 3’ and subcloned into pEGFPN1 
(Clontech, Palo Alto CA) using EcoRI and KpnI. The 3’ end of the H3 gene starting 
immediately after the stop codon and continuing until 18 nt downstream of the HDE 
was amplified using forward primer 5’ GGCCGGTACCACTTGCAGAT 
AAAGCGCTAGCG 3’ and reverse primer 5’ GGCCGGATCCTTGTTATAAATAG 
TCGGCAACA GAAAATTTTTTCTC 3’ followed by ligation to the 5’ product using KpnI 
and BamHI. The resulting construct contained the H3 promoter, amino acids 1-67 of 
histone H3 ORF, and H3 3’ end containing a portion of the downstream intergenic 
region upstream of an EGFP ORF. Note that the H3 ORF is in frame with GFP and that 
we created a single mutation (U to A) within the HDE in order to disrupt a stop codon 
(red box in Fig. S1). The OpIE2 promoter was removed from pIZ-V5/His (Invitrogen, 
Carlsbad CA) vector by inverse PCR using forward primer 5’ GGCCGCTAGCACAG 
CATCTGTTCGAATTTA 3’ and reverse primer 5’ GGCCGCTAGCAGACAT 
GATAAGATACATTGATGA 3’ followed by digestion with NheI and religation. The 
reporter was then subcloned into the promoterless pIZ/V5/His vector using forward primer 5’ 
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GGCCGAATTCCGACAAAAACCCGAGAGAG TAC 3’ and reverse primer 5’ 
GGCCTCTAGATTACTTGTACAGCTCGTCCAT GCC 3’ followed by digestion with 
EcoRI and XbaI (NEB) and subsequent ligation to form the Hisproc construct.  Note that the 
polyA site used by the GFP ORF is the insect OpIE2 polyadenylation sequences 3’ of the 
XbaI site in the pIZ/V5/His vector. 
 To create the Actproc construct, the Drosophila Actin 5C promoter was amplified from 
genomic DNA by PCR using forward primer 5’ 
GGCCAAGCTTTATGTATGTTTTGGCATACAATGAGTAGTTGG 3’ and reverse primer 
5’ CCGGGAATTCGTGTCGGGAGGAGTATCCAC 3’ and subcloned into the 
pIZ/promoterless/H3/GFP plasmid using HindIII and EcoRI.  The resulting Actproc reporter 
gene consisted of the Actin 5C promoter followed by a region encoding the first 67 amino 
acids of histone H3, a portion of the histone H3 3’ UTR that included the SL and HDE, an in-
frame GFP ORF, and a vector-encoded OpIE2 poly(A) signal.   
 The Histrans construct was created by amplifying the histone H3 promoter using 
forward primer 5’ GGCCAAGCTTCGACAAAAACCCGAGAGAGTAC 3’ and reverse 
primer 5’ GGCCACCGGTCTCCGATTTGGGTTTCACTAAAGTTCACGTTC 3’ and 
subcloning this piece into the pIZ/promoterless/H3/GFP plasmid using HindIII and AgeI.  
The resulting Histrans reporter consisted of the Histone H3 promoter followed by an EGFP 
ORF and a vector-encoded OpIE2 poly(A) signal. 
 The Acttrans construct was created by amplifying the Act 5C promoter with forward 
primer 5’ GGCCAAGCTTTATGTATGTTTTGGCATACAATGAGTAGTTGG 3’ and 
reverse primer 5’ CCGGGAATTCGTGTCGGGAGGAGTATCCAC 3’ and the EGFP ORF 
using forward primer 5’ GGCCGAATTCATGGTGAGCAAGGGCGAGGAG 3’ and reverse 
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primer 5’ GGCCTCTAGATTACTTGTACAGCTCGTCCATGCC 3’ and performing a three 
way ligation into the pIZ/promoterless vector using HindIII, EcoRI, and XbaI.  The resulting 
Acttrans reporter consisted of the Actin 5C promoter followed by an EGFP ORF and a vector-
encoded OpIE2 poly(A) signal. 
 
Generation of dsRNAs and RNA interference 
 DNA templates for double stranded RNAs (dsRNAs) were generated by PCR using 
Drosophila Gene Collection library clones (Open Biosystems) or genomic DNA, if 
appropriate, and primers containing a T7 promoter (Table 4-1).  In vitro transcription was 
carried out in a total volume of 300 µl using T7 RNA polymerase (Fermentas) or the 
TranscriptAid T7 high yield transcription kit (Fermentas), as recommended by the 
manufacturer.  Following transcription, the RNA was treated with 5 units of RNase-free 
DNase Q (Promega), purified on G-50 micro columns (GE Healthcare), boiled for 5 minutes 
and cooled to room temperature to form dsRNA.   
 To induce RNAi-mediated knockdown of a factor of interest, dsRNAs targeting the 
factor were introduced into Drosophila D.Mel-2 cultured cells by adding the dsRNAs 
directly to the growth medium.  For 384-well experiments, 5 ul diluted dsRNA containing 
250 ng dsRNA in water was added to 10 µl SF-900II SFM (Gibco) containing 8x103 cells in 
a black-walled, clear bottom tissue culture plate (Corning) in a final volume of 15 µl.  For 
96-well plates, 8x104 cells were plated in 40 µl SF-900II SFM and supplemented with 800 ng 
dsRNA.  For 24-well plates, 5x105 cells were plated in 250 µl SF-900II SFM to which 5 µg 
dsRNA was added.  For 6-well plate experiments, 3x106 cells were plated in 1 ml SF-900II 
SFM and 30 µg dsRNA was added.  For all experiments, the cells were allowed to 
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knockdown at 27 °C in a humidified growth chamber for 3-6 days, depending upon the 
experiment and dsRNA target.  If RNAi was to proceed longer than 3 days, an amount of 
dsRNA equal to the original application was added every 2 days to ensure continuous 
knockdown for all plating formats except 384-well format, for which dsRNA was added only 
on Day 0. 
 
Cell Transfections and Reporter Assays 
For experiments involving the Hisproc, and Histrans reporters, RNAi-depleted cells were 
transfected using the Amaxa Nucleofector electroporation system (Lonza) and the 
Nucleofector V kit (Lonza) according to the manufacturer’s protocol for the Drosophila S2 
cell line.  Briefly, 5x106 RNAi-depleted D.Mel-2 cells were isolated by centrifugation at 
1000xg for 3 min., followed by aspiration of the media from the cell pellet and addition of 
100 µl room-temperature supplemented Nucleofector solution.  To this was added 2 µg 
reporter plasmid DNA and the cells were resuspended gently and transferred to a 
Nucleofector electrporation cuvette.  The cuvette was capped and placed inside the 
Nucleofector device and the cells were subjected to electroporation using the G-030 
Nucleofector program.  After electroporation, 500 µl of room temperature growth medium 
(SF-900II Serum Free Medium supplemented with antibiotic/antimycotic solution) was 
added to the cuvette and the cells were transferred with a plastic pipette into 6-well tissue 
culture plates containing 400 µl room temperature growth medium.  The cells were then 
allowed to grow at 27 °C in a humidified growth chamber until viewing. 
 The Actproc construct was integrated stably into Drosophila D.Mel-2 cells using the 
Amaxa transfection protocol above and selection of the cells from Day 3 through Day 10 
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with 500 µg/ml Zeocin selection reagent (Invitrogen).  Note that most of the experiments 
using this reporter utilized the reporter stable line instead of the transiently transfected 
reporter.  RNAi experiments were performed in this cell line the same way as was done for 
experiments in which the reporter was transiently transfected. 
 
RT-PCR Analysis 
 Relative reporter and endogenous mRNA levels were measured using reverse 
transcriptase PCR (RT-PCR).  D.Mel-2 cells were harvested after treatment with dsRNAs 
and total RNA was isolated using TRIzol reagent (Invitrogen).  An aliquot of the isolated 
RNA (2 µg) was incubated with RNase-free DNase Q (Promega) followed by reverse 
transcription using MMLV-RT (Invitrogen) and random hexamers, as suggested by the 
manufacturer.  PCR amplification was carried out with 0.5 µl of cDNA using the following 
forward (F) and reverse (R) primers written in the 5’-3’ orientation: SLBP (F-
CAGTAAACAAACGAAAGATAATTGCACAAC3’, R- 
GACCTCCTGGGCCCAGCTCTG); FLASH (F-CGAAGCCAATCCGCATCG, R- 
CATCAGCTGGGCAATCTTCAG); misprocessed reporter (F within H3 ORF-
GAGCACCGAGCTTCTAATCC, R within GFP ORF-
GGCGGACTTGAAGAAGTCGTGC); Histone H1 total (F-CGTGGCGGTTCATCACTTC, 
R-GCTTCGCTGCAGTCACTTTC); Histone H2a total (F-
GGCCATGTCTGGACGTGGAAAAGGT, R-GGCCTTAGGCCTTCTTCTCGGTCTT); 
Histone H2b total (F-CCAAGAAGGCTGGCAAGG, R-GCTGGTGTACTTGGTGACAG); 
Histone H1 misprocessed (F-GCTAAGAAGGCTGTGGCTACC, R-
GTTGCTGCGAACGTCAGC); Histone H2A misprocessed (F-
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GTGACAACAAGAAGACTAGAATTATTC, R-CTAATTACAACAAATTGCCAAGC); 
Histone H2A misprocessed (F-CTGGCAAGGCTCAGAAGAAC, R-
GTAAATTCATATTCGATGATTGGTGGTTG); α1-Tubulin 84B (F-
GCCCTACAACTCCATCCTGA, R-GGTCACCAGAGGGAAGTGAA).  PCR products 
were run on a 2 % agarose gel and detected by ethidium bromide staining. 
 
Creation of GST-fusion and in vitro Transcription/Translation Constructs 
 Plasmid constructs encoding wild type and mutant dFLASH or dLsm11 ORFs N-
terminally fused to gluthione-s-tranferase were created by cloning the ORFs into the pET42a 
vector using EcoRI and XhoI (Fermentas). In vitro transcription/translation constructs were 
created by cloning the sequence of interest into the pOT2 vector using EcoRI and XhoI 
(Fermentas).  The resulting construct contained a wild type or mutant dFLASH or dLsm11 
ORF driven by a T7 promoter.  This construct was used in coupled in vitro 
transcription/translation reactions resulting in the synthesis of radiolabeled peptide 
corresponding to the dFLASH or dLsm11 region of interest.  A list of primers used for PCR 
amplification of inserts is shown in Tables 4-2 and 4-3. 
 
GST-fusion Protein Purification 
 Chemically-competent E. coli BL21(DE3) cells were transformed by standard heat 
shock with pET42a plasmid constructs encoding glutathione-S-transferase (GST) fused in 
frame to wild type or mutant dFLASH or dLsm11 coding sequences and plated onto selective 
LB agar plates containing 30 ug/ml kanamycin.  A single colony was picked from the plate 
and used to inoculate 300 ml of LB medium.  The cultures were grown at 37 °C with shaking 
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until their absorbance at 595 nm reached 0.6, at which time IPTG was added to a final 
concentration of 0.5 mM.  The cells were allowed to induce in the presence of IPTG for 3 h 
at 37 °C with shaking before harvesting by centrifugation.  Cell pellets were retained and 
frozen at -80 °C until needed for purification. 
 Bacterial cell pellets were resuspended in 20 ml lysis buffer (50 mM Tris, pH 8.0, 5 
mM EDTA, 50 mM NaCl, 10% glycerol, 0.5% NP-40).  After resuspension, PMSF was 
added to a final concentration of 1 mM and the cells were incubated 15 min with occasional 
mixing.  The cell suspension was then sonicated on ice three times for 20 seconds, with at 
least 2 min. between sonications.  The sonicated lysate was transferred to a 50 ml Oak Ridge 
tube and centrifuged for 10 min. at 10,000 RPM at 4 °C in a Sorvall RC-5B centrifuge.  The 
supernatant was transferred to a fresh 50 ml conical tube on ice and 300 µl of glutathione-
agarose beads (Sigma) pre-equilibrated with lysis buffer were added.  The beads were 
incubated with the lysate for 4 h at 4 °C with gentle rocking.  After incubation, the beads 
were recovered by centrifugation at 300xg for 5 min. at 4 °C and removal of the supernatant.  
The beads were then washed three times with 15 ml cold PBS at 4 °C with gentle rocking for 
10 min. per wash.  GST-fusion proteins were eluted from the beads by adding 500 µl elution 
buffer (50 mM Tris, pH 8.8, 10 mM glutathione) and rotating at 4 °C for 30 min.  Following 
this incubation, the beads were centrifuged and the supernatant, containing the free GST-
fusion proteins, was reserved and stored at -20 °C. 
 
In Vitro Translation 
 In vitro translation reactions were performed using either a coupled transcription and 
translation (TNT) kit (Promega) to express a plasmid construct containing a T7 promoter 
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sequence driving a FLASH or Lsm11 coding sequence or using nuclease-treated rabbit 
reticulocyte lysate (Promega) to translate in vitro transcribed and capped Lsm11 mRNA.  
Each reaction was set up according to the manufacturer’s protocol.  Briefly, for coupled 
transcription and translation reactions, 1 µg of a T7 promoter-containing plasmid encoding 
my protein of interest was added to a reaction mixture containing 25 µl TNT rabbit 
reticulocyte lysate, 2 µl TNT reaction buffer, 1 µl 1mM amino acid mixture minus 
methionine, 1 µl 40u/µl RiboLock ribonuclease inhibitor (Fermentas), 2 µl [35S]methionine 
(>1000Ci/ml), 1 µl TNT RNA polymerase (Promega) or 1 µl T7 RNA polymerase 
(Fermentas), and autoclaved deionized water to a total reaction volume of 50 µl.  The 
reactions were incubated at 30 °C for 90 min, after which ________ mM Ribonuclease A 
(Sigma) was added and the samples were incubated an additional 5 min. at 30 °C.  The 
reactions were then stored at -20 °C until needed. 
 For uncoupled in vitro translation reactions, capped messenger RNA to be used as 
template in the IVT reaction was first created using the mMESSAGE mMACHINE kit 
(Ambion) according to the manufacturer’s protocol.  pOT2 plasmid constructs containing a 
T7 promoter and the coding sequence of interest were linearized using (PUT THE NAME 
OF THE ENZYME HERE) and 1 µg of the linear plasmid was added to a reaction containing 
2 µl 10X reaction buffer (salts, buffer, DTT, and proprietary ingredients), 10 µl 2X 
NTP/CAP mixture (neutralized buffer containing 15 mM each ATP, CTP, UTP, 3 mM GTP, 
12 mM cap analog), 2 µl enzyme mix (buffered 50% glycerol containing T7 RNA 
polymerase, RNase inhibitor, and proprietary components), and nuclease-free water to a total 
20 µl reaction volume.  Transcription reactions were incubated at 37 °C for 2 h, after which 1 
µl TURBO DNase (Ambion) was added and the samples were incubated at 37 °C for an 
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additional 15 min.  Following incubation, the RNA was purified suing 
phenol:chloroform:isoamyl alcohol extraction followed by isopropanol precipitation.  
Briefly, 115 µl nuclease-free water was added to the transcription reaction along with 15 µl 
ammonium acetate stop solution (5 M ammonium acetate, 100 mM EDTA).  To this, 150 µl 
phenol:chloroform:isoamyl alcohol (Invitrogen) was added, the sample was shaken 
vigorously for 15 sec., and the sample was incubated at room temperature for 3 min.  After 
incubation, the sample was centrifuged at 16000xg in a microcentrifuge at 4 °C for 15 min.  
The aqueous phase was recovered and placed into a fresh microfuge tube.  The RNA was 
precipitated by adding 150 µl isopropanol and incubating at -20 °C for 15 min., followed by 
centrifugation at 16000xg for 15 min.  The supernatant was removed and the RNA was 
resuspended in nuclease-free water. 
 The in vitro synthesized capped mRNA was then used as template for in vitro 
translation reactions using nuclease-treated rabbit reticulocyte lysate (Promega) according to 
the manufacturer’s protocol.  Briefly, 2 µg capped mRNA were added to a reaction mixture 
containing 35 µl nuclease-treated rabbit reticulocyte lysate, 1 µl 1 mM amino acid mixture 
minus methionine, 1 µl 40u/µl RiboLock RNase inhibitor (Fermentas), 2 µl [35S]methionine 
(>1000Ci/ml), and autoclaved deionized water to a total reaction volume of 50 µl.  The 
reactions were incubated at 30 °C for 90 min.  The reactions were then stored at -20 °C until 
needed. 
 
GST Pulldown Experiments 
 GST pulldown reactions were set up by combining 6 µl in vitro translated protein 
(IVT) with 10 µg GST-fusion protein in a total of 100 µl of 1X binding buffer (15 mM Tris, 
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pH 8.0, 20 mM EDTA, 75 mM KCl, 0.375 mM DTT, 10% glycerol, and 0.1% NP-40).  
Samples were then incubated on ice for 30 min. with occasional mixing, followed by a 30 
min. incubation at room temperature for 30 min. with occasional mixing.  Samples were then 
clarified by centrifuging at 13000xg for 15 min. at 4 °C, after which the supernatant was 
transferred to a fresh microcentrifuge tube.  To the supernatant was added 370 µl of 1X 
binding buffer and 30 µl of a 1:1 slurry of glutathione-agarose beads (Sigma) pre-
equilibrated with 1X binding buffer and the supernatant and beads were rotated together for 1 
h at 4 °C.  After incubation, the beads were collected by centrifuging at 300xg for 1 min. and 
removing the supernatant.  The beads were then washed four times with 1X binding buffer 
for 10 minutes per wash.  After the final wash, the supernatant was removed by careful 
aspiration and 25 µl SDS loading buffer (100mM Tris-Cl, pH 6.8, 200 mM DTT, 4 % SDS, 
20 % glycerol, and 0.2% bromophenol blue) was added to the beads.  The samples were then 
boiled for 3 minutes and centrifuged at 300xg at room temperature to pellet the beads.  The 
entire non-bead volume was then loaded onto a 12.5% or 15% polyacrylamide gel.  
Following electrophoresis, the gels were stained with Coomassie stain and destained using a 
destain solution consisting of 10% acetic acid and 20% methanol in water, dried on a gel 
drier, and exposed to film or a phosphor screen. 
 
Creation of Drosophila Expression Constructs 
 Drosophila expression constructs were created by cloning the dFLASH promoter into 
the promoterless pIZ/V5/His vector, followed by subcloning a full or partial dFLASH ORF 
into this construct.  The endogenous dFLASH promoter and 5’UTR were amplified by PCR 
off of genomic DNA from wild type adult flies using primers targeting the entire genomic 
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region between the upstream gene, latheo (dORC3), and the start codon of dFLASH.  This 
region consists of a putative promoter of 233 nt followed by 336 nucleotides containing the 
dFLASH 5’UTR up to the start codon of the ORF.  The region encoding the 5’UTR is 
annotated to contain the entire first exon of dFLASH, from nucleotides 1-236, an intron 
spanning the next 70 nucleotides of the genomic sequence, and the first 30 nucleotides of the 
second exon, which continues into the dFLASH ORF.  This promoter/5’UTR sequence was 
cloned into the promoterless pIZ/V5/His gene using HindIII and EcoRI restriction enzymes 
(Fermentas), resulting in the pIZ/FLASHp/V5/His construct.  Portions of the dFLASH ORF 
were subcloned into this construct using EcoRI (Fermentas) and SacII (NEB) restriction 
enzymes.  The result was a construct containing the dFLASH promoter driving expression of 
the full length or truncated dFLASH ORF, followed by an in-frame V5 epitope and 
polyhistidine tag and a strong, vector-encoded polyadenylation signal.  A list of primers used 
for PCR amplification of inserts is shown in Table 4-4. 
 
Drosophila Cell Culture and Transfection of Expression Constructs 
 Drosophila D.Mel-2 cells (Invitrogen) were cultured  in 10 cm tissue culture plates 
(Greiner) in SF-900II Serum Free Medium (Gibco) supplemented with 1X 
antibiotic/antimycotic solution (Sigma) containing penicillin, streptomycin, and amphotericin 
B in a humidified growth chamber at 27 °C. 
For dFLASH localization experiments, pIZ/V5/His constructs containing the FLASH 
coding region of interest preceded by the natural FLASH promoter and 5’UTR were 
transfected into D.Mel-2 cells using the Amaxa Nucleofector electroporation system (Lonza) 
and the Nucleofector V kit (Lonza) according to the manufacturer’s protocol for the 
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Drosophila S2 cell line.  Briefly, 5x106 D.Mel-2 cells were isolated by centrifugation at 
1000xg for 3 min., followed by aspiration of the media from the cell pellet and addition of 
100 µl room-temperature supplemented Nucleofector solution.  To this was added 2 µg 
plasmid DNA containing the FLASH coding region of interest and the cells were 
resuspended gently and transferred to a Nucleofector electrporation cuvette.  The cuvette was 
capped and placed inside the Nucleofector device and the cells were subjected to 
electroporation using the G-030 Nucleofector program.  After electroporation, 500 µl of 
room temperature growth medium (SF-900II Serum Free Medium supplemented with 
antibiotic/antimycotic solution) was added to the cuvette and the cells were transferred with a 
plastic pipette into 6-well tissue culture plates containing 400 µl room temperature growth 
medium.  The cells were allowed to grow at 27 °C in a humidified growth chamber for 48-72 
h. before fixation. 
 
Confocal Microscopy 
 Drosophila D.Mel-2 cells transfected with pIZ/V5/His plasmid constructs containing 
a FLASH promoter and 5’UTR followed by a FLASH coding sequence were harvested on 
Day 2 or 3 post-transfection and replated onto laminin-treated glass coverslips (BD 
Biosciences) in 24-well tissue culture plates and allowed to adhere to the coverslips for 1 h at 
27 °C in a humidified growth chamber.  After the cells had adhered to the coverslips, the 
media was removed and the cells were washed briefly with PBS and fixed with 4% electron 
microscopy grade paraformaldehyde for 10 min. at room temperature.  The cells were 
washed briefly with PBS and permeabilized with 0.1% Triton X-100 (Sigma) in PBS for 30 
min.  The cells were then washed briefly three times with 0.1% Triton X-100 in PBS.  
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Following the washes, the cells were blocked with 5% normal goat serum (Sigma) in PBS for 
30 min.  Next, the coverslips were transferred onto parafilm, cell side up, into a humidified 
chamber and primary antibody (anti-V5 diluted at 1:500 to detect recombinant FLASH, anti-
Mxc diluted at 1:500 to mark HLBs) diluted in 5% normal goat serum in PBS was applied to 
the entire surface of the coverslip, followed by incubation at room temperature for 1 h.  After 
incubation, the coverslips were returned to the 24-well plate and washed with PBS three 
times for 10 min. per wash.  Next, the coverslips were transferred back to the parafilm and 
covered with a solution of 5% normal goat serum in PBS containing appropriate secondary 
antibodies, followed by incubation at room temperature for 1 h.  The coverslips were then 
transferred back to the 24-well plate and washed with PBS three times for 10 min. per wash.  
Next, the cells were stained with DAPI diluted to 0.5 µg/ml in PBS for 5 min., followed by 
three brief washes with PBS.  The coverslips then mounted onto microscope slides, allowed 
to dry, and stored at -20 °C. Antibody-stained cells were viewed using a confocal 
microscope at 400X magnification. 
 
Functional Reporter Assays 
 Drosophila D.Mel-2 cells stably expressing the Actproc reporter were transfected with 
pIZ/FLASHp/FLASHORF/V5/His constructs encoding FLASH ORFs lacking the C-terminal-
most 111 amino acids using the Amaxa Nucleofector electroporation protocol.  The cells 
were allowed to express the FLASH constructs for 2 days before the addition of a dsRNA 
targeting the region of FLASH encoding the C-terminal 111 amino acids of the FLASH open 
reading frame.  Cells were then viewed 2-3 days later using an inverted fluorescence light 
microscope to detect GFP signal. 
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Results 
 
 Recent work by our group in both Drosophila and mammalian systems has further 
defined the role of FLASH in histone expression.  Human FLASH was identified as a 
binding partner of the N-terminal region of Lsm11 in a yeast-two-hybrid screen, and the 
Drosophila ortholog was identified bioinformatically, and also shown to interact with Lsm11 
(Yang et al., 2009).  A fragment containing less than 200 amino acids of human FLASH 
contains all the elements required for histone pre-mRNA processing in vitro.   
 
The Role of dFLASH in Histone Transcription and pre-mRNA Processing 
 Early studies of the role of FLASH in histone gene expression suggested that FLASH 
is involved in histone gene transcription in mammals (Barcaroli et al., 2006a,b).  However, 
because dFLASH was only recently identified (Yang et al., 2009), no information about any 
possible role in transcription role of dFLASH in Drosophila was available.  To help answer 
this question, I used the reporters described in Chapter II to distinguish effects on histone 
pre-mRNA processing and transcription.  RNAi-mediated knockdown of dFLASH had no 
effect on fluorescence off of the Histrans reporter when compared to PTB, Lsm11, or SLBP-
depleted cells (Fig. 4-1A), suggesting that dFLASH is not involved in the transcription of 
histone genes in Drosophila. 
 Since FLASH was found to interact with Lsm11, a known component of the U7 
snRNP, this strongly suggested a role for FLASH in the histone pre-mRNA processing 
reaction.  Despite this, dFLASH did not score strongly in the initial histone pre-mRNA 
processing screen (Wagner et al., 2007; Chapter III of this dissertation), although it was 
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placed in the “weakest category” of positive hits and reproducibly activated the reporter to a 
small extent (Fig. 4-1B).  Since there is not quality control on all 22,000 siRNAs used in the 
initial screen, I performed experiments using dsRNA targeting dFLASH using the original 
Hisproc reporter and found that RNAi-mediated depletion of dFLASH results in significant 
fluorescence off the Hisproc reporter (Fig.4-1C), suggesting technical problems with the 
dsRNA targeting this factor in the initial screen.  Consistent with the interaction data, these 
results support the notion that dFLASH is not required for transcription off the histone 
promoter, but that it is required for the histone pre-mRNA cleavage reaction. 
To investigate the processing role of dFLASH further, I used the Actproc reporter that I 
stably integrated into Drosophila cultured cells (Chapter II).  This stable cell line was used in 
experiments conducted over a period of 3 days, with fluorescence images taken after two and 
three days (Fig. 4-1D).  As expected, RNA interference-mediated knockdown of PTB, a 
splicing factor with no role in histone pre-mRNA processing, resulted in only background 
levels of GFP fluorescence off the reporter.  When SLBP, a factor required for histone pre-
mRNA processing, was depleted, the cells showed robust fluorescence by the second day, 
which was intensified by the third day, likely due to increased depletion of SLBP.  When 
dsRNAs targeting dFLASH were added to the reporter stable cell line, a similar result was 
observed.  By the second day, appreciable amounts of fluorescence were visible from these 
cells and by the third day, this fluorescence was even more robust.  Note that two 
independent dsRNAs, targeting two completely separate regions of dFLASH, were used in 
this experiment, indicating that the fluorescence that arises is specific to knockdown of 
dFLASH and not due to secondary effects.  These results suggested that dFLASH is required 
for processing histone pre-mRNAs and played no role in transcription of histone genes.  
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These experiments provided functional evidence that dFLASH has an active role in 
processing. 
 To detect the presence of misprocessed histone mRNAs in the reporter cells, total 
RNA was extracted and reverse transcriptase PCR (RT-PCR) was employed (Fig. 4-1E) 
using primers specific for misprocessed histone mRNAs (Fig. 4-1E).  Also, total histone 
mRNA levels were assessed using primers located within the histone ORF, and knockdown 
was assessed using primers to detect the levels of SLBP and FLASH (Fig. 4-1E).  There was 
significant knockdown of both SLBP and FLASH in these experiments, but no effect of 
FLASH siRNAs on SLBP mRNAs.  As was seen visually using the reporter stable line (Fig. 
4D), while PTB dsRNA-treated cells showed only background expression off the reporter, 
cells depleted of SLBP and FLASH showed high amounts of misprocessing (Fig. 4-1E).  
Similar results were found with the endogenous histone mRNAs, which showed little to no 
misprocessing in PTB dsRNA-treated cells, while cells depleted of SLBP or FLASH showed 
significant amounts of misprocessing by RT-PCR.  Note that histone H1 was affected less by 
knockdown of dFLASH than by knockdown of dSLBP.  The significance of this is unknown. 
 Similar results were found when histone H3 mRNA from FLASH knockdown cells 
was analyzed by Northern blotting (Fig. 4-1F).  Substantial amounts of polyadenylated 
histone H3 mRNA were present in total cell RNA, similar to that observed when SLBP was 
knocked down.  Importantly, despite suggestions from earlier studies in mammalian cells that 
FLASH is involved in transcription of histone genes, no effect is seen on the overall histone 
mRNA levels for histones H1, H2A, and H2B.  This is in agreement with the results using 
the histone H3 promoter-driven transcriptional reporter (Fig. 4-1C). 
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The in vivo processing data from RNAi experiments described above is corroborated 
by the results of in vitro histone pre-mRNA processing assays using nuclear extract from 
Drosophila Kc cells (Yang et al., 2009).  When antibody targeting the N-terminus of 
dFLASH is added to nuclear extract that is competent to support processing of histone 
mRNA, processing is completely blocked (Fig. 4-1G, lanes 4 and 6), while addition of an 
antibody targeting the N-terminus of human FLASH has no effect (Fig. 4-1G, lane 3).  When 
the N-terminal fragment of dFLASH used to create the antibody is added to the reaction 
along with the antibody, the processing defect observed for the dFLASH antibody-treated 
sample is eliminated (Fig. 4-1G, lane 8).  Together, these results, along with the reporter 
experiments described above, reveal that dFLASH is required for processing histone pre-
mRNA both in vivo and in vitro. 
 
Sequence Conservation of FLASH and Lsm11 from Mammals to Flies 
 At 1982 amino acids (~200 kDa), mammalian FLASH is considerably larger than its 
Drosophila counterpart, which is only 844 amino acids (~96 kDa) in length.  In addition, the 
mammalian protein contains C-terminal domains that are not readily identifiable in dFLASH.  
The two proteins share some conserved amino acid residues within their N termini, with the 
region between amino acids 45-177 in dFLASH containing 25 % sequence identity and 48 % 
sequence similarity with amino acids 30-169 of human FLASH (Fig. 4-2A).  This region of 
conservation is contained within the longer N-terminal fragment (amino acids 1-177 in flies) 
that was found to interact with the N-terminus of U7 snRNP component Lsm11 via yeast-
two-hybrid assay and later by GST-pulldown experiments (Yang et al., 2009).  There is no 
significant homology outside of this region.   
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 There is a high degree of conservation from mammals to flies within the N-terminus 
of Lsm11 (Fig.4-2B).  Most intriguing is a stretch of conserved residues located between 
amino acids 20-37 in the Drosophila protein (24-40 in human Lsm11).  Within the conserved 
region, 12 out of 17 amino acids are perfectly conserved.  No factors that interact with this 
region have been described.  Other regions of Lsm11 have been characterized, including the 
Sm binding domains (Pillai et al., 2003) and the ZFP100-interacting domain in mammals 
(Azzouz et al., 2005), but the identification of FLASH as a binding partner gave the first 
suggestion of a possible function for these highly conserved N-terminal residues.  
Specifically, the binding interaction with FLASH absolutely requires amino acids 1-40 of 
Lsm11, as deletion of these residues abolishes binding (Yang et al., 2009).  However, it 
remained unclear precisely which residues were involved. 
 
Biochemical Interactions between dFLASH and dLsm11 
Regions of dFLASH required for binding.  Recent work by our group, including yeast-two-
hybrid assays and GST pulldowns, has shown that the N-terminus of dFLASH physically 
interacts with the N-terminus of dLsm11.  Specifically, it was shown that a conserved region 
corresponding to the first 177 amino acids of dFLASH interacts with the first 153 amino 
acids of dLsm11 and that the first 40 amino acids of dLsm11, containing several conserved 
residues, are essential for binding to occur (Yang et al., 2009).  In order to investigate the 
details of this binding interaction further, I created deletion and point mutants for both 
proteins (Figs. 4-3A and 4-4A), cloned them into a vector encoding an N-terminal 
glutathione-S-transferase (GST) cassette, and assayed binding interactions using GST-
pulldown assays.  For these assays, 35S-labeled dLsm11 or dFLASH, as appropriate, was 
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synthesized by in vitro translation and incubated with the recombinant GST-fusion proteins, 
and the bound proteins were detected by autoradiography (Fig. 4-3B-E and 4-4B-E). 
 In order to narrow down the possible binding region within dFLASH, I created a 
number of deletion mutants in which residues were removed from the N-terminal and C-
terminal ends of a polypeptide consisting of the first 178 amino acids of dFLASH (Fig. 4-3A) 
and used these mutants in GST pulldown experiments with 35S-labeled dLsm11 and GST-
FLASH fusion proteins.  Deleting amino acids 1-66 or 1-77 from the N-terminus of FLASH 
protein had no effect on binding (Fig. 4-3B, lanes 3 and 4), suggesting the binding region lies 
downstream of position 77.  Similarly, removal of amino acids 155-178 had no effect on 
binding (Fig. 4-3B, lane 5), indicating that this region is not required for the interaction with 
dLsm11 and narrowing the binding region to between amino acids 78-154.   
I next systematically deleted regions from the C terminal end of the N-terminal 178 
amino acids using 35S-labeled FLASH and GST-Lsm11 and found that deleting residues 144-
178 decreased binding (Fig. 4-3C, lane 12) and deletion of residues 138-178 and 132-178 
abolished binding (Fig. 4-3C, lanes 9 and 6, respectively), suggesting critical binding 
residues reside C-terminal to amino acid 137.  I tested point mutants in and around this 
region and found that two conserved residues, E136 and E141, led to reduced binding when 
mutated (Fig. 4-3D, lanes 4 and 8, respectively).  Mutation of residues RK139,140 (Fig. 4-3, 
lane 6), I144 (Fig. 4-3, lane 10), and L147 (Fig. 4-3, lane 12) had no significant effect on 
binding compared to wild type (Fig. 4-3, lane 2). 
In order to define better the N-terminal boundary of the binding region, I created 
deletion mutants from which the first 104, 121, 141, and 166 amino acids were removed from 
the N-terminus.  I found that deletion of amino acids 1-104 had no effect on binding (Fig. 4-
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3E, lane 3).  However, removal of residues 1-122 decreased binding almost completely (Fig. 
4-3E, lane 4) and removal of residues 1-141 and 1-166 completely abolished the ability of 
dFLASH to bind dLsm11 (Fig. 4-3E, lanes 5 and 6, respectively).  Together with earlier data, 
this indicates that crucial binding residues reside in a region between amino acids 105-154.  
Consistent with this, mutation of residues NL125,126 and LL129,130 to alanine abolished 
binding (Fig. 4-3E, lanes 7 and 8, respectively), as did mutating leucines 118 and 119.  My 
results are consistent with a set of parallel experiments exploring the interaction between 
human FLASH and human Lsm11 (X. Yang and Z. Dominski, unpublished results).  In these 
experiments, mutation of human FLASH at residues LI118,119 (corresponding to LL129,130 
in flies) abolishes binding to Lsm11 (Fig. 4-3F, lane 5), while mutation of KD129,130 
(KE140,141 in flies) reduces binding (Fig. 4-3F, lane 6).  Further, mutation of hFLASH 
residue L136 (L147 in flies) had no effect on binding (Fig. 4-3F, lane 4), in agreement with 
my findings for dFLASH (Fig. 4-3D, lane 12), nor did mutation of residue N101 (Fig. 4-3F, 
lane 3). 
Region of dLsm11 that binds dFLASH.  In order to define the residues of dLsm11 that 
bind dFLASH, I used a similar approach as above by creating deletion and point mutants 
(Fig. 4-4A) of dLsm11 and testing them in GST-pulldown assays.  It was shown previously 
that deleting the first 40 amino acids eliminates proper binding between the two proteins 
(Yang et al., 2009).  However, even the presence of the first 54 amino acids fused to GST is 
not enough to facilitate proper binding (Fig. 4-4B, lane 6), which indicates that residues 1-40, 
while necessary, are not sufficient for binding.  When I used a GST fusion protein containing 
amino acids 1-78, binding was restored to near control levels (Fig. 4-4B, lane 5).  This 
suggests the presence of important residues, not only within the first 40 amino acids, but also 
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further downstream, and broadens the possible total region of interaction to the first 78 amino 
acids of dLsm11. 
Because the first 40 amino acids of dLsm11 were shown previously to be required for 
binding dFLASH, I focused my efforts for determining essential binding residues in this 
region.  Mutation of residues FN27,28 to alanine eliminates the binding interaction between 
dLsm11 and the N-terminal 178 amino acids of dFLASH (Fig. 4-4C, lane 7), while mutation 
of residues SD24,25 (Fig. 4-4C, lane 6), PL29,30 (Fig. 4-4C, lane 8), or PN36,37 (Fig. 4-4C, 
lane 9) had no effect on binding.  Note that, as revealed above, inclusion of only the first 40 
amino acids of dLsm11 was not sufficient to allow binding to occur (compare Fig. 4-4C, 
lanes 6 and 11, and lanes 9 and 12).  This result was repeated using full length dFLASH 
protein (Fig. 4-4D), revealing again that residues FN27,28 are critical for the binding 
interaction between dFLASH and dLsm11.  Using the reverse approach than I used in panels 
B-D, I in vitro synthesized and 35S-labeled wild type and mutant dLsm11 and incubated these 
with wild type GST-FLASH protein (AA1-178).  The results of this experiment confirm the 
earlier findings that FN27,28 are critical residues for binding (Fig. 4-4E, lane 9) and also 
reveal that mutation of residues LDV20,21,22 or residues LY33,34 to alanine abolishes 
binding (Fig. 4-4E, lanes 15 and 18, respectively).  Together, these results indicate that 
critical residues exist between amino acids 20-34 and three distinct patches of residues in this 
14 amino acid region have been identified as essential for binding (Fig. 4-4, panel B). 
These results agree with data from the human proteins (X. Yang and Z. Dominski, 
unpublished results), indicating that mutation of residues LDV24,25,26 (LDV20,21,22 in 
flies) results in reduced binding (Fig. 4-4F top, lane 5; Fig. 4-4F bottom, lane 6) and mutating 
residues FD31,32 (FN27,28 in flies) causes complete loss of binding (Fig.4-4F top, lane 7), 
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while mutating residues PL33,34 (PL29,30 in flies) has no effect on binding (Fig. 4-4F top, 
lane 9).  In contrast to the fly data, mutation of residues LY37,38 (LY33,34 in flies) has no 
effect on binding (Fig. 4-4F bottom, lane 9).  
 
Localization of dFLASH 
 FLASH is known to localize to the HLB in both mammals and flies, based upon 
colocalization experiments with NPAT in mammals (Barcaroli et al., 2006) and MPM-2 in 
flies (Yang et al., 2009; Fig. 4-5A).  Immunofluorescence experiments were used to help 
characterize the localization of dFLASH and, specifically, whether dLsm11 is required for its 
localization.  I created V5 epitope-tagged dFLASH deletion mutants (Fig. 4-5B), expressed 
them in Drosophila cultured cells, and used immunofluorescence against the V5 epitope to 
determine localization of these proteins.  Localization to the HLB was determined by 
costaining for Mxc, a known HLB component.  Deletion of the first 165 residues, including 
the dLsm11 binding region, did not affect dFLASH localization (Fig. 4-5C).  Further, 
deletion of the last 111 amino acids from the C-terminus of dFLASH has no effect on its 
localization (Fig. 4-5C).  Taken together, these results point to the requirement for an 
uncharacterized region of dFLASH between amino acids 165 and 733 for proper localization 
to the HLB.  Further deletions will allow us to narrow down this region further. 
 
Functional Characterization of dFLASH 
 The first 177 amino acids of dFLASH are necessary and sufficient to support 
processing of histone pre-mRNA in nuclear extracts (Yang et al., 2009).  This region binds 
dLsm11, and presumably at least one other factor required for histone pre-mRNA processing.  
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In order to help determine which regions of the N-terminus of dFLASH are required for 
proper processing of histone pre-mRNA and not for binding dLsm11, I developed a 
functional assay involving the use of the constitutive histone pre-mRNA processing reporter.  
The idea behind this assays is that depletion of dFLASH from Drosophila cultured cells 
results in misprocessing of the reporter, but if recombinant dFLASH protein containing the 
region required for processing is introduced into cells that are subsequently RNAi-depleted 
of endogenous dFLASH, this should rescue the misprocessing phenotype, preventing the 
cells from turning green.  Ideally in this case, dsRNAs targeting UTR sequences of dFLASH 
could be used, effectively knocking down the endogenous message while leaving the 
recombinant dFLASH mRNA, which does not contain this sequence, able to accumulate in 
the cell.  I tested several dsRNAs targeting 5’ and 3’ UTRs of dFLASH, yet none of the 
dsRNAs used knocked down dFLASH well enough to trigger misprocessing of the reporter 
(Fig. 4-6A).  One problem was that the 3’ UTR of FLASH was quite short and there is one 
annotated form that only has a 20 nt 3’ UTR. 
Because targeting the UTRs was ineffective, I designed a dsRNA targeting the very 
C-terminus of the dFLASH ORF, in a region encoding amino acids 734-844, which is not 
required for localization of the protein to the HLB or for its interaction with dLsm11.  
Importantly, this dsRNA knocks down dFLASH sufficiently to elicit misprocessing of the 
reporter, as evidenced by increased green fluorescence in treated cells versus the negative 
control (Fig. 4-6B).  For the preliminary rescue experiment, a dFLASH construct was created 
that did not encode the C-terminal 111 amino acids of the endogenous protein.  In this way, 
endogenous dFLASH can be knocked down while the deletion mutant is expressed, allowing 
for a determination of rescue to be made based upon the activity of the reporter. 
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The results of these RNAi/reporter experiments reveal that transfection of the 
construct encoding dFLASH amino acids 1-733 driven by the natural dFLASH promoter 
reduces the amount of fluorescence from the reporter, although it is not sufficient to rescue 
the misprocessing phenotype completely (Fig. 4-6C).  Before attempting the rescue 
experiment with N-terminal deletion mutants, I transfected a number of the dFLASH 
constructs with deletions from the N and C-terminus into the reporter stable line with no 
dsRNA treatment.  Transfecting full-length FLASH or FLASH 1-733 had no effect on the 
reporter, but surprisingly, transfection of a construct with a deletion of amino acids from 1-77 
from FLASH (FLASH 78-733) resulted in significant fluorescence off the reporter (Fig. 4-
6D), indicating that this protein inhibits histone pre-mRNA processing in vivo.  FLASH 78-
133 acts as a dominant negative inside the cell.  This protein still binds Lsm11 normally.  
This result suggests that the region from 1-77 is important for histone pre-mRNA processing.  
Presumably the mutant protein may bind Lsm11 but is not able to bind another essential 
factor, effectively rendering the U7 snRNP inactive.   
In agreement with this interpretation are results from in vitro processing assays using 
human FLASH.  A recombinant protein containing GST fused to the N-terminus of hFLASH 
(amino acids 1-139) is active in processing histone pre-mRNA in mammlian nuclear extract 
(Yang et al., 2009).  When the first 61 amino acids (corresponding to dFLASH amino acids 
1-77) are deleted from the active recombinant hFLASH and this fragment (amino acids 62-
139) is added to processing-competent nuclear extract from HeLa cells, the processing 
reaction is inhibited (X. Yang and Z. Dominski, unpublished results), demonstrating that the 
protein is a dominant negative in a biochemical system.   
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Discussion 
 
 Mammalian FLASH is a protein of many and varied functions, playing key roles in 
pro-life and pro-death processes, both inside the nucleus and out in the cytoplasm.  Initially 
characterized as a factor involved in apoptosis, FLASH was later implicated in histone gene 
expression.  In this chapter I report experiments defining a role for FLASH in histone pre-
mRNA processing in Drosophila, which support the biochemical experiments in mammals 
that show it is required for histone pre-mRNA processing in nuclear extracts (Yang et al., 
2009).  Many questions about how FLASH participates in histone pre-mRNA processing, as 
well as other possible functions of FLASH, remain to be answered.  Here, I have attempted 
to answer a few of these, providing information about the portions of dFLASH required for 
efficient histone pre-mRNA 3’ end formation in vivo, for the binding of FLASH to dLsm11, 
and for localizing dFLASH to the histone locus body.  These studies precisely define a site in 
dLsm11 that is required to bind dFLASH, as well as the site on dFLASH required to bind 
dLsm11. 
 
FLASH and Histone mRNA Expression 
 The finding that dFLASH interacts with dLsm11, a known histone pre-mRNA 
processing factor (Yang et al., 2009), suggested that dFLASH may have a role in histone pre-
mRNA processing.  However, if this were the case, this factor should have been among the 
validated hits from the genome-wide screen for factors involved in histone pre-mRNA 
processing (Wagner et al., 2007; Chapter III of this dissertation).  One possibility was that if 
FLASH was required for transcription as well as processing, the reporter would not have 
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been expressed and hence FLASH would not have been detected.  In fact, dFLASH, then 
known only as CG4616, was among over 300 factors from the screen identified as 
preliminary positive hits.  However, this factor scored as a weak hit, a 1 on an initial scoring 
scale of 1 to 3, with 3 being a strong positive like SLBP or Lsm11, 2 being a moderate hit, 
and 1 being classified as weak, putting it between 100 and 300 in the list of the top 300 hits.  
Since we now know from my more recent experiments that RNAi depletion of FLASH using 
the same dsRNA target as in the original screen strongly activates the screening reporter, it 
seems likely that this factor did not score very well in the screen for technical reasons, most 
likely related to poor quality or insufficient concentration of dsRNA in that well.   
Besides its relatively low score in the initial screen, bioinformatics did not identify a 
clear mammalian homolog, since there is only a small amount of homology between 
dFLASH and hFLASH.  As a result, although over 100 of the top hits from the screen 
underwent further validation, based on intensity of scoring and potential interest based on 
bioinformatics, FLASH was not included in this group.    
 The results in this chapter suggest that dFLASH plays a role predominantly, if not 
exclusively in processing histone pre-mRNA in vivo, and is not involved in histone gene 
transcription.  There was no difference in the ability of RNAi against FLASH to activate the 
processing reporter driven by the histone promoter or the actin promoter.  In addition, RNAi 
against FLASH did not affect expression of GFP driven by the histone promoter.  The RNAi 
experiments utilizing the Actproc reporter indicated a functional role of dFLASH in 
processing in the context of live cells.  The GFP signal for FLASH RNAi-depleted cells was 
similar to the signal from cells depleted of SLBP, putting it in the top tier of genes in 
activation of the reporter.  Subsequent analysis using RT-PCR confirmed the results of the 
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reporter experiment, that is, that FLASH depletion results in readthrough of the reporter 
mRNA as well as readthrough of the endogenous histone mRNA.  Indeed, FLASH-depleted 
cells exhibited misprocessed histone message for each histone class.  Northern blotting 
demonstrated that a majority of the endogenous histone H3 mRNA in Drosophila cells was 
polyadenylated when dFLASH was depleted.  These results indicated that FLASH likely 
plays a direct role in formation of the 3’ end of the mature histone mRNA.  For the core 
histones, the amount of readthrough for FLASH-depleted cells was similar to that of SLBP-
depleted cells.  However, for histone H1, the linker histone, there was a reduced level of 
misprocessed message relative to the SLBP control.  The significance of this is not known, 
though it could be due to the nature of the histone H1 gene, which differs somewhat from the 
core histone genes and may be regulated in a slightly different way (Isogai et al., 2007). 
 The RNAi and reporter experiments indicated that dFLASH has some role in the 
histone pre-mRNA processing reaction.  However, though the data are highly suggestive, 
they do not unequivocally reveal whether this role is direct or indirect.  Evidence of the direct 
biochemical involvement of dFLASH in the cleavage reaction requires isolation of the 
processing reaction outside of the context of the living cell.  A role for FLASH in this 
reaction has been clearly demonstrated in mammalian cells.  In vitro processing reactions 
performed using Drosophila Kc cell nuclear extract reveal that antibody targeting the N-
terminal region of dFLASH can inhibit the cleavage reaction, suggesting that this region is 
required for the processing reaction to occur (Yang et al., 2009).  Addition of the N-terminal 
fragment of dFLASH reversed this inhibition (Yang et al., 2009).  Taken together, these 
experiments reveal that dFLASH not only affects processing of histone message in the cell, 
but that it is directly involved in the biochemical reaction resulting in cleavage. 
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Another important finding from the RNAi and reporter experiments is that depletion 
of FLASH does not have any appreciable effect on overall levels of histone message.  Based 
upon RT-PCR data for histones H1, H2A, and H2B, Northern blots on total cell RNA, as 
well as reporter experiments using histone promoter-driven reporters, there was no effect of 
FLASH depletion on histone gene transcription or overall histone mRNA levels (Fig.4-
1A,C,E,F).  This is in contrast to previous reports from mammalian systems suggesting that 
FLASH has a role in transcription of the histone genes.  This interpretation was largely based 
on the loss of histone mRNA when FLASH was knocked down.  Since there is not extensive 
production of polyadenylated histone mRNA in mammalian cells when processing is 
inhibited, the reduction in histone mRNA levels in mammalian cells is almost certainly due 
to the failure to process the pre-mRNA, and not to a reduction in transcription.  It is also 
possible that FLASH function varies between flies and mammals.    
 
Direct Biochemical Interactions between dFLASH and dLsm11 
 The first suggestion that FLASH might be involved in the processing reaction was 
made through yeast-two-hybrid experiments aimed at detecting novel factors that interact 
with the N-terminus of Lsm11 (Yang et al., 2009).  The shortest length of FLASH that 
interacted with Lsm11 was the N-terminal 138 amino acids of the human protein.   
 Ultimately, the yeast-two-hybrid experiments, in conjunction with GST-pulldown 
assays, pointed to an interaction between an N-terminal fragment of human FLASH (amino 
acids 1-178 in flies) and the N-terminal half of human Lsm11 (amino acids 1-153 in flies).  
Additionally, it was found that deletion of the first forty amino acids of Lsm11, which 
contain several conserved residues, were essential for the binding interaction.  Beyond this, 
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however, not much more was known about which residues of each protein are required for 
the interaction.  In order to answer this question, I created several deletion and point mutants 
for both dFLASH and dLsm11. 
 I found that deleting the region of dFLASH from amino acid 1-105 or from 155-178 
had no effect on dLsm11 binding, while deletion of amino acids 1-122 or 144-178 showed 
significantly reduced binding and deletion of residues 1-141 or 138-178 completely 
abolished the ability to bind dLsm11.  These results defined a region between amino acids 
105-154 that contains residues essential for binding. 
 Within this binding region, I created a number of point mutants in an attempt to 
define which residues are required for the binding interaction.  Ultimately, I found mutating 
the asparagine and leucine residues at 125-126 (NL125,126) or the two leucine residues at 
129 and 130 (LL129,130) abolished binding in vitro, while mutation of the glutamate 
residues at 136 and 141 (E136 and E141, respectively) reduced binding, but did not abolish 
it.  None of the other residues tested had any appreciable effect on binding.  These results 
agree with data from human FLASH generated by Xiao-cui Yang at the same time, which 
showed that mutation of the leucine and isoleucine residues (LI118,119; corresponding to 
LL129,130 in Drosophila) abolishes binding to Lsm11, while mutation of the lysine and 
aspartate residues at sites 129 and 130 (KD129,130; KE140,141 in Drosophila) reduces 
binding (X. Yang and Z. Dominski, unpublished results).  Together, these results point to the 
requirement for several key residues within the N-terminus of dFLASH that are absolutely 
required for binding Lsm11 (Fig. 4-7A). 
I also mapped the precise region of Lsm11 required for binding FLASH.  I 
demonstrated that mutations of dLsm11 in the region from 20-35 revealed three distinct 
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sections of that region required for binding, LDV 20-22, FN 27-28 and LY 32-33.  In 
particular the FN27,28 mutant did not bind Lsm11, while mutation of adjacent amino acids 
(SD24,25) had no effect (Fig. 4-4C,D,E).   
 
Mutations in the FLASH binding site do not rescue an Lsm11 mutant. 
A transgene encoding Lsm11 tagged with V5 at the N-terminus and containing either 
the SD24,25 mutation or the FN27,28 mutation were created (A. Godfrey and R. Duronio) to 
allow characterization of the binding interaction in the context of the whole organism.  These 
mutants and wild-type Lsm11 were introduced into a site on chromosome 3 using site-
specific recombination.  The transgenic flies were crossed with heterozygous flies carrying 
an Lsm11 null mutation (Godfrey et al., 2009).  The wild-type and the SD24,25 dFLASH 
mutant rescues lethality of the Lsm11 mutant fly, while the FN27,28 mutation does not (P. 
Gasdaska and R. Duronio, unpublished results).  This result supports the biochemical data 
that the FN27,28 residues are critical for the interaction between dFLASH and dLsm11, and 
that disruption of this interaction is lethal.  It is interesting to note that the Lsm11 null mutant 
flies have a lethal phenotype, while the U7 snRNA null mutants do not, despite the fact that 
nearly all of the histone message in U7 snRNA null flies being misprocessed (Godfrey et al., 
2007; Godfrey et al., 2009).  This suggests that Lsm11 may have an additional role in the cell 
beyond histone pre-mRNA processing (Godfrey et al., 2009).  The implications of this for 
dFLASH are presently unknown, but may suggest that whatever the cause of lethality, it 
likely requires the interaction between dFLASH and dLsm11.  Whether that involves histone 
pre-mRNA processing or some other cellular process remains to be seen. 
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 Surprisingly, although removal of the first 40 amino acids from Lsm11 abolished 
binding to FLASH, these 40 amino acids alone did not bind FLASH.  However, inclusion of 
an additional 38 amino acids restores binding.   This suggests that although critical binding 
residues reside within the first 40 amino acids of dLsm11, there are other required residues. 
Whether these residues directly contact FLASH or whether they help fold the first 40 amino 
acids correctly is not known.   
 The residues required for binding are not continuous with each other but are 
interrupted by conserved residues that are not required for binding.  Indeed, mutation of the 
serine and aspartate residues at sites 24-25, the proline and leucine residues at sites 29-30, or 
the proline and asparagine residues at sites 36-37 had no effect on the ability of dLsm11 to 
bind dFLASH.  Together, these results suggest that this binding portion of dLsm11 may 
adopt a structure in which one face interacts with dFLASH, while the other does not.  
Whether the non-dFLASH binding face interacts with another protein or has some other 
function has not been determined. 
 
Localization of dFLASH to the HLB Does Not Require dLsm11 Binding 
 Because dFLASH binds dLsm11 and both proteins localize to the HLB, it is possible 
that dFLASH could be recruited to the HLB by the U7 snRNP.  Alternatively, it is possible 
that FLASH is recruited first by another factor and that FLASH may then be responsible for 
recruitment of the U7 snRNP by binding Lsm11.  The results of my experiments reveal that 
deleting the Lsm11 binding site from FLASH had no effect on the ability of dFLASH to 
localize to the HLB.  Thus, dFLASH localization is not dependent upon its interaction with 
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dLsm11 and there must be a region of FLASH between amino acids 166 and 733 that is 
required for recruitment to the HLB. 
This indicates that a factor other than dLsm11 is required for dFLASH localization to 
the HLB.  In mammalian cells, FLASH has been reported to interact with at least two other 
proteins related to histone expression, NPAT and Ars2 (Barcaroli et al., 2006a,b; Kiriyama et 
al., 2009).  The Mxc gene product in Drosophila is almost certainly the NPAT homologue, 
since it is a direct target of cyclin E/cdk2 and reacts directly with the MPM-2 antibody (A. 
White and Duronio, unpublished results).  Indeed, when Mxc is depleted by RNAi, dFLASH 
is delocalized from the HLB (Anne White, unpublished results).  Depletion of Mxc affects 
both the histone processing and transcription reporters (Chapter 2).  In the case of Ars2, there 
has been no evidence for or against binding of these two proteins in flies.  It is possible that 
Mxc is a core factor for formation of the HLB, and that it recruits FLASH.  There may also 
be another unknown factor(s) that participates in HLB formation. 
 
Testing the Functionality of dFLASH in vivo 
 I have established that the portion of the N-terminus of dFLASH (aa 105-154) 
responsible for binding dLsm11 is not required for localizing dFLASH to the HLB.  There 
are conserved residues in the region upstream of the dLsm11 binding region that may interact 
with other processing factors.  In support of this possibility, deletion of this region (which 
leaves the dLsm11 binding site intact), inhibits histone pre-mRNA processing in vivo in the 
presence of the wild-type FLASH, consistent with it binding a critical processing factor.  A 
diagram depicting this and other characterized regions of dFLASH and dLsm11 is shown in 
Figure 4-7. 
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To identify other regions of FLASH essential for processing, I have taken advantage 
of the fact that I can deplete endogenous FLASH using RNA I against the C-terminus of the 
protein, which is not essential for function, and then introduce different FLASH proteins to 
see if they restore processing (as evidenced by diminished GFP).  Thus, I will be able to 
carry out an in vivo “structure-function” analysis of FLASH in cultured cells in the future.  A 
similar approach can also be taken in flies, since there is a mutant of FLASH which produces 
large amounts of polyadenylated histone mRNA (T. K. Rajendra and Z. Dominski, 
unpublished).  FLASH likely plays important roles in addition to its role in histone pre-
mRNA processing, and these will be best elucidated in the intact organism, rather than in 
cultured cells. 
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Table 4-1.  Oligonucleotides used to create DNA template for transcription of dsRNAs.  
Shown is a list of oligonucleotides that were used to prime amplification of DNA to make 
template for transcription.  The final amplicon contained T7 promoter sequences on each 
end, allowing for transcription off of both strands.  “Target” indicates the gene being 
amplified, “Annotation ID” is the CG number for that gene, “Forward” and “Reverse” 
indicate primers that prime in these orientations with respect to the gene being amplified.  
Note that the T7 promoter sequence is abbreviated as “T7” for brevity.  The T7 promoter 
sequence is GGTAATACGACTCACTATAGGG. 
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Target Forward Reverse 
PTB T7-GCCCATAGCGACTACAGC 
T7-
TGGAATGAATTGTTCTTTGTGA
A 
SLBP T7-TCCAGTTCCTTGAATAGCAG T7-AGTCCGCTCGTCCTTTG 
FLASH-1 
T7-
GCAACCCCTGGACAAATTCAAG
G T7-ATCGGGCTTGGCGTATAAT 
FLASH-2 
(INTERNAL) T7-CGAAAGTAAGCGTCCGAAAG T7-ATTCCTGTGATGATCTCGCC 
FLASH 5' UTR T7-ACAAATACACGGCAGGGAAA T7-CGCTTACGTTTCTTCTTGGC 
FLASH 3' UTR-1 T7-CCGCCGATGATAAGGAATAA T7-ATGGGAACGTTTGAGGTCAG 
FLASH 3' UTR-2 T7-AATGATTGGGTGAATAGGTG T7-TCTTTTCCAGAAATCCAAAA 
FLASH C-TERM. 
T7-
GATCCACTAAGATCCCAAACG 
T7-
AATTGGTTTGTCCGCAGCAGT 
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Table 4-2.  Oligonucleotides used to create GST-FLASH constructs.  Shown is a list of 
oligonucleotides used to create deletion and point mutants of FLASH fused to glutathione-S-
transferase (GST) for use in GST pulldown assays.  “dFLASH Amplicon” indicates the 
region of dFLASH that is amplified (for deletion mutants) or the mutation introduced into a 
fragment of dFLASH containing amino acids 1-178 (for point mutants).  For point mutants, 
5’ indicates the primer pair used to amplify the 5’ end of the mutated dFLASH and 3’ 
indicates the primer pair used to amplify the 3’ end of the mutated dFLASH.  After this first 
round of PCR, these fragments were used as template for overlap PCR reactions containing 
forward primer 5’-GGCCGAATTCATGGAAACGCCTGCATATG-3’ and reverse primer 
5’-GGCCCTCGAGTCATTTCGGACGCTTACTTTC-3’ to make a dFLASH fragment from 
amino acids 1-178 containing the desired point mutations.  “Forward” and “Reverse” indicate 
primers that prime dFLASH in these orientations with respect to the 5’ and 3’ ends of the 
gene. 
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dFLASH 
Amplicon Forward Reverse 
1-131 
GGCCGAATTCATGGAAACGCCTG
CATATG 
GGCCCTCGAGTCAGTCCAGTAGATTCTGTAGATT
AACCTC 
1-137 
GGCCGAATTCATGGAAACGCCTG
CATATG GGCCCTCGAGTACCTCCGCCTTAGCTGTGTC 
1-143 
GGCCGAATTCATGGAAACGCCTG
CATATG GGCCCTCGAGCAGTGTCTCTTTTCTCTTTACCTC 
1-154 
GGCCGAATTCATGGAAACGCCTG
CATATG GGCCCTCGAGTCATACATCGTCCTTTTCGTTTCG 
1-178 
GGCCGAATTCATGGAAACGCCTG
CATATG GGCCCTCGAGTCATTTCGGACGCTTACTTTC 
67-178 
GGCCGAATTCAGATCCCTTGAACT
GGACATCTAC GGCCCTCGAGTCATTTCGGACGCTTACTTTC 
78-178 
CGCGGAATTCGACGACTTTCAGA
AGGCCGA GGCCCTCGAGTCATTTCGGACGCTTACTTTC 
105-400 
GGCCGAATTCATGATTGAAGCGC
TAAAGGTTGAGAATAAG 
GGCCCTCGAGTCACTTCGTCTCTACTTTTGATTCC
TTTGA 
122-400 
GGCCGAATTCATGGAGGTTAATC
TACAGAATCTACTG 
GGCCCTCGAGTCACTTCGTCTCTACTTTTGATTCC
TTTGA 
141-400 
CGCGGAATTCATGGAGACACTGA
TTGCCGAGC 
GGCCCTCGAGTCACTTCGTCTCTACTTTTGATTCC
TTTGA 
166-400 
CGCGGAATTCATGGTACCAGGTG
CAAGGGAAC 
GGCCCTCGAGTCACTTCGTCTCTACTTTTGATTCC
TTTGA 
NL125, 
126AA 5' 
GGCCGAATTCATGGAAACGCCTG
CATATG 
GTCCAGTAGATTCTGAGCAGCAACCTCCATGGTT
TT 
NL125, 
126AA 3' 
AAAACCATGGAGGTTGCTGCTCA
GAATCTACTGGAC GGCCCTCGAGTCATTTCGGACGCTTACTTTC 
LL129, 
130AA 5' 
GGCCGAATTCATGGAAACGCCTG
CATATG 
CGCCTTAGCTGTGTCAGCAGCATTCTGTAGATTA
AC 
LL129, 
130AA 3' 
GTTAATCTACAGAATGCTGCTGAC
ACAGCTAAGGCG GGCCCTCGAGTCATTTCGGACGCTTACTTTC 
E136A 5' 
GGCCGAATTCATGGAAACGCCTG
CATATG CTCTTTTCTCTTTACAGCCGCCTTAGCTGTGTC 
E136A 3' 
GACACAGCTAAGGCGGCTGTAAA
GAGAAAAGAG GGCCCTCGAGTCATTTCGGACGCTTACTTTC 
RK139, 
140AA 5' 
GGCCGAATTCATGGAAACGCCTG
CATATG 
GGCAATCAGTGTCTCAGCAGCCTTTACCTCCGCC
TT 
RK139, 
140AA 3' 
AAGGCGGAGGTAAAGGCTGCTGA
GACACTGATTGCC GGCCCTCGAGTCATTTCGGACGCTTACTTTC 
E141A 5' 
GGCCGAATTCATGGAAACGCCTG
CATATG CTCGGCAATCAGTGTAGCTTTTCTCTTTACCTC 
E141A 3' 
GAGGTAAAGAGAAAAGCTACACT
GATTGCCGAG GGCCCTCGAGTCATTTCGGACGCTTACTTTC 
I144A 5' 
GGCCGAATTCATGGAAACGCCTG
CATATG GTTTCGCAGCTCGGCAGCCAGTGTCTCTTTTCT 
I144A 3' 
AGAAAAGAGACACTGGCTGCCGA
GCTGCGAAAC GGCCCTCGAGTCATTTCGGACGCTTACTTTC 
L147A 5' 
GGCCGAATTCATGGAAACGCCTG
CATATG 
ATCGTCCTTTTCGTTTCGAGCCTCGGCAATCAGT
GT 
L147A 3' 
ACACTGATTGCCGAGGCTCGAAA
CGAAAAGGACGAT GGCCCTCGAGTCATTTCGGACGCTTACTTTC 
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Table 4-3.  Oligonucleotides used to create GST-Lsm11 constructs.  Shown is a list of 
oligonucleotides used to create deletion and point mutants of dLsm11 fused to glutathione-S-
transferase (GST) for use in GST pulldown assays.  “dLsm11 Amplicon” indicates the region 
of dLsm11 that is amplified (for deletion mutants) or the mutation introduced into full length 
dLsm11 (for point mutants).  For point mutants, 5’ indicates the primer pair used to amplify 
the 5’ end of the mutated dFLASH and 3’ indicates the primer pair used to amplify the 3’ end 
of the mutated dFLASH.  After this first round of PCR, these fragments were used as 
template for overlap PCR reactions containing forward primer 5’-
GGCCGAATTCATGGAATCGAGGGACCGGA-3’ and reverse primer 5’-
GGCCCTCGAGCTATTTTGTTGGTATTAAACTAACTAGAACCAC-3’ to make full 
length dLsm11 containing the desired point mutations.  “Forward” and “Reverse” indicate 
primers that prime dLsm11 in these orientations with respect to the 5’ and 3’ ends of the 
gene. 
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dLsm11 
Amplicon Forward Reverse 
1-40 
GGCCGAATTCATGGAATCGAGGGA
CCGGA 
GGCCCTCGAGTCACACCCTAAAATTG
GGTTCGTATAACGCT 
1-54 
GGCCGAATTCATGGAATCGAGGGA
CCGGA 
GGCCCTCGAGTCAGGCAGCCAGATTC
TGGTAGATGTC 
1-78 
GGCCGAATTCATGGAATCGAGGGA
CCGGA 
GGCCCTCGAGTCATCCTTCTGCGGAT
CCCGGCTTTTG 
1-100 
GGCCGAATTCATGGAATCGAGGGA
CCGGA 
GGCCCTCGAGTCATCGCTCAGGAGGT
AGAATATCTAC 
1-153 
GGCCGAATTCATGGAATCGAGGGA
CCGGA 
GGCCCTCGAGTCACCGAACTCTTCTC
CTTTCGTTGGA 
FULL 
LENGTH 
GGCCGAATTCATGGAATCGAGGGA
CCGGA 
GGCCCTCGAGCTATTTTGTTGGTATT
AAACTAACTAGAACCAC 
LDV20,21,2
2AAA 5' GGTTCTTTGTTCTATCAGACTTC 
AAACCTATCACTGCCAGCAGCAGCTT
CGGAGATTTCCGA 
LDV20,21,2
2AAA 3' 
TCGGAAATCTCCGAAGCTGCTGCT
GGCAGTGATAGGTTT 
GGCCCTCGAGCTATTTTGTTGGTATT
AAACTAACTAGAACCAC 
SD24, 
25AA 5' GGTTCTTTGTTCTATCAGACTTC 
CAGAGGATTAAACCTAGCAGCGCCCA
CATCCAATTC 
SD24, 
25AA 3' 
GAATTGGATGTGGGCGCTGCTAGG
TTTAATCCTCTG 
GGCCCTCGAGCTATTTTGTTGGTATT
AAACTAACTAGAACCAC 
FN27, 
28AA 5' GGTTCTTTGTTCTATCAGACTTC 
TAACGCTCGCAGAGGAGCAGCCCTAT
CACTGCCCAC 
FN27, 
28AA 3' 
GTGGGCAGTGATAGGGCTGCTCCT
CTGCGAGCGTTA 
GGCCCTCGAGCTATTTTGTTGGTATT
AAACTAACTAGAACCAC 
PL29, 
30AA 5' GGTTCTTTGTTCTATCAGACTTC 
TTCGTATAACGCACGAGCAGCATTAA
ACCTATCACT 
PL29, 
30AA 3' 
AGTGATAGGTTTAATGCTGCTCGT
GCGTTATACGAA 
GGCCCTCGAGCTATTTTGTTGGTATT
AAACTAACTAGAACCAC 
LY33, 
34AA 5' GGTTCTTTGTTCTATCAGACTTC 
CCTAAAATTGGGTTCAGCAGCCGCTC
GCAGAGGATTAAA 
LY33, 
34AA 3' 
TTTAATCCTCTGCGAGCGGCTGCT
GAACCCAATTTTAGG 
GGCCCTCGAGCTATTTTGTTGGTATT
AAACTAACTAGAACCAC 
PN36, 
37AA 5' GGTTCTTTGTTCTATCAGACTTC 
ATCGGTCACCCTAAAAGCAGCTTCGT
ATAACGCTCG 
PN36, 
37AA 3' 
CGAGCGTTATACGAAGCTGCTTTT
AGGGTGACCGAT 
GGCCCTCGAGCTATTTTGTTGGTATT
AAACTAACTAGAACCAC 
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Table 4-4.  Oligonucleotides used to create pIZ-FLASH constructs.  Shown are 
oligonucleotides used to create Drosophila expression constructs using the pIZ/V5/His vector 
(Invitrogen).  “dFLASH Amplicon” indicates the region of dFLASH that is amplified.  
“dFLASHp + 5’ UTR” is the dFLASH promoter and 5’ UTR.  “Forward” and “Reverse” 
indicate primers that prime dFLASH in these orientations with respect to the 5’ and 3’ ends 
of the gene. 
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dFLASH 
Amplicon Forward Reverse 
dFLASH
p + 5' 
UTR 
GGCCAAGCTTCGAGTATTATTGTTTG
TATTGTGATGT 
GGCCGAATTCACCAATCGCTTACG
TTTCTT 
1-844 
GGCCGAATTCCAAAATGGAAACGCC
TGCATATG 
GAACCCGCGGAATTGGTTTGTCAG
CAGCA 
105-844 
GGCCGAATTCCAAAATGATTGAAGC
GCTAAAGGTTGAGAATAAG 
GAACCCGCGGAATTGGTTTGTCAG
CAGCA 
166-844 
GGCCGAATTCCAAAATGGTACCAGG
TGCAAGGGAAC 
GAACCCGCGGAATTGGTTTGTCAG
CAGCA 
1-733 
GGCCGAATTCCAAAATGGAAACGCC
TGCATATG 
GAACCCGCGGAGCCTGTTTTGGAG
TCTGGGTGAG 
78-733 
GGCCGAATTCCAAAATGGACGACTT
TCAGAAGGCCGA 
GAACCCGCGGAGCCTGTTTTGGAG
TCTGGGTGAG 
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Figure 4-1.  Drosophila FLASH is required for processing histone pre-mRNA but not 
for transcribing it.  (A) Drosophila D.Mel-2 cells were treated with dsRNAs targeting PTB, 
SLBP, or FLASH, transfected with the Histrans reporter (model shown at top), and viewed on 
Day 5 by fluorescence microscopy to detect GFP expression.  (B) Image of wells from the 
genome-wide screen for factors that participate in histone pre-mRNA processing.  The 
postive control well containing a 2’-OCH3 oligonucleotide targeting dU7 snRNA and the 
experimental well containing dsRNA targeting CG4616 (dFLASH) are indicated by red 
boxes.  (C) D.Mel-2 cells were treated with dsRNAs targeting PTB, SLBP, or FLASH, 
transfected with Hisproc reporter (model shown at top), and viewed on Day 5 by fluorescence 
microscopy to detect GFP.  (D) D.Mel-2 cells stably expressing the Actproc reporter (model 
shown at top), were treated with dsRNAs targeting PTB, SLBP, or one of two independent 
regions of FLASH, then viewed by fluorescence microscopy on Days 2 and 3 to detect GFP.  
(E) Total RNA from the Day 3 cells shown in panel D was isolated and amplified by PCR 
with (+) or without (-) prior reverse transcription.  RT-PCR targets were SLBP and FLASH 
(to show knockdown), misprocessed reporter, total histone H1, H2A, and H2B (to show total 
mRNA levels), misprocessed histone H1, H2A, and H2B (to show improperly cleaved 
mRNA), and tubulin (loading control).  A model of the histone-specific primer locations is 
shown at the bottom.  Note that p1 and p2 are forward and reverse primers, respectively, for 
detecting total histone message, while p1’ and p2’ are forward and reverse primers, 
respectively, for detecting misprocessed histone message.  The normal cleavage site is 
depicted by a red slash just after the stem loop.  (F)  Northern blot analysis of total RNA 
taken from cells RNAi-depleted of (G) In vitro 3’ end processing of Drosophila H3 (dH3) 
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histone pre-mRNA in a nuclear extract from Kc cells.  Processing was carried out under 
control conditions (lanes 2 and 5) or in the presence of the indicated antibodies (lanes 3, 4, 
and 6) and/or 1 µg of the N-terminal dFLASH protein fused to GFP (lanes 7 and 8).  Lane 1 
contains the input dH3 substrate.  Abbreviations:  PTB = pyrimidine tract binding protein; 
SLBP = stem loop binding protein; GFP = green fluorescent protein; Actproc = Actin 5C 
promoter-driven histone pre-mRNA processing reporter.  (panels F and G courtesy of Xiao-
cui Yang and Zbigniew Dominski; Yang et al., 2009) 
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Figure 4-2.  Drosophila FLASH shares a limited sequence similarity with human 
FLASH.  (A) A comparison of the amino acid sequences of human FLASH (Hs) and 
Drosophila FLASH (Dm).  (B) A comparison of the amino acid sequences of human Lsm11 
(Hs) and Drosophila Lsm11 (Dm).  The first 40 amino acids containing a region conserved 
between the two species are denoted by a double-headed arrow and the highly conserved 
region between Drosophila amino acids 20 and 37 is highlighted.  (Figure adapted from 
Yang et al., 2009) 
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Figure 4-3.  Biochemical characterization of the region of dFLASH that binds dLsm11.  
(A) Model of the dFLASH N-terminus showing sequence conservation between flies and 
mammals, with blue boxes indicating perfectly conserved residues and orange boxes 
indicating residues with similar characteristics.  Numbers represent Drosophila residues used 
in deletion mutants created for GST pulldown assays.  A diagram of the dFLASH deletion 
mutants is shown below.  Orange bars correspond to N-terminal residues (amino acids 1-178) 
and green bars to downstream residues.  The ability of each mutant to bind dLsm11, 
determined by experiments depicted in panels B-E of this figure, is shown, with + indicating 
binding and – indicating failure to bind.  (B) Full length dLsm11 was in vitro synthesized and 
labeled with 35S, followed by incubation with GST-FLASH fusion proteins containing the 
full N-terminus (AA1-178) or containing the N-terminus with either N- (AA67-178, AA78-
178) or C-terminal (AA1-154) residues deleted.  GST alone was used as a negative control to 
show any non-specific binding.  The 35S-labeled dLsm11 bound to GST-FLASH or GST was 
bound by glutathione agarose beads, separated on a 12 % SDS-PAGE gel and detected by 
autoradiography.  Input = 10 % of radiolabeled protein used in the assay  (C) dFLASH 
proteins containing either the full N-terminus (1-178) or the N-terminus with C-terminal 
deletions (AA1-131, AA1-137, AA1-143) were in vitro synthesized and labeled with 35S, 
followed by incubation with GST-Lsm11 fusion proteins containing the first 153 amino acids 
of dLsm11.  GST alone was used as a negative control.  The 35S-labeled dFLASH bound to 
GST-Lsm11 or GST was bound by glutathione agarose beads, separated by electrophoresis, 
and detected by autoradiography.  Input = 5 % of radiolabeled protein used in the assay.  (D) 
Diagram of FLASH sequence conservation between human and flies with the location of 
point mutations examined in panels D-F underlined (top).  dFLASH proteins containing 
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amino acids 1-178 with the wild type (WT) amino acid sequence or containing point 
mutations were in vitro synthesized and 35S-labeled and incubated with GST-dLsm11 fusion 
proteins containing the first 153 amino acids of dLsm11.  The radiolabeled dFLASH proteins 
bound to GST-dLsm11 were bound by glutathione agarose beads, separated by 
electrophoresis, and detected by autoradiography (middle).  Note that the GST-dLsm11 was 
combined with the other reagents and added to each radiolabeled dFLASH protein as a 
master mix.  A Coomassie stain of the SDS-PAGE gel is shown to verify equal loading 
(bottom).  (E) As in Panel B, in vitro synthesized and 35S-labeled dLsm11 (AA1-153) was 
combined with GST-dFLASH deletion and point mutants, bound by glutathione agarose 
beads, separated by electrophoresis, and detected by autoradiograhy (top).  A Coomassie 
stain of the SDS-PAGE gel is shown as a loading control (bottom).  (F) The N-terminus of 
human Lsm11 up to the first Sm binding site was in vitro synthesized and labeled with 35S 
and combined with GST-hFLASH fusion proteins containing wild type amino acid sequence 
(WT) or point mutations.  Abbreviations:  GST = glutathione-S-transferase; SDS-PAGE = 
sodium dodecyl sulfate polyacrylamide gel electrophoresis. (panel F courtesy of Xiao-cui 
Yang and Zbigniew Dominski) 
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Figure 4-4.  Biochemical characterization of the region of dLsm11 that binds dFLASH.  
(A) Schematic of dLsm11 with a depiction of the conserved residues within the first 40 
amino acids of the protein.  Asterisks indicate residues that were altered to make point 
mutants for GST pulldown assays.  (B) dFLASH protein consisting of the first 178 amino 
acids of the N-terminus was in vitro synthesized and labeled with 35S and incubated with 
GST-dLsm11 fusion proteins, either full length or C-terminal deletions.  The labeled 
dFLASH bound to GST-dLsm11 was bound by glutathione agarose beads, separated by 
electrophoresis, and detected by autoradiography.  A Coomassie stain of the gel is shown 
below to indicate loading.  (C) dFLASH protein consisting of the first 178 amino acids of the 
N-terminus was in vitro synthesized and labeled with 35S and incubated with GST-dLsm11 
fusion proteins, either full length or corresponding to the first 40 amino acids of the N-
terminus, that contain either wild type sequence or point mutations.  GST alone is included as 
a control for non-specific binding.  The labeled dFLASH bound to GST-dLsm11 was bound 
by glutathione agarose beads, separated by electrophoresis, and detected by autoradiography.  
(D) Full length dFLASH protein was in vitro synthesized and labeled with 35S and incubated 
with GST-dLsm11 fusion proteins that contain either wild type sequence or point mutations.  
GST alone is included to control for non-specific binding.  The labeled dFLASH bound to 
GST-dLsm11 was bound by glutathione agarose beads, separated by electrophoresis, and 
detected by autoradiography.  (E) dLsm11 protein corresponding to the first 153 amino acids 
of the N-terminus containing either wild type sequence or point mutations was in vitro 
synthesized and labeled with 35S and incubated with GST-FLASH fusion protein consisting 
of the first 178 amino acids of its N-terminus.  GST alone is included as a control for non-
specific binding.  Radiolabeled dLms11 bound to GST-FLASH was bound by glutathione 
212 
 
agarose beads, separated by electrophoresis, and detected by autoradiography.  (F) Human 
Lsm11 protein corresponding to the N-terminus up to the first Sm binding site was in vitro 
synthesized and labeled with 35S and incubated with the N-terminal portion of hFLASH 
fused to GST.  GST alone is included as a control for non-specific binding.  Radiolabeled 
hLsm11 bound to GST-hFLASH or GST was bound by glutathione agarose beads, separated 
by electrophoresis, and detected by autoradiography.  GST = glutathione-S-transferase (Panel 
4F courtesy of Xiao-cui Yang and Zbigniew Dominski) 
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Figure 4-5.  dFLASH does not require dLsm11 for recruitment to the HLB.  (A) 
Drosophila D.Mel-2 cells were stained with antibodies targeting dFLASH and the MPM-2 
reactive epitope, which marks the HLB in Drosophila.  (B) Diagram of dFLASH V5-tagged 
expression constructs created for localization experiments.  These constructs contain the 
natural dFLASH promoter and 5’ UTR followed by full length dFLASH (AA 1-844) or 
dFLASH deleted at its N- or C-terminus.  Note:  None of the deletions introduced resulted in 
delocalization of recombinant dFLASH from the HLB, as shown in panel C.  (C) Drosophila 
D.Mel-2 cells were transfected with the indicated expression constructs, allowed to express 
V5-tagged dFLASH for two days, then fixed and stained with antibodies targeting the V5 tag 
on the recombinant protein (red), Mxc as an HLB marker (green), and DAPI (blue) to stain 
the nuclear material.  Untransfected cells (Mock) are included to show the specificity of 
staining of the V5 antibody.  Abbreviations:  MPM-2 = mitotic protein monoclonal #2; HLB 
= histone locus body; V5 = epitope tag consisting of the amino acids GLPIPNPLLGLDST; 
UTR = untranslated region. 
217 
 
 
 
 
 
218 
 
 
 
219 
 
 
Figure 4-6.  The N-terminus of dFLASH contains a region upstream of the dLsm11 
binding site that is required for histone pre-mRNA processing.  (A) Sequence of the 3’ 
end of the dFLASH ORF and 3’ UTR as defined in online databases (top).  The stop codon is 
indicated by bold red lettering and polyadenylation signals by bold blue lettering.  Sites of 
polyadenylation indicated by cDNA sequences in databases are depicted by two red vertical 
bars.  Amplicon corresponding to dFLASH 3’ UTR-1 is shown between green brackets and 
amplicon corresponding to dFLASH 3’ UTR-2 is shown between purple brackets.  
Drosophila D.Mel-2 cells stably expressing the Actproc reporter were treated with dsRNAs 
targeting dPTB, the dFLASH ORF, the dFLASH 5’ UTR, or one of two regions within the 
dFLASH 3’ UTR and incubated for 5 days, after which the cells were viewed using a 
fluorescence microscope to detect GFP signal (bottom).  (B) Drosophila D.Mel-2 cells stably 
expressing the Actproc reporter were treated with dsRNAs targeting either a region of the 
dFLASH ORF upstream of amino acid 733 (dFLASH Internal) or the C-terminal region of 
dFLASH downstream of amino acid 733 (dFLASH C-term.) and incubated for three days, 
after which the cells were viewed under a fluorescence microscope to detect GFP signal.  (C) 
D.Mel-2 cells containing the constitutive processing reporter were transfected with an 
expression construct encoding dFLASH amino acids 1-733 (∆734-844) and driven by the 
dFLASH promoter and 5’UTR.  Untransfected cells are used as a control.  Cells were treated 
36 hours later with dsRNA targeting the region of dFLASH downstream of amino acid 733 
(AA733-844) and incubated for 3 days.  The cells were the viewed under a fluorescence 
microscope to detect GFP signal.  (D) D.Mel-2 cells containing the constitutive processing 
reporter were transfected with an expression construct encoding dFLASH full length or 
deletion constructs.  Untransfected cells are used as a control.  Cells were viewed after five 
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days using a fluorescence microscope to detect GFP signal.  Note that there is no RNAi in 
this experiment and that the same GFP expression pattern shown here is observable just one 
day after transfection.  Abbreviations:  PTB = pyrimidine tract binding protein; ORF = open 
reading frame; UTR = untranslated region; GFP = green fluorescent protein; Actproc = Actin 
5C promoter-driven histone pre-mRNA processing reporter. 
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Figure 4-7. Summary of newly identified regions of dFLASH and dLsm11.  (A) Diagram 
of dFLASH with the dLsm11 binding region sequence zoomed in.  The purple box is a 
region of dFLASH that is not required for binding dLsm11, but is required for histone pre-
mRNA processing.  The orange box is the region of dFLASH containing residues required 
for binding dLsm11.  The residues that are required for this interaction are underlined in red 
and the residues that are not required are underlined in blue.  (B) Diagram of dLsm11 with 
the dFLASH binding region zoomed in.  The orange box is the region of dLsm11 containing 
residues required for binding dFLASH.  The residues that are required for this interaction are 
underlined in red and the residues that are not required are underlined in blue.  The blue 
boxes correspond to Sm-binding domains 1 and 2. 
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CHAPTER V 
SUMMARY AND CONCLUSIONS 
 
INTRODUCTION 
 Histone expression is highly regulated and tightly linked to DNA replication and the 
cell cycle.  These proteins comprise the primary protein component of chromatin and are 
responsible for packaging the cell’s DNA.  Histone proteins H2A, H2B, H3, and H4 form a 
core octamer around which approximately 146 base pairs of DNA are wound, thus forming 
the primary unit of chromatin, the nucleosome.  Histone H1 acts as a linker protein outside 
the core octamer and participates in the formation of higher order chromatin structures.  
Nucleosomal chromatin is condensed into higher order chromatin fibers and ultimately into 
its most condensed form, the chromosome. 
In addition to a structural role, histone proteins are also important for gene regulation.  
Post-translational modifications of the protruding histone tails allow the cell to define regions 
of active chromatin that are available for transcription and, conversely, to demarcate inactive, 
or heterochromatic chromatin that is transcriptionally inactive.  This allows the cell to exact 
greater control of gene expression than would be possible from the DNA sequence alone.  
Because of its role in chromatin structure and gene expression, proper coordination of histone 
levels is crucial for cell viability.  For this reason, a number of regulatory targets exist that 
allow modulation of histone expression.
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Most of the control of histone expression exists at the level of the histone mRNA.  
Regulatory targets include histone gene transcription, pre-mRNA processing, and mRNA 
stability.  The greatest contributors to increased histone expression during S phase are 
upregulation of transcription and increased pre-mRNA processing efficiency.  Most of my 
work has focused on describing these early events in histone mRNA metabolism, with 
special emphasis on pre-mRNA processing and the factors that participate in it. 
 
THE USE OF REPORTERS TO DEFINE EARLY ASPECTS OF HISTONE mRNA 
METABOLISM 
In Chapter II, I discussed the design and validation of a histone pre-mRNA 
processing reporter by Dr. Eric J. Wagner and me, as well as the creation of a number of 
other reporters I have used to learn more about histone pre-mRNA processing, histone 
transcription, and snRNA processing.  Three different reporters allow one to distinguish 
effects on transcription, pre-mRNA processing, and a role in both transcription and 
processing.  One of the most useful tools I have created during my research has been the 
constitutive histone pre-mRNA processing reporter, especially once integrated into a stable 
line of Drosophila cultured cells.  This construct gave the first functional indication that 
CG4616, later known as dFLASH, is an essential histone pre-mRNA processing factor (Yang 
et al., 2009).  In addition to this, I have used this reporter extensively to screen many other 
factors for a possible role in the cleavage reaction, trying to determine whether there are 
factors or pathways that impact both histone gene transcription and histone pre-mRNA 
processing.  Among these are the origin recognition complex (ORC) subunits and several 
other factors that have a role in DNA replication.  Knockdown of these factors reduce 
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expression of a reporter driven by the histone promoter, but had a minimal impact on the 
processing reporter.  Although none of these proteins appear to have any significant role in 
processing histone mRNA, these experiments have given us a better understanding of how 
DNA replication and histone expression are linked, likely primarily at the level of 
transcription and/or mRNA degradation, by ruling out the possibility of significant 
modulation through the histone pre-mRNA cleavage reaction. 
In addition to these experiments, the constitutive histone pre-mRNA processing 
reporter can be readily used as a rapid and robust secondary screening tool for factors 
identified in a primary genome-wide screen.  One such primary screen was performed by 
Anne White in Dr. Bob Duronio’s lab.  The screen is based upon the observation that the 
MPM-2 antibody recognizes a cell cycle regulated phosphoepitope that localizes to the HLB.  
However, it is unknown what protein is being recognized there.  It was hypothesized that this 
factor may be the Drosophila homolog of NPAT, a crucial factor for histone expression in 
mammalian cells that relies on phosphorylation for its activity and localization to the HLB.  
Thus, Anne developed an assay in which she used RNAi to deplete various factors, and then 
stained these cells with the MPM-2 antibody to visualize the presence or absence of this 
phosphoepitope at the HLB.  She did this on a genome-wide scale and came up with a list of 
factors that, when depleted, result in loss of the MPM-2 reactive epitope from the HLB.  This 
list was pared down to around 100 factors of special interest.  These 100 factors were 
subsequently depleted by RNAi in my constitutive reporter stable line and analyzed for 
production of GFP arising as a result of a histone processing defect.  We found a number of 
interesting factors that scored positively in this secondary screen, among these, dFLASH, 
MBD-R2, MCRS1, and Mxc.  The first three of these had been implicated previously for 
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involvement in the histone pre-mRNA processing reaction (Wagner et al., 2007; Yang et al., 
2009).  The possible involvement of Mxc, however, had never been addressed.  Of note, 
depletion of this factor by RNAi in the reporter stable line never elicits fluorescence at the 
level seen for depletion of a core processing factor, such as SLBP or FLASH.  However, the 
effect on the reporter is reproducible and always above background.  This may suggest a 
more indirect role for this protein in the processing reaction, with depletion of Mxc resulting 
in some sort of structural perturbation of the HLB, for example.  Indeed, results from Anne 
indicate that depletion of Mxc results not only in elimination of the MPM-2 reactive epitope 
from the HLB, but also delocalization of a number of other factors, including dFLASH.  This 
could explain the misprocessing phenotype observed in the secondary screen.   
A select set of these factors were tested with all three reporters to define at what steps 
they might function.  Results from my histone transcription reporter suggest that Mxc may 
also have a role in transcribing histone mRNA, which is supported by data from others that 
depletion of this factor results in an overall reduction in histone mRNA levels (Z. Dominski, 
unpublished results).  Because of its localization to the HLB, the effect of its depletion on the 
existence of the MPM-2 reactive epitope, its putative role in transcription, the presence of a 
LisH domain, and the recent finding the MPM-2 antibody directly binds to phosphorylated 
Mxc (White and Duronio, unpublished), Mxc has been suggested to be the Drosophila 
homolog of mammalian NPAT.  Like Mxc, NPAT contains a LisH domain and has a role in 
histone gene transcription and HLB integrity.  Future experiments will determine whether 
these two proteins are indeed orthologous. 
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THE USE OF REPORTERS TO CHARACTERIZE THE U7 snRNA PROCESSING 
REACTION 
I also introduced the creation of U7 snRNA reporters to probe snRNA 3’ end 
formation and these results are shown in Chapter II.  My contribution to this project came on 
the heels of Eric’s genome-wide screen for U7 pre-snRNA processing factors.  In this screen, 
he used a U7 pre-snRNA processing reporter construct akin to the histone pre-mRNA 
processing reporter used in the earlier screen.    
In addition to Eric’s screen for processing factors, I created a number of new 
reporters in an effort to better define the cis elements that are required for properly 
processing U7 pre-snRNA.  Through these experiments, I discovered that the U7 promoter 
sequence is required for maximally efficient pre-snRNA processing, but that a histone 
promoter can be substituted and still give significant amounts of correctly processed U7 
snRNA, while the actin promoter is completely inactive in supporting U7 snRNA processing.  
This is in agreement with previous studies on U1 pre-snRNA processing in sea urchins 
(Wendelburg and Marzluff, 1992), but in contrast to results from vertebrates (Neuman de 
Vegvar et al., 1986; Hernandez and Weiner, 1986; Pilch and Marzluff, 1991), indicating that 
requirements for the snRNA processing reaction differ somewhat between invertebrates and 
vertebrates.  The fact that the histone promoter allows some U7 snRNA processing may be 
related to the fact that the histone genes are the other set of genes transcribed by RNA 
polymerase II that do not encode polyadenylated RNAs. 
I also tested whether U7 pre-snRNA processing has a length dependence, as has been 
seen for mammalian snRNAs.  Indeed, my results indicate that insertions in excess of 300 
nucleotides are sufficient to elicit some level of readthrough.  Again, these data are in 
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agreement with published results revealing that the degree of snRNA misprocessing 
increases as the transcript length increases (Ramamurthy et al., 1996).  Together with the 
promoter data, these experiments reveal important details about the requirements for efficient 
pre-snRNA processing, and Eric has continued to modify the reporter to define elements in 
the snRNA sequence required for efficient cleavage.  I am a co-author on the paper 
describing these studies. 
 
A GENOME-WIDE SCREEN FOR FACTORS REQUIRED FOR HISTONE mRNA 3’ 
END FORMATION 
 One of the most important lines of research to come out of the initial reporter 
experiments was the genome-wide screen for factors that participate in histone pre-mRNA 
processing that Eric and I did (Wagner et al., 2007), which is discussed in Chapter III.  This 
was the first genome-wide screen that targeted RNA metabolism.  This project led to the 
identification of 24 protein factors that appear to have some role in processing histone pre-
mRNA.  Some of these factors, such as SLBP, Lsm10, Lsm11, CPSF73, and Symplekin had 
been described previously, (although two of these, CPSF-73 and Symplekin) were identified 
as we were preparing to do the screen.  Most, however, had not been previously implicated 
and offer us many new research projects for the future. 
 
IDENTIFICATION AND CHARACTERIZTAION OF FLASH AS A HISTONE PRE-
mRNA PROCESSING FACTOR 
 One of the factors that was initially identified in the genome-wide screen, but which 
was not subsequently validated since it scored weakly, was an uncharacterized factor known 
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at the time as CG4616.  This factor was a weak hit in the screen, did not have an obvious 
human homologue, and was not among the top 100 hits that were explored further.  The 
importance of this factor to the cleavage reaction was not suggested again until a yeast-two-
hybrid screen for factors that interact with the N-terminus of Lsm11 was performed by Xiao-
cui Yang and Dr. Zbigniew Dominski.  In their work, they found that human FLASH 
interacts with human Lsm11 and subsequently identified CG4616 as the closest putative 
homolog of the human FLASH protein based upon a region of partial sequence conservation 
in the N-terminus of each protein.  The first functional data implicating that this factor plays 
an essential role in processing histone pre-mRNA came from my experiments using the 
constitutively expressed histone pre-mRNA processing reporter.  Using RNA interference to 
deplete CG4616 from Drosophila cultured cells stably expressing the processing reporter 
construct gave robust fluorescence off the reporter at levels comparable to that elicited by 
depletion of core processing factors, such as SLBP or Lsm11.  The strength of the 
fluorescence signal indicated that CG4616 most likely had a direct role in the processing 
reaction.  Significantly, the results from the reporter accurately reflect the response of the 
endogenous histone message upon depletion of CG4616.  Using RT-PCR, I determined that 
endogenous histone mRNAs were being misprocessed upon depletion of CG4616.  In 
addition to the misprocessing phenotype, I also addressed whether this factor has any role in 
transcription of histone genes, as had been suggested for human FLASH.  Contrary to these 
suggestions, CG4616 did not have any effect on expression off of a histone transcription 
reporter I created, nor was there an effect on overall endogenous histone levels.  This 
indicated that this factor is not involved in transcribing histone genes.  Further work by Xiao 
and Zbig revealed that this protein is, however, required for processing histone message in 
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vitro, again suggesting that it directly participates in the cleavage reaction.  Based upon the 
accumulated evidence, CG4616 was dubbed dFLASH. 
 Upon identification of dFLASH as an essential histone pre-mRNA processing factor 
that interacted with Lsm11,  I defined the region of dFLASH that binds dLsm11 and define at 
least one obligate binding region between amino acids 125-130, as well as potential 
accessory regions slightly upstream and slightly downstream of these residues.  In addition I 
identified the specific amino acids in dLsm11 required to bind dFLASH, a region of 
interaction that includes several conserved residues between amino acids 20-34 present in 
human and Drosophila.  Significantly, the interaction between dFLASH and dLsm11 does 
not require all of the conserved residues in this region, but rather, three distinct patches that 
are separated from each other by intervening conserved residues that are not involved in 
binding dFLASH.  This suggests the contribution of some level of secondary structure in the 
binding interaction in which binding occurs on one face of the structure, while the other is 
reserved for some other function.  That the residues in this region not involved in binding 
dLsm11 are well conserved through evolution suggests their importance, though their precise 
role is unknown.  In addition, I used deletion constructs to determine that, while the region 
from amino acids 1-40 is necessary for binding to dFLASH, it is not sufficient for binding to 
occur.  Based upon these results, it now seems that there are residues between amino acids 
40-78 that are required for binding, though their identity is presently unknown. 
 In addition to refining the definition of the binding regions of dFLASH and dLsm11, 
I also addressed the requirement of dLsm11 binding for dFLASH recruitment to the Histone 
Locus Body (HLB).  Using V5-tagged dFLASH mutants, I found that deletion of the N-
terminus of dFLASH up to amino acid 166, which includes the region responsible for 
232 
 
binding dLsm11, did not affect the ability of dFLASH to localize to the HLB.   These results 
indicate that dFLASH is recruited to the HLB independently of dLsm11 through the 
interaction of a region downstream of amino acid 166 with an unknown factor.  It is possible 
that the region between amino acid 166-177, which contains at least a few relatively 
conserved residues, may be involved in this interaction.  Equally plausible is that recruitment 
requires a region well downstream of this, though upstream of amino acid 733, since deletion 
of amino acids 734-844 has no effect on localization.  Future experiments will include the 
creation of N-terminal and C-terminal deletion mutants to better define where this 
recruitment domain may lie. 
 One of the most surprising results to come out of this study was the finding that 
deleting the first 77 amino acids from the N-terminus of dFLASH results in significant 
fluorescence off the constitutive histone pre-mRNA processing reporter even in the presence 
of wild-type FLASH, identifying this protein as an inhibitor of processing and a dominant 
negative.  Importantly, deletion of these residues results in a dFLASH protein that can still 
localize to the HLB and still bind dLsm11.  These results suggest a model in which this 
protein localizes to the HLB, where it interacts with dLsm11, but is unable to stimulate 
processing of the histone pre-mRNA because it cannot bind to another key factor(s) which is 
as yet unknown.  Whether these residues bind some other factor or whether they are a target 
for some modification that activates the dFLASH/dU7 snRNP particle is unclear.  It is 
possible that this region is required for recruitment of the cleavage factor or for converting 
the naturally exonucleolytic CPSF73 into an endonuclease once it has arrived at the cleavage 
site.  In the case of the former, cleavage will not occur because the nuclease is not available 
to make the cut.  If the latter is the case, deleting this region of dFLASH would result in 
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assembly of the cleavage machinery, but in an inactive form.  In this event, cleavage does not 
occur, thus allowing for the use of downstream polyadenylation signals.  At this juncture, the 
precise mechanism of cleavage factor recruitment and activation remains unknown, as does 
the seemingly crucial role of FLASH in these processes. 
 
FINAL REMARKS AND FUTURE DIRECTIONS 
 At the beginning of my research, the general mechanism of histone pre-mRNA 
processing was known and a few of the key components were described in relative detail.  
Included among the known core processing factors were the stem loop binding protein 
(SLBP) and the U7 snRNP components, Lsm10, Lsm11, and, in mammals, ZFP100.  
However, little else was known, including the identity of the nuclease that cleaves the histone 
pre-mRNA or any other factors that are required for processing. 
 Our current knowledge about the processing reaction, now several years later, has 
been dramatically transformed by several key observations by us and others.  Among the 
highlights are the identification of CPSF73 as the histone pre-mRNA endonuclease 
(Dominski et al., 2005), the definition of components of the core cleavage factor, including 
CPSF73, CPSF100, and Symplekin (Kolev and Steitz, 2005; Wagner et al., 2007; Sullivan et 
al., 2009), the identification of several novel processing factors using a genome-wide RNAi 
screen (Wagner et al., 2007), and the identification and characterization of FLASH as an 
essential component of the processing machinery in mammals and flies (Yang et al., 2009).  I 
have been privileged to be a part of much of this work and am excited about the prospects for 
the future that have been made possible by these studies. 
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 Among the new directions for study made possible by this research is the 
characterization of the remaining proteins identified in the genome-wide screen for histone 
pre-mRNA processing factors.  The most promising of these include the factors that scored 
strongest in the screen, including MCRS1, MBD-R2, Rack1, and CG17361.  The first three 
of these have been characterized as participating in other cellular functions; although, like 
FLASH, this does not preclude them from also particpating in processing.  The last protein, 
CG17361, is an uncharacterized protein that has been suggested bioinformatically as a zinc 
binding protein that binds nucleic acids.  Further work on these factors will determine their 
precise role in the processing reaction. 
 Another aspect of this work that is continuing is refinement of the regions of FLASH 
and Lsm11 that are responsible for binding the other, as well as a determination of the region 
of dFLASH that is responsible for its recruitment to the HLB.  I have developed a system for 
deleting regions of dFLASH and expressing them efficiently in Drosophila cultured cells that 
will allow me to determine the answer to this question.  In addition to deleting the N- and C-
terminal regions, I will also introduce dFLASH protein having point mutations that I have 
shown abolish dLsm11 binding in vitro.  Although these residues are not required for 
dFLASH recruitment, it remains possible that the dU7 snRNP is recruited to the HLB by 
dFLASH and these experiments will allow me to determine if this is the case.  
 Finally, the observation that deletion of the first 77 amino acids from dFLASH results 
in a dominant negative effect on histone pre-mRNA processing when this construct is 
transfected into the processing reporter stable line has given us a great tool for discovering 
inhibitors of processing.  Natural inhibitors can be detected by overexpressing candidate 
proteins in the reporter stable line and looking for increased fluorescence.  This can be done 
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currently in a targeted fashion and is possible on a genome-wide scale given the proper 
overexpression library.  There is an ongoing study by a graduate student in our lab, Ivan 
Sabbath, and Zbigniew Dominski that is investigating proteins that were found to interact 
with the N-terminus of hFLASH uisng the yeast-two-hybrid assay.  To date, dsRNAs 
targeting several of these factors have been synthesized and screened using my processing 
reporter stable line.  None of these factors scored as being required for the processing 
reaction.  However, it remains possible that one or more of these factors may participate in 
inhibiting the cleavage reaction. 
As an extension of these studies, it is now possible to screen thousands of chemical 
compounds to detect chemical inhibitors of histone pre-mRNA processing.  This research 
could lead to new biotherapeutic compounds to be used in human health or alternatively, but 
not mutually exclusively, could identify compounds that researchers could use to inhibit the 
processing reaction in a targeted and more efficient way than is currently possible.  At the 
present time, we do not have the capability to perform such targeted inhibition outside of 
RNAi depletion of required processing factors or overexpression of the dominant negative 
dFLASH construct.  The identification of such an inhibitory compound would allow us to 
study the mechanisms that work to inhibit processing and the downstream implications of 
misprocessing histone mRNA without having to mutate or deplete any processing factors, 
thus eliminating possible indirect, or secondary effects. 
In conclusion, the research presented here has helped fill in many gaps in our 
knowledge about RNA processing and, especially, histone pre-mRNA processing.  It has also 
given us invaluable tools that we can now use to discover other aspects of the reaction, 
including a definition of all of the factors that are involved in promoting and inhibiting it.  
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Several questions have now been answered, but even more have been raised, giving me and 
others many possible avenues to pursue in our efforts to achieve a more complete 
understanding of this critical cellular process. 
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Figure 5-1. Model of dFLASH function in histone pre-mRNA processing.  Shown is one 
of several possible models outlining the importance of the first 77 amino acids of dFLASH 
for histone pre-mRNA processing. Under normal conditions (left panel), dFLASH is 
recruited to the HLB, where it binds the U7 snRNP through interactions with Lsm11.  This 
interaction requires amino acids 105-154 of dFLASH.  dFLASH is then able to recruit an 
unknown factor “X,” which, in this model, is associated with the cleavage factor, to near the 
site of cleavage.  This interaction requires the first 77 amino acids of dFLASH.  Once 
localized to the cleavage site, the cleavage factor is able to cleave the histone pre-mRNA to 
form a normal, mature histone mRNA with the stem loop and a 4 nt ssRNA tail at its 3’ end.  
However, when the first 77 amino acids are deleted from the dFLASH N-terminus (right 
panel), FLASH is still recruited to the HLB, where it interacts with dLsm11, but is unable to 
interact with factor “X.”  As a result, the cleavage factor is not recruited to the cleavage site 
and the histone pre-mRNA is not cleaved properly.  Instead, a downstream poly(A) signal is 
recognized by the canonical cleavage and polyadenylation machinery and the histone pre-
mRNA is cleaved after this signal and polyadenylated.    Abbreviations:  HLB = Histone 
Locus Body; snRNP = small nuclear ribonucleoprotein; Lsm = Sm-like; nt = nucleotide; 
ssRNA = single-stranded RNA; poly(A) = polyadenylation. 
238 
 
 
 
 
239 
 
 
Appendix A: Initial hits from the genome-wide screen for histone pre-mRNA 
processing factors 
 
This appendix contains a table of all factors that scored positively in the genome-wide 
screen for factors that participate in histone pre-mRNA processing, described in Chapter III.  
Those factors that were validated in the initial study (Wagner et al., 2007) are highlighted in 
green.  The Drosophila FLASH homolog, CG4616, which was validated after the initial 
study (Yang et al., 2009), is highlighted in yellow.  “Strength of Hit” is how strongly positive 
the factor was by visual inspection of GFP signal, with 3 being a strong hit, 2 being a 
moderate hit, and 1 being a weak hit.  Each factor was graded independently by Dr. Eric J. 
Wagner and me and the results combined, followed by a final scoring based upon the 
combined list.  Note that these designations were further refined for the validated factors in 
the final report (Wagner et al., 2007; Chapter III), but this is not reflected here.  “DRSC 
Amplicon” identifies the specific dsRNA from the genome-wide dsRNA library used at the 
Drosophila RNAi Screening Center.  More information about each amplicon can be accessed 
online at http://www.flyrnai.org.  “Gene” designates the CG number or abbreviated name of 
the postively-scoring gene, while “Gene Name” gives the full name.  If a factor has a 
predicted human homolog, it is indicated in the “Human Homolog” column.  Any protein 
domains indicated by bioinformatics are listed under “Protein Domains.” 
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Strength of Hit DRSC Amplicon Gene Gene Name Human Homolog Protein Domains 
3 DRSC14146 CG1957 CG1957 CPSF2/CPSF100 
RNA-metabolising metallo-
beta-lactamase, Beta-
lactamase-like 
3 DRSC03555 kuz kuzbanian ADAM10 
Peptidase M12B, 
ADAM/reprolysin, 
Disintegrin, Peptidase M, 
neutral zinc metallopeptidases, 
zinc-b 
3 DRSC06250 CG12938 CG12938 Lsm10   
3 DRSC06238 CG12924 CG12924 Lsm11   
3 DRSC11726 CG14565 CG14565     
3 DRSC16764 Or85a 
Odorant 
receptor 85a   Olfactory receptor, Drosophila 
3 DRSC16393 CG8165 CG8165 JMJD1B 
Transcription factor jumonji, 
jmjC, Cupin region 
3 DRSC16291 CG7698 CG7698 CPSF3/CPSF73 
Beta-lactamase-like, RNA-
metabolising metallo-beta-
lactamase 
3 DRSC16863 Slbp 
Stem-loop 
binding 
protein SLBP   
3 DRSC20522 CG15450 CG15450   
Phospholipid/glycerol 
acyltransferase 
2 DRSC03223 CG9466 CG9466   
Glycosyl hydrolases 38, C-
terminal, Galactose 
mutarotase-like, Glycoside 
hydrolase, family 38 
2 DRSC02771 CG4705 CG4705 WDR59 
WD-40 repeat, Nitrous oxide 
reductase, N-terminal, RWD 
2 DRSC01987 CG4778 CG4778   Chitin binding Peritrophin-A 
2 DRSC02781 CG31743 CG31743 CHST11 
Chondroitin 4-O-
sulfotransferase 
2 DRSC02112 CG10949 CG10949   
MADF, HMG-I and HMG-Y, 
DNA-binding 
2 DRSC02441 CG15141 CG15141 C14orf130 
Zn-finger (putative), N-
recognin, Zn-finger-like, PHD 
finger 
2 DRSC08180 CG1135 CG1135 MCRS1 
SMAD/FHA, Forkhead-
associated 
2 DRSC12301 CG2097 CG2097 SYMPK HEAT, Armadillo-like helical 
2 DRSC16702 His2Av 
Histone H2A 
variant H2AFV 
Histone-fold, Histone core, 
Histone-fold/TFIID-TAF/NF-
Y, Histone H2A 
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2 DRSC08603 CG7955 CG7955 ABCB7 
ABC transporter, 
transmembrane region, type 1, 
AAA ATPase, ABC 
transporter, transmembrane 
region, ABC transporter 
related 
2 DRSC10550 mib1 mind bomb 1 MIB1 
Zn-finger, ZZ type, Zn-finger, 
RING, Ankyrin, Mib_herc2 
2 DRSC09954 CG13071 CG13071     
2 DRSC11651 CG11310 CG11310   Insect cuticle protein 
2 DRSC11873 Pc Polycomb   Chromo 
2 DRSC11850 CG32441 CG32441     
2 DRSC16537 CG9684 CG9684   
Maternal tudor protein, Tudor, 
Zn-finger, MYND type 
2 DRSC14365 CG31454 CG31454     
2 DRSC14180 MBD-R2 MBD-R2   
Tudor, Zn-finger, C2H2 type, 
Zinc-finger protein 
THAP_DM3, Zn-finger-like, 
PHD finger, Methyl-CpG 
binding 
2 DRSC15587 CG4509 CG4509   
Sugar transporter superfamily, 
Cadherin 
2 DRSC16015 Bruce Bruce BIRC6 
Cytochrome cd1-nitrite 
reductase-like, C-terminal h, 
WD40-like, Proteinase 
inhibitor I32, inhibitor of 
apoptosis, Ubiquitin-
conjugating enzymes 
2 DRSC14531 dpr4 dpr4     
2 DRSC16914 bon bonus   
B-box, C-terminal, Zn-finger-
like, PHD finger, Zn-finger, 
RING, Bromodomain, Zn-
finger, B-box, FYVE/PHD 
zinc finger 
2 DRSC15843 CG5611 CG5611   
Enoyl-CoA 
hydratase/isomerase 
2 DRSC17217 activin-beta activin-beta   
Transforming growth factor 
beta, Inhibin, alpha subunit 
2 DRSC17861 sdt stardust MPP5 
Variant SH3, Guanylate 
kinase/L-type calcium channel 
region, Guanylate kinase, L27, 
SH3, PDZ/DHR/GLGF 
2 DRSC18774 flw flap wing PPP1CB 
Serine/threonine-specific 
protein phosphatase and b, 
Metallophosphoesterase 
2 DRSC19605 CG1492 CG1492   
Gamma-
glutamyltranspeptidase 
2 DRSC17855 CG32694 CG32694     
2 DRSC07817 HDC07662       
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2 DRSC09492 
HDC16776, 
etc.       
2 DRSC12755 HDC12763        
2 DRSC12767 tws twins   
Protein phosphatase 2A 
regulatory subunit PR55, WD-
40 repeat, WD40-like 
2 DRSC12434 HDC12200       
2 DRSC13229 HDC14118        
2 DRSC21138 HDC20527        
2 DRSC20317 caz cabeza FUS 
Eggshell protein, Zn-finger, 
Ran-binding, RNA-binding 
region RNP-1 (RNA 
recognition motif) 
2 DRSC01832 HDC03525        
2 DRSC22111 CG32663 CG32663 BCAS3 WD40-like 
2 DRSC21257         
2 DRSC23205 CG13894 CG13894   
Homeodomain-like, Zinc-
finger protein THAP_DM3, 
Centromere protein B, DNA-
binding region 
1 DRSC07116 CG8233 CG8233 FLJ10081   
1 DRSC08699 Shab 
Shaker 
cognate b KCNB1 
Ion transport protein, Cation 
channel, non-ligand gated, Kv 
channel, Kv9 voltage-gated 
K+ channel, K+ channel 
tetramerisation, Voltage-
dependent potassium channel, 
K+ channel, pore region 
1 DRSC08450 Fit1 Fermitin 1 PLEKHC1 
FERM, Pleckstrin-like, Band 
4.1, Pleckstrin homology-type 
1 DRSC10929 Ect4 Ect4   
Armadillo-like helical, Sterile 
alpha motif homology 2, 
Sterile alpha motif homology, 
Sterile alpha motif SAM, TIR 
1 DRSC09787 CG10724 CG10724 WDR1 
Nitrous oxide reductase, N-
terminal, WD-40 repeat 
1 DRSC11324 asf1 
anti-silencing 
factor 1 ASF1A 
Anti-silencing protein, ASF1-
like 
1 DRSC10847 AGO2 Argonaute 2   
Stem cell self-renewal protein 
Piwi, Argonaute and Dicer 
protein, PAZ 
1 DRSC17089 trx trithorax   
Nuclear protein SET, Zn-
finger, RING, Zn-finger-like, 
PHD finger, SET-related 
region, FY-rich, N-terminal, 
FY-rich, C-terminal 
1 DRSC16253 CG7518 CG7518   Myb, DNA-binding 
1 DRSC16731 MRG15 MRG15 MORF4L1 MRG 
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1 DRSC14613 Orct2 
Organic cation 
transporter 2 SLC22A4 
Major facilitator superfamily, 
Major facilitator superfamily 
MFS_1 
1 DRSC14257 CG10562 CG10562   
Protein of unknown function 
DUF227, Protein kinase-like 
1 DRSC16791 Pkc98E 
Protein C 
kinase 98E PRKCE 
Protein kinase-like, 
Serine/threonine protein 
kinase, active site, 
Serine/threonine protein 
kinase, Protein kinase C, 
phorbol ester/diacylglycerol 
bind, Protein kinase, C-
terminal, Protein kinase 
1 DRSC16676 Fur1 Furin 1 FURIN 
Proteinase inhibitor, 
propeptide, Galactose-binding 
like, Furin-like repeat, 
Proprotein convertase, P, 
Peptidase S8 and S53, 
subtilisin, kexin, sedolisin, 
Growth factor, receptor 
1 DRSC18568 CG14782 CG14782 PLEKHF2 
Pleckstrin homology-type, 
FYVE/PHD zinc finger, 
Pleckstrin-like, Zn-finger, 
FYVE type 
1 DRSC18512 CG32810 CG32810 KCTD5 
BTB/POZ, K+ channel 
tetramerisation 
1 DRSC15434 CstF-50 CstF-50 CSTF1 WD40-like, WD-40 repeat 
1 DRSC17002 Dr Drop   
Homeodomain-like, 
Homeobox 
1 DRSC16948 ferrochelatase ferrochelatase FECH Ferrochelatase 
1 DRSC17163 Crk Crk CRKL SH2 motif, SH3, Variant SH3 
1 DRSC18775 fs(1)K10 
female sterile 
(1) K10     
1 DRSC17148 MED26 
Mediator 
complex 
subunit 26   
Transcription factors TFIIS, 
elongin A, CRSP70, con, 
Flagellar basal body rod 
protein 
1 DRSC17202 CG11148 CG11148     
1 DRSC16671 Fer1HCH 
Ferritin 1 
heavy chain 
homologue   
Ferritin, Ferritin and Dps, 
Ferritin-like, 
Ferritin/ribonucleotide 
reductase-like 
1 DRSC19326 Actr13E 
Actin-related 
protein 13E ACTR6 Actin/actin-like 
1 DRSC19442 CG12204 CG12204     
1 DRSC19906 CG32573 CG32573     
1 DRSC03405 Rack1 
Receptor of 
activated 
protein kinase 
C 1 GNB2L1 
Nitrous oxide reductase, N-
terminal, WD-40 repeat 
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1 DRSC04547 Phk-3 Pherokine 3   
Insect pheromone-binding 
protein A10/OS-D 
1 DRSC06649 CG17048 CG17048   Zn-finger, RING 
1 DRSC07695 san 
separation 
anxiety MAK3 
GCN5-related N-
acetyltransferase 
1 DRSC07026 CG7639 CG7639 SAMM50 
Bacterial surface antigen 
(D15) 
1 DRSC06375 CG13338 CG13338     
1 DRSC07575 RacGAP50C RacGAP50C RACGAP1 
Rho GTPase activation 
protein, Protein kinase C, 
phorbol ester/diacylglycerol 
bind, RhoGAP 
1 DRSC06312 Rep3 Rep3   
Caspase-activated nuclease 
CIDE-N 
1 DRSC07715 vg vestigial   
Vestigial/tondu, Protein of 
unknown function TDU, 
Tubulin 
1 DRSC07170 HDC06345       
1 DRSC06267 CG30089 CG30089     
1 DRSC07014 CG7097 CG7097 MAP4K3 
Protein kinase, Citron-like, 
Serine/threonine protein 
kinase, Protein kinase-like 
1 DRSC06008 CG10911 CG10911     
1 DRSC06928 CG5267 CG5267   
EGF-like, Cysteine-rich TIL 
region 
1 DRSC08374 CG34056 CG34056     
1 DRSC06393 l(2)05510 
lethal (2) 
05510   Endoglin/CD105 antigen 
1 DRSC08240 CG12038 CG12038     
1 DRSC08379 bab1 bric a brac 1   
Helix-turn-helix, Psq-like, 
Helix-turn-helix, Psq, HMG-I 
and HMG-Y, DNA-binding, 
BTB/POZ 
1 DRSC06037 CG11110 CG11110 IMMP2L 
Peptidase S24 and S26, C-
terminal region, Peptidase 
S26A, signal peptidase I, 
Peptidase S24, S26A and 
S26B 
1 DRSC08195 CG32269 CG32269   
Peptidase, trypsin-like serine 
and cysteine proteas, 
Peptidase S1A, chymotrypsin, 
Peptidase S1, chymotrypsin 
1 DRSC05988 CG33786 CG33786   
SUA5/yciO/yrdC, N-terminal, 
Sua5/YciO/YrdC/YwlC 
1 DRSC08619 CG9094 CG9094     
1 DRSC08674 LysC, LysD 
LysC: 
Lysozyme C, 
LysD: 
Lysozyme D LYZ   
1 DRSC06403 CG13443 CG13443     
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1 DRSC08222 CG12014 CG12014 IDS Sulfatase 
1 DRSC07772 CG17510 CG17510     
1 DRSC08334 CG13800 CG13800     
1 DRSC08444 Gr64b 
Gustatory 
receptor 64b   Trehalose receptor 
1 DRSC08739 trh trachealess NPAS3 
Helix-loop-helix DNA-
binding, Basic helix-loop-
helix dimerization region 
bHLH, Legume lectin, beta 
domain, PAS 
1 DRSC08362 Cypl 
Cyclophilin-
like PPIL1 
Peptidyl-prolyl cis-trans 
isomerase, cyclophilin ty 
1 DRSC08359 CG13889 CG13889 KIAA0373 
Haem peroxidase, 
plant/fungal/bacterial 
1 DRSC08198 CG32271 CG32271   
Peptidase, trypsin-like serine 
and cysteine proteas, 
Peptidase S1, chymotrypsin, 
Peptidase S1A, chymotrypsin 
1 DRSC08590 CG7447 CG7447 EGFL7 
EMI, EGF-like calcium-
binding, Aspartic acid and 
asparagine hydroxylation site, 
EGF-like, EGF-like, subtype 2 
1 DRSC11020 CG8620 CG8620     
1 DRSC10672 CG6600 CG6600   
Major facilitator superfamily 
MFS_1, Major facilitator 
superfamily 
1 DRSC10745 CG6902 CG6902     
1 DRSC08321 CG13712 CG13712     
1 DRSC10567 Nelf-E 
Negative 
elongation 
factor E   
RNA-binding region RNP-1 
(RNA recognition motif) 
1 DRSC09775 CG10674 CG10674 PTD008 
Protein of unknown function 
UPF0139 
1 DRSC10663 CG6576 CG6576     
1 DRSC09765 CG32423 CG32423 RBMS3 
RNA-binding region RNP-1 
(RNA recognition motif), 
Paraneoplastic 
encephalomyelitis antigen 
1 DRSC11329 bol boule BOLL 
RNA-binding region RNP-1 
(RNA recognition motif) 
1 DRSC10420 
CG4446, 
Klp67A 
Klp67A: 
Kinesin-like 
protein at 67A, 
CG4446: 
CG4446 PDXK 
Klp67A: Kinesin, motor 
region, CG4446: PfkB, 
CG4446: Pyridoxal kinase 
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1 DRSC09740 sti sticky CIT 
Protein kinase, Protein kinase, 
C-terminal, Citron-like, 
Protein kinase C, phorbol 
ester/diacylglycerol bind, 
Serine/threonine protein 
kinase, Serine/threonine 
protein kinase, active site, 
Protein kinase-like 
1 DRSC10579 CG6071 CG6071   
Peptidase M1, membrane 
alanine aminopeptidase 
1 DRSC10642 CG33493 CG33493     
1 DRSC10148 CG32070 CG32070     
1 DRSC11240 Or67a 
Odorant 
receptor 67a   
Olfactory receptor, 
Drosophila, PAP/25A core 
1 DRSC09831 CG11262 CG11262   Citrate transporter 
1 DRSC10791 CG7257 CG7257   
AAA ATPase, central region, 
26S proteasome subunit P45, 
AAA-protein subdomain, 
AAA ATPase, Nucleic acid-
binding OB-fold 
1 DRSC10788 CG7248 CG7248   Chitin binding Peritrophin-A 
1 DRSC10260 CG17300 CG17300     
1 DRSC10166 CG14165 CG14165     
1 DRSC10697 CG6707 CG6707 TMEM55B   
1 DRSC09784 CG10710 CG10710     
1 DRSC10584 CG33270 CG33270     
1 DRSC10266 CG17361 CG17361   Zn-finger, C2H2 type 
1 DRSC10027 CG32138 CG32138 FMNL2 
Diaphanous GTPase-binding, 
Diaphanous FH3, Actin-
binding FH2 
1 DRSC11379 nuf nuclear fallout RAB11FIP4   
1 DRSC10435 CG4613 CG4613   
Peptidase, trypsin-like serine 
and cysteine proteas, 
Peptidase S1A, chymotrypsin, 
Peptidase S1, chymotrypsin 
1 DRSC11129 shd shade   
Cytochrome P450, E-class 
P450, group I 
1 DRSC10018 CG13474 CG13474     
1 DRSC09914 CG32159 CG32159     
1 DRSC11115 CkIIalpha-i1 
CKII-alpha 
subunit 
interactor-1   Zn-finger, C2H2 type 
1 DRSC10016 CG13472 CG13472 TDRD3   
1 DRSC10521 CG32187 CG32187   Calycin 
1 DRSC10225 CG16775 CG16775     
1 DRSC09889 BobA 
Brother of 
Bearded A     
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1 DRSC09912 CG13032 CG13032     
1 DRSC11128 Cyp312a1 Cyp312a1   
E-class P450, group IV, 
Cytochrome P450 
1 DRSC11140 Dab Disabled   
Pleckstrin homology-type, 
Phosphotyrosine interaction 
region, Peptidase, eukaryotic 
cysteine peptidase active sit, 
Fumarate lyase 
1 DRSC10494 CG5235 CG5235   
PHM/PNGase F Fold, Copper 
type II, ascorbate-dependent 
monooxygenase, DOMON, 
Dopamine-beta-
monooxygenase 
1 DRSC10503 CG5389 CG5389   
H+-transporting two-sector 
ATPase, alpha/beta subun, 
ATP synthase F1, beta 
subunit, H+-transporting two-
sector ATPase, alpha/beta 
subun, H+-transporting two-
sector ATPase, alpha/beta 
subun, AAA ATPase 
1 DRSC10008 CG13461 CG13461     
1 DRSC10334 CG18649 CG18649     
1 DRSC10048 CG13699 CG13699     
1 DRSC11221 
Met75Cb, 
Met75Ca 
Met75Cb: 
Met75Cb, 
Met75Ca: 
Met75Ca     
1 DRSC10922 CG7841 CG7841     
1 DRSC10074 CG14057 CG14057     
1 DRSC10662 HDC10619        
1 DRSC10730 CG6856 CG6856 DTNBP1   
1 DRSC10805 CG7306 CG7306   
Chitin binding Peritrophin-A, 
Blue (type 1) copper domain 
1 DRSC09849 CG11619 CG11619     
1 DRSC11707 CG14450 CG14450     
1 DRSC11706 SPoCk 
Secretory 
Pathway 
Calcium 
atpase ATP2C1 
Haloacid dehalogenase-like 
hydrolase, Cation transporting 
ATPase, C-terminal, Calcium-
transporting P-type ATPase, 
PMR1-type, ATPase, E1-E2 
type, Cation transporting 
ATPase, N-terminal, H+ 
transporting ATPase, proton 
pump, E1-E2 ATPase-
associated region 
1 DRSC10083 CG14079 CG14079     
1 DRSC11605 Aef1 
Adult 
enhancer 
factor 1   Zn-finger, C2H2 type 
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1 DRSC10092 CG14088 CG14088   
Peptidase S1, chymotrypsin, 
Peptidase, trypsin-like serine 
and cysteine proteas 
1 DRSC11695 CG13247 CG13247     
1 DRSC11784 CG5847 CG5847   
Endoglin/CD105 antigen, 
YLP motif 
1 DRSC11855         
1 DRSC11843 CG7634 CG7634     
1 DRSC11757 CG4825 CG4825 PTDSS1 Phosphatidyl serine synthase 
1 DRSC11737 ORMDL ORMDL ORMDL3 ORMDL 
1 DRSC11645 CG11249 CG11249   
Pyruvate kinase, Pyruvate 
kinase, beta-barrel-like 
1 DRSC11068 CG9372 CG9372   
Peptidase S1A, chymotrypsin, 
Disulfide knot CLIP, 
Peptidase, trypsin-like serine 
and cysteine proteas, 
Peptidase S1, chymotrypsin 
1 DRSC11856 CG11489 CG11489   
Protein kinase, 
Serine/threonine protein 
kinase, active site, Protein 
kinase-like 
1 DRSC11659 CG11437 CG11437   
Acid phosphatase/vanadium-
dependent haloperoxidase, 
Phosphoesterase, PA-
phosphatase related 
1 DRSC11900 Trxr-2 
thioredoxin 
reductase 2 TXNRD2 
FAD-dependent pyridine 
nucleotide-disulfide oxidore, 
Pyridine nucleotide-disulfide 
oxidoreductase dimeri, 
Thioredoxin and glutathione 
reductase selenoprotein, 
Pyridine nucleotide-disulfide 
oxidoreductase, class, 
Mercuric reductase, NAD-
binding site 
1 DRSC11716 CG33766 CG33766     
1 DRSC12215 CG12589 CG12589     
1 DRSC16451 CG8866 CG8866 SCAMP2 
Protein kinase-like, 
Serine/threonine protein 
kinase, active site, MIT, 
Serine/threonine protein 
kinase, Tyrosine protein 
kinase, Protein kinase 
1 DRSC14959 CG14739 CG14739   
Ubiquitin-conjugating 
enzymes 
1 DRSC15649 Tctp 
Translationally 
controlled 
tumor protein TPT1 
Mss4-like, Translationally 
controlled tumor protein, 
Transposase, IS4 
1 DRSC15253 CG17721 CG17721     
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1 DRSC14179 CG10041 CG10041   
Peptidase, trypsin-like serine 
and cysteine proteas, 
Peptidase S1A, chymotrypsin, 
Peptidase S1, chymotrypsin 
1 DRSC15346 GstD10 
Glutathione S 
transferase 
D10   
Glutathione S-transferase, N-
terminal, Glutathione S-
transferase, C-terminal-like, 
Glutathione S-transferase, C-
terminal 
1 DRSC16688 GstD7 
Glutathione S 
transferase D7   
Glutathione S-transferase, C-
terminal-like, Glutathione S-
transferase, C-terminal, 
Glutathione S-transferase, N-
terminal 
1 DRSC17072 stich1 sticky ch1   
Helix-loop-helix DNA-
binding, Orange, Basic helix-
loop-helix dimerization region 
bHLH 
1 DRSC14927         
1 DRSC15390         
1 DRSC16415 Pnn Pinin PNN Pinin/SDK/memA protein 
1 DRSC15163 CG16908 CG16908 KIAA0406   
1 DRSC14940 CG14717 CG14717   
Esterase/lipase/thioesterase, 
Alpha/beta hydrolase fold 
1 DRSC14331 CG11598 CG11598   
Alpha/beta hydrolase fold, 
AB-hydrolase associated 
lipase region, 
Esterase/lipase/thioesterase, 
Lipase, active site 
1 DRSC15861 CG5724 CG5724   
UDP-glucuronosyl/UDP-
glucosyltransferase 
1 DRSC14845 beat-Vb beat-Vb   
Immunoglobulin-like, 
Immunoglobulin subtype 
1 DRSC15011 CG14889 CG14889   
Collagen helix repeat, 
Collagen triple helix repeat 
1 DRSC16854 Scp2 
Sarcoplasmic 
calcium-
binding 
protein 2   
EF-Hand type, Calcium-
binding EF-hand 
1 DRSC14538 CG12783 CG12783   
Major facilitator superfamily, 
General substrate transporter 
1 DRSC14106 Actn3 alpha actinin 3   Calponin-like actin-binding 
1 DRSC16423 wntD 
wnt inhibitor 
of Dorsal   
Secreted growth factor Wnt 
protein, Wnt superfamily 
1 DRSC16333 CG7886 CG7886     
1 DRSC14403 CG31183 CG31183 NPR2 
Natriuretic peptide receptor, 
N-terminal, Protein kinase-
like, Extracellular ligand-
binding receptor, Protein 
kinase, Guanylate cyclase 
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1 DRSC16821 Rh2 Rhodopsin 2 OPN4 
Rhodopsin-like GPCR 
superfamily, Opsin, Opsin 
RH1/RH2 
1 DRSC14772 CG14292 CG14292     
1 DRSC15283 CG17836 CG17836   
HMG-I and HMG-Y, DNA-
binding 
1 DRSC14798 tinc tincar     
1 DRSC15109 CG31209 CG31209     
1 DRSC15708 CG5060 CG5060     
1 DRSC16224 Rim Rim   
C2 calcium/lipid-binding 
region, CaLB, 
PDZ/DHR/GLGF, C2 
1 DRSC15740 CG5217 CG5217     
1 DRSC15714 Sirt2 Sirt2 SIRT2 
Silent information regulator 
protein Sir2 
1 DRSC17090 tsl torso-like   
Membrane attack complex 
component/perforin/compleme 
1 DRSC14760 CG31212 CG31212 INOC1 
DEAD/DEAH box helicase, 
N-terminal, SNF2-related, 
Helicase, C-terminal 
1 DRSC16371 CG31241 CG31241 NCOA6IP   
1 DRSC14506 CG18600 CG18600     
1 DRSC15113 CG31203 CG31203     
1 DRSC14701 CG31160 CG31160   
FLYWCH Zn-finger, 
BTB/POZ 
1 DRSC15220 Obp93a 
Odorant-
binding 
protein 93a   
Pheromone/general odorant 
binding protein, PBP/GOBP 
1 DRSC16149 CG6954 CG6954 ANKFN1 
Ankyrin, Fibronectin, type III, 
RA 
1 DRSC16781 OstStt3 
Oligosaccharyl 
transferase 3 SIMP 
Phosphopantetheine 
attachment site, 
Oligosaccharyl transferase, 
STT3 subunit 
1 DRSC14678 CG13828 CG13828     
1 DRSC17084 tld tolloid   
Peptidase M, neutral zinc 
metallopeptidases, zinc-b, 
EGF-like, Peptidase, 
metallopeptidases, CUB, 
Peptidase M12A, astacin, 
Aspartic acid and asparagine 
hydroxylation site, EGF-like, 
subtype 2, EGF-like calcium-
binding 
1 DRSC14437 CG11913 CG11913   
NADH dehydrogenase I, D 
subunit, NADH-ubiquinone 
oxidoreductase, chain 49kDa, 
Pectinesterase 
1 DRSC15844 CG5612 CG5612     
1 DRSC14735 CG31080 CG31080     
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1 DRSC15687 CG4963 CG4963 SLC25A37 
Mitochondrial carrier protein, 
Mitochondrial substrate carrier 
1 DRSC14950 PH4alphaEFB 
prolyl-4-
hydroxylase-
alpha EFB P4HA1 
Prolyl 4-hydroxylase, alpha 
subunit, 2OG-Fe(II) 
oxygenase 
1 DRSC15288 CG17856 CG17856 RP11-278E11.2 
Cytochrome bd ubiquinol 
oxidase, 14 kDa subunit 
1 DRSC14864 CG14512 CG14512 GLT28D1   
1 DRSC15505 CG3669 CG3669   
Carbonic anhydrase, 
eukaryotic 
1 DRSC15104 CG15566 CG15566     
1 DRSC18782 gt giant   
Basic leucine zipper, Basic-
leucine zipper (bZIP) 
transcription factor 
1 DRSC18566 CG14780 CG14780   
Peptidase, trypsin-like serine 
and cysteine proteas, 
Peptidase S1A, chymotrypsin, 
Peptidase S1, chymotrypsin 
1 DRSC18832 sgg shaggy GSK3B 
Protein kinase, 
Serine/threonine protein 
kinase, active site, Protein 
kinase-like 
1 DRSC18638 CG14417 CG14417     
1 DRSC18180 mus81 mus81 MUS81   
1 DRSC18642 CG3699 CG3699   
Glucose/ribitol 
dehydrogenase, Short-chain 
dehydrogenase/reductase SDR 
1 DRSC18472 CG14424 CG14424     
1 DRSC18090 CG15784 CG15784     
1 DRSC18045 CG15375 CG15375     
1 DRSC18014 CG15330 CG15330     
1 DRSC17753 CG10761 CG10761     
1 DRSC18691 Or7a 
Odorant 
receptor 7a   Olfactory receptor, Drosophila 
1 DRSC18341 CG4064 CG4064     
1 DRSC18795 mof 
males absent 
on the first MYST1 
Winged helix repressor DNA-
binding, MOZ/SAS-like 
protein 
1 DRSC18357 Ca-alpha1T Ca-alpha1T   
Ion transport protein, Cation 
channel, non-ligand gated, 
Carbamoyl-phosphate 
synthase L chain, ATP-
binding, T-type voltage-
dependent calcium channel 
alpha 1 su, Cation (not K+) 
channel, TM region, 
Glyceraldehyde 3-phosphate 
dehydrogenase, Ca2+/Na+ 
channel, pore region 
1 DRSC17966 CG15034 CG15034     
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1 DRSC17939 CG14446 CG14446 DKFZp761O2018   
1 DRSC18330 CG3898 CG3898     
1 DRSC18430 fh frataxin-like FXN Frataxin, Frataxin-like 
1 DRSC19796 CG1824 CG1824 ABCB8 
ABC transporter, 
transmembrane region, AAA 
ATPase, ABC transporter, 
transmembrane region, type 1, 
ABC transporter related 
1 DRSC17740 Hmr 
Hybrid male 
rescue   MADF 
1 DRSC18439 CG9686 CG9686     
1 DRSC19604 CG1490 CG1490 USP7 
TRAF-like, Peptidase C19, 
ubiquitin carboxyl-terminal 
hydrolas, MATH 
1 DRSC19867 CG2750 CG2750     
1 DRSC19862 CG2574 CG2574   
Ubiquitin-conjugating 
enzymes 
1 DRSC19393 NFAT NFAT   
RHD, p53-like transcription 
factor, DNA-binding, Nuclear 
factor of activated T cells 
(NFAT), Cell surface receptor 
IPT/TIG 
1 DRSC19742 CG15927 CG15927     
1 DRSC19473 CG12609 CG12609     
1 DRSC20472 CG10918 CG10918     
1 DRSC20037 CG7326 CG7326     
1 DRSC21057         
1 DRSC19781 CG17757 CG17757     
1 DRSC19545 CG14190 CG14190     
1 DRSC19546 CG14191 CG14191     
1 DRSC20527 CG15456 CG15456     
1 DRSC20494 CG1304 CG1304   
Peptidase, trypsin-like serine 
and cysteine proteas, 
Peptidase S1A, chymotrypsin, 
Peptidase S1, chymotrypsin 
1 DRSC00105 HDC00355       
1 DRSC00205 HDC00659       
1 DRSC00128 HDC00401       
1 DRSC00217 HDC00689       
1 DRSC00906 CG31643 CG31643 FLJ21901 FAST kinase leucine-rich 
1 DRSC00241 HDC00760       
1 DRSC00922 HDC01071       
1 DRSC00064 HDC00239       
1 DRSC00960 xl6 xl6 SFRS7 
Zn-finger, CCHC type, RNA-
binding region RNP-1 (RNA 
recognition motif) 
1 DRSC00964 HDC01229        
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1 DRSC01261 HDC02204       
1 DRSC01090 HDC01659        
1 DRSC01003 HDC01363       
1 DRSC01101 CG33300 CG33300     
1 DRSC01224 HDC02112        
1 DRSC01345 HDC02404       
1 DRSC01253 HDC02192       
1 DRSC01351 HDC02434       
1 DRSC01454 HDC02642        
1 DRSC01363 HDC02478       
1 DRSC01493 HDC02700       
1 DRSC01687 HDC03210        
1 DRSC01408 HDC02555       
1 DRSC01423 HDC02581        
1 DRSC01436 HDC02612       
1 DRSC01634 HDC03051       
1 DRSC01731 HDC03321       
1 DRSC03903 HDC03986       
1 DRSC01760 
HDC04718, 
etc.       
1 DRSC03920 HDC04033        
1 DRSC03932 HDC04086       
1 DRSC03963 HDC04202       
1 DRSC03988 HDC04256        
1 DRSC03997 HDC04272        
1 DRSC05135 Tom7 
Translocase of 
outer 
membrane 7     
1 DRSC04032         
1 DRSC04753 HDC04678        
1 DRSC05317 HDC05864        
1 DRSC05222 lola 
longitudinals 
lacking   
Aspartate 
carbamoyltransferase, 
regulatory chain, C, Zn-finger, 
C2H2 type, Calcium-binding 
EF-hand, Flagellar basal body 
rod protein, BTB/POZ 
1 DRSC05406 HDC06176        
1 DRSC05259 HDC05705        
1 DRSC05362 HDC06052       
1 DRSC05606 HDC06739       
1 DRSC05702 HDC07069        
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1 DRSC05621 CG30463 CG30463   
Ricin B-related lectin, 
Glycosyl transferase, family 2, 
Ricin B lectin, Putative DNA 
binding 
1 DRSC05717 HDC07110       
1 DRSC05635 HDC06835        
1 DRSC05826 HDC07406       
1 DRSC05647 HDC06896        
1 DRSC05761 HDC07242       
1 DRSC07806 HDC07650       
1 DRSC07928 trio trio TRIO 
Pleckstrin homology-type, 
Spectrin repeat, Pleckstrin-
like, SH3, Cellular 
retinaldehyde-binding)/triple 
function, C-, DH 
1 DRSC07810 CG17082 CG17082     
1 DRSC08782 CG13291 CG13291     
1 DRSC08815 HDC08760       
1 DRSC09098 HDC09594       
1 DRSC09100 
HDC17427, 
etc.       
1 DRSC09104 HDC09602       
1 DRSC09033 HDC09444        
1 DRSC08859 HDC08829       
1 DRSC08889 HDC08951       
1 DRSC09081 HDC09528        
1 DRSC09185 HDC09845       
1 DRSC09188 HDC09850        
1 DRSC09541 HDC10807       
1 DRSC12745 HDC12669       
1 DRSC12784 HDC12851       
1 DRSC12088 HDC12016       
1 DRSC12105 HDC12040       
1 DRSC12938 HDC13300        
1 DRSC12889 HDC13149       
1 DRSC13085 HDC13758       
1 DRSC17699 ptr proximal to raf     
1 DRSC17245 HDC17203       
1 DRSC14069 HDC16604       
1 DRSC20530 CG15459 CG15459     
1 DRSC21158 HDC20545       
1 DRSC08997 CG8177 CG8177 SLC4A3 
HCO3- transporter, eukaryote, 
Anion exchange protein, 
HCO3-transporter 
255 
 
1 DRSC06872 CG4616 CG4616 FLASH   
1 DRSC21826 Bap170 
Brahma 
associated 
protein 170kD ARID2 
Winged helix repressor DNA-
binding, Zn-finger, C2H2 
type, AT-rich interaction 
region 
1 DRSC22142 CG30058 CG30058     
1 DRSC21874 gfzf 
GST-
containing 
FLYWCH 
zinc-finger 
protein   FLYWCH Zn-finger 
1 DRSC22354 CG32299 CG32299     
1 DRSC22112 HDC02243       
1 DRSC04716 slbo 
slow border 
cells   
Basic leucine zipper, Basic-
leucine zipper (bZIP) 
transcription factor 
1 DRSC06545 CG18367 CG18367     
1 DRSC18320 CG3726 CG3726   
Helix-turn-helix, Fis-type, 
HMG-I and HMG-Y, DNA-
binding, BTB/POZ, Helix-
turn-helix, Psq, Helix-turn-
helix, Psq-like 
1 DRSC23345 CycG Cyclin G CCNG2 
Cyclin-like, Cyclin, N-
terminal, Cyclin 
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